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ABSTRACT OF DISSERTATION

BIOSENSING SYSTEMS FOR THE DETECTION OF BACTERIAL QUORUM SENSING
MOLECULES: A TOOL FOR INVESTIGATING BACTERIA-RELATED DISORDERS AND FOOD
SPOILAGE PREVENTION

Quorum sensing enables bacteria to communicate with bacteria of the same or
different species, and to modulate their behavior in a cell-density dependent manner.
Communication occurs by means of small quorum sensing signaling molecules (QSMs)
whose concentration is proportional to the population size. When a QSM threshold
concentration is reached, certain genes are expressed, thus allowing control of several
processes, such as, virulence factor production, antibiotic production, and biofilm
formation. Not only many pathogenic bacteria are known to produce QSMs, but also
QSMs have been identified in some bacteria-related disorders. Therefore, quantitative
detection of QSMs present in clinical samples may be a useful tool in the investigation
and monitoring of bacteria-related diseases, thus prompting the use of QSMs as
biomarkers of disease. Herein, we have developed and utilized whole-cell biosensing
systems and protein based biosensing systems to detect QSMs in clinical samples, such
as, saliva, stool, and bowel secretions. Additionally, since bacteria are responsible for
food spoilage, we employed the developed biosensing systems to detect QSMs in food
samples and demonstrated their applicability for early identification of food
contamination. Furthermore, we have utilized these biosensing systems to screen
antibacterial compounds employed for food preservation, namely, generally regarded as
safe (GRAS) compounds, for their effect on quorum sensing.
Keywords: Whole-cell based biosensing systems, protein based biosensing systems, LuxP
binding protein, Inflammatory bowel disease, Generally recognized as safe compounds
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CHAPTER ONE
INTRODUCTION

Cutting edge scientific and technological research has given rise to a gamut of
new analytical tools that were previously unimaginable. With advancements in genetic
research, an understanding of the workings of DNAs, RNAs, and proteins of prokaryotes
as well as eukaryotes developed. Techniques of molecular biology have been used to
manipulate and investigate these biological elements. A few of these techniques are
Polymerase Chain Reaction (PCR) to amplify and mutate DNA, gel electrophoresis to
purify DNAs and proteins, protein expression and purification techniques to produce
and isolate proteins, southern and northern blotting to quantitatively detect target
genes, and enzyme linked immunosorbent assay (ELISA) for analyte detection.
Subsequently, nucleic acids and proteins as well as entire bacterial cells have been
modified to be used in the design and development of biosensors1-5.
A biosensor is defined as a biological element coupled with a transducer so that
an analyte biospecific recognition event is translated into a measurable output. To date,
a number of biosensors based on proteins and cells as the recognition elements have
emerged, and a few of them have been applied as point of care devices6 and for
environmental monitoring7. Although such biosensing systems offer huge promise in the
management of a variety of disorders, including bacteria related conditions, such as
infections, inflammatory bowel disease (IBD), and cystic fibrosis (CF), their use is still
limited. Furthermore, complexities in the treatment of bacteria related conditions have
1

been on the rise due to the emergence of several antibiotic resistant bacteria and
demand urgent attention for alternative treatment approaches.
Bacterial quorum sensing (QS) — a system of communication among bacteria
that is based on small signaling molecules termed quorum sensing molecules (QSMs) —
may offer an avenue of alternative therapy. In that regard, bacteria are known to
employ QS to control processes, such as virulence factor production and biofilm
formation, in a population size dependent manner; hence, disruption of the bacterial
chatter necessary for pathogenicity may lead to a new way to treat bacterial infections.
Additionally, investigations into bacteria related disorders have led to discoveries
pointing to a role for QS in disease. For instance, QSMs have been identified in clinical
samples of CF patients8,9. Bacterial communities thrive in the human body; it has been
suggested that the number of bacteria in the human body is at least one order of
magnitude higher than the number of human cells. For example, bacteria colonize the
gastrointestinal (GI) tract from mouth to anus and contribute to about 60 percent dry
mass of feces. Usually, a symbiotic relationship exists between the host and the
bacterial flora. However, evidence suggests that there may be changes in the microflora
and host-microbial interactions during the course of disease. A change in the microflora
would also result in alteration of the relative balance of QSMs. Therefore, detection of
QSMs in physiological samples may be a valuable means to evaluate variations in
bacterial composition and serve as a tool for monitoring the disease status and for
investigating the disease mechanisms.

2

The present thesis work is focused on the development and application of
biosensing systems that can be employed to detect QSMs in clinical samples. Different
categories of QSMs exist as described in detail later. Specifically, we developed and
utilized whole cell based biosensing systems to detect the following QSMs: long and
short chain N-acyl homoserine lactones (AHLs) and Autoinducer-2 (AI-2). For that,
several clinical matrices were investigated, including stool, saliva, bowel secretion,
blood serum, and blood plasma. Each type of biological matrix is unique in its
composition and, therefore, needs to be assessed for potential effects that it may exert
on the analytical performance of each whole cell biosensing system.
With progress in the field of biotechnology, which led to important
advancements, such as the large-scale production of recombinant protein drugs and
vaccines, it has also been easier than ever to create biological threats that can be used
in a bioterrorism attack and spread by means of daily utilized food products, such as
milk and beef, thus affecting a larger percentage of the population. Additionally,
bacteria are well known to be responsible for food spoilage. Forty eight million
foodborne illnesses per year are reported in the United States, which leads to elevated
health care costs, with more than a quarter million hospitalizations and more than 3000
deaths per year10. Therefore, there is a need for rapid, easy-to-use, cost-effective
analytical tools for early detection of food decay and prevention of biological food
contamination threats.
To that end, we evaluated the analytical performance of the developed whole
cell biosensing systems in food matrices and employed them for the detection of QSMs
3

in food samples as a method for early detection of bacterial contamination in food. In
addition, we explored a number of Generally Recognized As Safe (GRAS) compounds for
their effect on bacterial QS. The selected compounds are known to inhibit bacterial
growth and, due to their safety, have potential to be employed for food preservation;
however, their mechanisms of action are not fully elucidated. Understanding the
mechanism of action of these compounds would enable targeted preventive measures
in combating bacterial contaminations as well as biological threats.
Lastly, a protein based sensor for the detection of AI-2 was designed and
developed. This sensor relies on the direct interaction of a binding/recognition protein
with a target analyte. Therefore, in addition to being useful for AI-2 detection in
physiological and food samples, it is suitable for binding studies aimed at investigating
and characterizing a variety of compounds able to interfere with QS, including the GRAS
compounds mentioned above and molecules to be explored as new treatments for
bacterial infections. We envision that the availability of a panel of biosensing systems
for detection of QSMs will help augmenting our understanding of bacterial communities
and, thus, facilitate the design of alternative strategies to combat bacteria related
disorders.

Quorum sensing signaling molecules
Bacteria, although single-cell organisms, have complex behavior. One such
behavior relates to the ability of bacterial cells to communicate with their neighboring
cells. This phenomenon was first reported in 1965 by Tomasz11 who described
4

“hormone like activators” that were crucial in the propagation of the Gram-positive
bacterium Streptococcus pneumoniae, which is one of the organisms responsible for
pneumonia pathogenicity in their hosts. Later, in 1970, Hastings et al. observed that the
Gram-negative marine bacterium Photobacterium fischeri produces bioluminescence
only when bacteria reach a certain cellular density in terms of number of cells present,
and speculated that light emission was under a bacterial “control mechanism”. It is now
well understood that bacteria of the same species or of different species communicate
with each other by producing and sensing small chemical molecules in a process termed
as quorum sensing. This phenomenon has been observed in a number of bacteria12, and
it is now understood that by means of QS, bacteria are able to control several processes,
for example bioluminescence, virulence factor production, biofilm formation, antibiotic
production, competence, nodulation, sporulation, clumping, and motility. The small
chemical molecules that bacteria utilize for QS are known as QSMs. By detecting the
QSMs, bacteria can modulate the above mentioned processes in a cell densitydependent manner. For example, in a bacterial infection, bacteria do not produce
virulence factors until they reach a critical population density and, by doing so, they
ensure that they can overwhelm the host’s immune response13.
Several groups of QSMs have been identified, which include AHLs in Gramnegative bacteria and a class of autoinducing peptides (AIPs) in Gram-positive bacteria.
Whereas AHLs and AIPs are species-specific and, therefore, used for intra-species
communication, a third category of molecules, AI-2, has been found in both Grampositive and Gram-negative bacteria, suggesting a potential role in inter-species
5

communication within bacteria14. Table 1 lists some of these signaling molecules and
the bacteria that use them in cell-to-cell communication. Briefly, AIPs are peptides
ranging from 5 to 17 amino acids in length, which are post-translationally modified to
yield a variety of linear and cyclic structures in Gram-positive bacteria. QSMs of Gram
negative bacteria, AHLs, are composed of fatty acyl chain of 4 to 18 carbons in length
attached to a homoserine lactone ring through an amide bond; AHLs present in nature
have acyl chains of even numbers of carbons. Furthermore, the third carbon in the acyl
chain can be fully reduced or may contain a hydroxyl or a carbonyl group. This
substitution at the third carbon varies based on the fatty acid from which it is derived.
Among the three types of QSMs mentioned above, AI-2 has been discovered more
recently and shown to be comprised of a group of structurally related compounds; at
least two of these compounds have been demonstrated to be employed as QSMs by
bacteria, namely, a furanosyl borate diester form of AI-2 used by the marine bacterium
Vibrio harveyi and a hydrated form, not containing boron, used by the intestinal
pathogen Salmonella typhimurium15. Furthermore, some bacteria have multiple QS
circuits based on more than one kind of QSM; for example, V. harveyi utilizes N-(3hydroxybutanoyl)-L-homoserine lactone and the furanosyl borate diester form of AI-2 to
control bioluminescence16. Recently, Sperandio et al. have discovered an additional
QSM, autoinducer-3, AI-3 (unknown structure), which binds to the membrane protein
QseC and activates virulence in enterohemorrhagic Escherichia coli (EHEC)17,18. Further,
it has been shown that the mammalian hormones, epinephrine and norepinephrine, are
recognized by the same protein QseC and activate virulence in EHEC7, suggesting
6

involvement of the AI-3 QS system in interkingdom bacterial–mammalian cells
communication.

Quorum sensing regulatory systems
The QS pathways of the three major types of bacterial QSMs listed above are
outlined in Figures 1, 2, and 3. Most Gram-negative bacteria utilize AHLs as QSMs; their
QS systems are similar to that of Vibrio fischeri, which was one of the first QS regulatory
systems to be thoroughly investigated. This bacterium uses QS to regulate expression of
the genes responsible for bioluminescence. It utilizes N-3-oxo-hexanoyl homoserine
lactone (3-oxo-C6-HSL) as the cognate QSM, which is synthesized in the cytoplasm by
the AHL synthase protein LuxI. Once formed, 3-oxo-C6-HSL diffuses out of the cell and
freely enters into the neighboring bacteria, where it binds to the transcriptional
regulatory protein LuxR upon reaching a threshold concentration. As the population
density increases, the concentration of 3-oxo-C6-HSL also increases proportionally. By
being able to synthesize and detect 3-oxo-C6-HSL, V. fischeri can thus estimate its
population size. The LuxR protein, upon binding 3-oxo-C6-HSL, forms the LuxR–3-oxoC6-HSL complex, which binds to the operator/promoter region of the luxICDABE operon
to express the enzymes involved in bioluminescence. Specifically, the genes luxA and
luxB encode bacterial luciferase, and the luxC, luxD, and luxE genes code for the
enzymes required for the synthesis and recycling of the long chain aldehyde substrate
for luciferase. The light output obtained is proportional to the amount of 3-oxo-C6-HSL
present in the environment, which is relevant for the development of whole-cell sensing
7

systems based on QS regulatory systems, as highlighted in following sections of this
work. While AHL based QS controls bioluminescence in V. fischeri, it regulates diverse
functions in other bacteria by means of a variety of LuxI and LuxR homologue proteins.
Notable examples are the AHL-dependent LasI/LasR and RhlI/RhlR QS systems of
Pseudomonas aeruginosa, which control production of virulence factors and biofilm
formation in this microorganism. Figure 1 shows a general schematic of AHL dependent
QS system.
AIPs are utilized by Gram-positive bacteria for QS. Various peptide lengths and
post-translational modifications have led to diverse structures of AIPs, thus conferring
selectivity and specificity. Several Gram-positive bacteria have been studied in detail
and shown to follow a general theme, as outlined in Figure 2. Briefly, AIP originates from
a precursor peptide through post-translational processing and modifications, and is then
secreted out of the cell by an ATP-binding cassette transporter. The AIP signaling
pathways are comprised of two component signaling systems. These two components
include a sensing receptor protein, which binds the AIP, and a response regulatory
protein, which translates the binding event into expression of target genes, including
the QS regulated genes and those responsible for synthesis of the AIP precursor and
release of AIP. Specifically, AIP binding to the receptor protein, which is a histidine
sensor kinase, triggers autophosphorylation at a conserved histidine residue, followed
by a cascade of phosphorylation events, which ultimately transfer the phosphate group
to a conserved aspartate residue of the response regulatory protein. The
phosphorylated response regulatory protein then binds to specific DNA regions and
8

activates transcription of the regulated genes. Some examples of two component
systems include the ComD/ComE competence system in S. pneumoniae, ComP/ComA
competence and sporulation system in Bacillus subtilis, and AgrC/AgrA virulence system
in Staphylococcus aureus.
In contrast to QS systems utilizing AHLs and AIPs, which are usually specific to
Gram-negative and Gram-positive bacteria respectively, those that utilize AI-2 have
been found in both types of bacteria. Bassler et al. have reported that AI-2 is not only
produced, but also sensed by a large number of bacterial species19. Generally, AI-2
refers to a group of isomers derived from the hydrated form of the precursor 2,3dihydroxy-4,5-pentanedione (DPD) (Figure 3A). Although only the borate isomer
derivative of DPD, S-THMF-borate, was previously thought to be the active form
recognized by the protein LuxP and its homologues, more recently, a different isomer,
R-THMF has been found to be the cognate molecule of the sensor protein LsrB in S.
typhimurium. The mechanism of QS in AI-2 based systems is represented in Figure 3B.
Briefly, AI-2 is synthesized in the cell by Pfs and LuxS enzymes. Pfs converts Sadenosylhomocysteine (SAH) to S-ribosylhomocysteine, which is converted to DPD by
action of LuxS. Once formed, DPD undergoes instantaneous cyclization to form an
isomeric mixture (Figure 3B). In the presence of borate, which is abundant in the
oceanic environment, S-THMF-borate is formed. AI-2 diffuses out of the cell and can
enter bacteria of the same or other species. The receptor of AI-2 in V. harveyi is the
protein LuxP, which belongs to the class of periplasmic binding proteins. Upon AI-2
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binding to LuxP, the LuxP-AI-2 complex regulates the expression of controlled genes
through a cascade of phosphorylation/dephosphorylation steps.

Quorum sensing molecules in disease
Numerous in vitro and in vivo studies have demonstrated that expression of
bacterial virulence factors responsible for infections in mammalian hosts is regulated by
QS. Several such studies concerning GI tract infections have been discussed in a recent
review by Kaper and Sperandio20. For example, in the case of EHEC, which causes bloody
diarrhea and hemolytic-uremic syndrome, involvement of AI-3 in regulating the
expression of virulence factors was demonstrated in a HeLa cell infection model using
wild-type EHEC and a LuxS mutant-LuxS has been shown to be involved in the
production of AI-321. In an animal study22, burn wounds of mice models were infected
with wild-type P. aeruginosa and variants of the same bacterium carrying mutations in
the genes encoding for AHL synthase. The objective of the study was to determine the
efficiency of infection by assessing the ability of the bacteria to spread the infection and
the time required for the onset of infection. It was observed that in mice infected with
P. aeruginosa mutants unable to synthesize AHLs, the extent of infection was lower than
in those infected with wild type bacterium. The evidence gathered is indicative of the
relevance of bacterial communication in diseases of bacterial origin and, thus, the
importance of detecting QS signaling molecules in physiological samples.
Identification of QS regulatory pathways in a number of bacteria 12 has enabled
whole-cell-based biosensing systems to be engineered to detect QSMs by coupling the
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genes coding for different QSM recognition and/or regulatory proteins to those of a
variety of reporter genes20. As an example, Winson et al. designed reporter plasmids by
placing the reporter gene cassette luxCDABE under the control of the PlasI and PRhlI
promoters from the P. aeruginosa QS regulatory systems LasI/LasR and RhlI/RhlR,
respectively. The plasmids also contained the sequences of the LasR and RhlR proteins,
which, upon binding AHLs, bind to the respective promoters, thus activating expression
of the reporter protein23. In another example16, Bassler et al. engineered a strain of V.
harveyi in such a way that the bacterium’s bioluminescence, which depends on
expression of the luxCDABE gene cassette, was only triggered by AI-2, thus enabling
detection of this QSM (as reported above, in wild-type V. harveyi expression of the
bioluminescence genes is triggered by both AI-2 and an AHL, N-(3-hydroxybutanoyl)-Lhomoserine lactone).
Most of the above cell-based systems have been used as bioassays to evaluate
the ability of cultured bacteria to produce QSMs. However, only a few have been
applied to the detection of QSMs in physiological and clinical samples in order to
correlate the presence of pathogenic bacteria with the onset or status of disease. Two
independent studies demonstrated the presence of AHLs in sputum samples from
patients with cystic fibrosis8,9 by using whole-cell sensing systems. It is known that P.
aeruginosa and Burkholderia cepacia colonize the airway passage and lungs in CF
patients, leading to chronic lung infection and finally to destructive lung disease 24. These
two species of bacteria use AHL-dependent QS regulation. In the study conducted by
Middleton8 et al., sputum samples from CF patients colonized by either P. aeruginosa or
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B. cepacia, were extracted and then analyzed using an E. coli whole-cell-based
biosensing system containing plasmids pSB401 and pSB1075 to detect short and longchain AHLs, respectively. Among P. aeruginosa-colonized sputum samples, 71% showed
the presence of short-chain AHLs and 61% showed presence of long-chain AHLs.
Similarly, among B. cepacia-colonized sputum samples, 81% contained short chain AHLs
and 50% contained long-chain AHLs. This AHL production profile was different from that
of laboratory cultures of the same microorganisms isolated from sputum samples, in
which long-chain AHLs were predominant. The difference in AHL profile was thought to
be explained by dissimilar growth conditions, in vitro and in the lung. In that regard, this
varied behavior of P. aeruginosa from lung infection had previously been observed by
Singh25 et al., who hypothesized that P. aeruginosa exists predominantly as a biofilm in
CF sputum. Further, LC–MS analysis of the same samples revealed the presence of
short-chain AHLs, but not that of long-chain AHLs, indicating that the whole-cell-based
biosensing system was more sensitive for detection of AHLs in sputum samples. Another
study published the same year by Erickson et al. further corroborated the presence of
AHLs in sputum samples from CF patients9. P. aeruginosa-based whole-cell biosensing
systems containing plasmids pKDT17 (to detect long-chain AHLs) and pECP61.5 (to
detect short chain AHLs), both utilizing lacZ as a reporter, were used.
Although the levels of AHLs detected were low, over 75% of the samples had
long-chain AHLs whereas only 26% of the samples had short-chain AHLs. This finding is
in contrast with the results of the study by Middleton8 et al. However, differences in the
groups of patients, along with different sample extraction and/or processing methods
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and the use of sensing systems based on different microorganisms might explain
different results. Along the same lines, Chambers et al. detected a broad range of AHLs
in mucopurulent respiratory secretion samples obtained from CF patients 26. They used
Agrobacterium tumefaciens-based whole-cell biosensing system A136, containing
plasmids pCF218 and pMV26 with luxCDABE as a reporter, allowing it to respond to both
long and short-chain AHLs (4–12 carbon atoms). AHLs were extracted from the
mucopurulent respiratory secretion samples, separated by reversed-phase fast pressure
liquid chromatography (FPLC), and each fraction was then assayed with the A.
tumefaciens A136 sensing system in 96-well microtiter plate format. Further, identities
of the AHLs present in positive fractions were confirmed by comparing their retention
times with those of standard AHLs. Using the whole-cell sensing system combined with
FPLC, the authors were able to detect low concentrations of AHLs in small volumes of
samples from nine (out of thirteen) CF patients and to identify seven different AHLs.
Our research group used whole-cell biosensing systems to evaluate QSMs in
physiological samples from individuals affected by bacterial GI disorders, including IBD.
Two of the major conditions of IBD, ulcerative colitis (UC) and Crohn’s disease (CD),
involve chronic and relapsing acute inflammation in the large and small intestine,
respectively, with CD being able to affect any portion of the GI tract. Current methods of
diagnosis and monitoring rely on endoscopic techniques and analysis of mucosal tissue
biopsies taken from the inflamed regions. Alternative tools that can serve as noninvasive biomarkers for such diseases can prove very beneficial. To that end, we have
developed and optimized E. coli based bioluminescent whole-cell sensing systems
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containing plasmids pSB406 and pSB1075, which bear luxCDABE as a reporter, for
detection of short and long-chain AHLs, respectively23,27. These biosensing systems have
then been used to evaluate AHLs in human samples, for example saliva and stool
samples, which bear the advantage of being collected non-invasively. The effect of
components of the sample matrix was evaluated by generating dose–response curves in
spiked pooled samples after minimal processing (no sample extraction or extensive
preparation). Importantly, nanomolar limits of detection were obtained in biological
matrices, which is relevant in that nanomolar concentrations of QSMs are necessary to
initiate cell-to-cell communication

27

. Saliva samples from IBD and healthy individuals,

and stool samples from newborns admitted to a neonatal intensive care unit (NICU)
were then assayed27. AHLs were detected at different levels in the specimens tested,
showing for the first time the presence of these QSMs in such physiological samples.
More recently, we also detected QSMs in blood samples of IBD patients (manuscript in
preparation). If a correlation is established between the QSM levels in samples and the
health status of a patient, it may be possible to use QSMs as biomarkers of bacteriarelated disorders, which should aid in the management of the disease. Studies are
currently in progress in our group in which physiological samples from selected sets of
GI patients and matched controls are analyzed for their QSM content to evaluate
relationships between QSM levels and disease status. One such clinical study involved
stool samples that were obtained from infants admitted to the NICU for a variety of
illnesses, including bowel inflammation and bacterial sepsis28 (submitted manuscript).
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Interference with quorum sensing
QS has evolved to assist bacteria to effectively communicate among each other
and regulate expression of phenotypes that are involved in pathogenicity, such as,
virulence determinant production and biofilm formation. In the past few decades,
several examples of interference with bacterial communication as a means to interrupt
the bacterial chatter and, thus, block pathogenicity, have been reported. Since bacterial
QS depends on the presence of QSMs and their interaction with cognate receptors, any
molecule or enzyme that either blocks the synthesis or accumulation of QSMs, or
prevents them from binding to the receptor proteins, can interfere with QS.
QS interfering compounds include those from natural sources29-31 as well as those that
are synthesized32,33 in the lab. Jakobsen34 et al. have analyzed over 60 extracts of
vegetables, fruits, and spices, and found that extracts from horseradish, Tasmanian blue
gum, and ginkgo showed a clear QS inhibitory activity in the screening assays employed.
Further investigation using LC-MS and NMR spectroscopy led to the identification of
iberin, an isothiocyanate (Figure 4A), as the compound responsible for the potent
inhibitory effect of horseradish on QS in P. aeruginosa. Widmer and co-workers35
studied several fatty acids from poultry meat and proved that four of them, linoleic acid,
oleic acid, palmitic acid, and stearic acid, exhibited an inhibitory effect on the AI-2 based
QS system (Figure 4B). Few other natural compounds that have been reported to
interfere with QS include cinnamaldehyde from cinnamon36 and ursolic acid from
apples37. Works by Koh et. al and by Zahin et. al provide further evidence of the anti-QS
activities of the traditional Chinese medicinal plants38 and medicinal plants from India39,
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respectively. These studies prompted us to investigate GRAS compounds for their effect
on QS. GRAS compounds are food additives that are considered to be safe and are
approved by food and drug administration10. A database of GRAS compounds is
maintained by the FDA40, and currently includes 373 compounds, with more compounds
added each year.

Inhibition of QSM synthesis
Since all types of QSMs are synthesized in the bacterium by their respective
synthases, it is apparent that if the synthase enzyme is inhibited, QS and the genes
regulated by QS will also be affected. As a result, several compounds that interfere with
QS by inhibiting the synthesis of QSMs have been identified. For example, in P.
aeruginosa the AHL synthase RhlI synthesizes N-butanoyl-L-homoserine lactone (C-4
HSL) by using crotonyl-acyl carrier proteins and S-adenosylmethionine (SAM). The
compounds S-adenosylhomocysteine and sinefungin are analogues of SAM (Figure 5A)
that inhibit the RhlI catalyzed synthesis of C-4 HSL41. Similar studies have been
conducted to find inhibitors that can block AI-2 synthesis42-44. The precursor S-ribosyl-Lhomocysteine (SRH) is required for AI-2 synthesis; Zhou et. al reported that the SRH
analogues, S-anhydroribosyl-L-homocysteine and S-homoribosyl-L-cysteine, exhibited
inhibitory activity against the AI-2 synthase, LuxS43 (Figure 5B). In addition, Shen et.al
synthesized and analyzed several SRH analogs for their activity as LuxS inhibitors. They
found

that

two

analogs

of

SRH,

(2S)-2-amino-4-[(2R,3S)-2,3-dihydroxy-3-N-

hydroxycarbamoylpropylmercapto]butyric

acid
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and

(2S)-2-amino-4-[(2R,3R)-2,3-

dihydroxy-3-N-hydroxycarbamoylpropylmercapto]butyric

acid,

acted

as

potent

inhibitors of LuxS42.

Degradation of QSMs
A well-studied example of interference with AHL-mediated QS is that of QSM
degradation by AHL lactonases, which break open the lactone ring of AHLs to produce
the corresponding acyl homoserines, thus reducing the activities regulated by QS45. In
addition to lactonases, there are acylases that work by breaking the AHL amide bond to
produce fatty acids and homoserine lactones45. Genome analysis revealed that acylase
and lactonase homologues are present in a number of bacterial species. The
fundamental knowledge of lactonases was put to use by Dong et. al, who introduced the
aiiA gene encoding for an AHL-lactonase into the genome of tobacco and potato
plants46. After infecting these plants with pathogenic Erwinia carotovora, the transgenic
plants showed a substantial reduction in the extent of infection as compared to the
control plants without aiiA. In addition to these naturally existing interfering enzymes
that exert their action by degrading the QSMs, an alternative approach was proposed by
Janda47 et. al who produced an anti-autoinducer monoclonal antibody that could inhibit
QS by sequestration of the AIP-4 produced by group 4 S. aureus. Further, they utilized
the anti-autoinducer antibody in a mouse model and found that it did not only suppress,
but also provided complete protection against the S. aureus infection.

Interference with QSM receptor
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Irrespective of the type of bacteria, a QSM either binds to a membrane bound
receptor or passively transported in the cell where it binds to its cognate receptor 48.
Therefore, molecules that bind to the QSM receptor but do not elicit subsequent
biological response, can serve as inhibitors of QS and the processes regulated by the
QSM receptor.
A number of molecules have been investigated that inhibit QS by binding to the
QSM receptor. In the Gram positive bacteria S. aureus, a truncated form of an
autoinducing peptide specific for a certain group of bacterial strains was able to inhibit
the agr virulence response in all four groups of S. aureus strains49; it was found that the
inhibited target was the AIP receptor, histidine sensor kinase AgrC. Further studies
identified several compounds that were able to show an inhibitory effect due to binding
to the AIP receptors50,51. QS systems utilizing AHLs as QSMs can also be inhibited by
compounds that bind to the AHL receptors. Efforts have been mostly focused on finding
AHL antagonists by modifying AHLs, which are comprised of a lactone ring and an acyl
side chain. Therefore, inhibitors that block the AHL-receptor interaction usually are AHL
derivatives with structural modifications in the lactone ring or acyl side chain or both52.
Gram-negative bacteria have evolved to express different receptors for recognizing
structurally diverse AHL molecules. While a type of AHL molecule might act as agonist in
some bacterial species, it might act as antagonist in others. As an example, C-6 HSL is an
agonist of CviR of Chromobacterium violaceum, but an antagonist of LuxR of V. fischeri53.
By using a QS inhibitor selector system30, Persson et. al designed and synthesized a
number of derivatives of AHLs that showed an inhibitory effect in the las system of P.
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aeruginosa54, with N-(heptylsulfanylacetyl)-L-homoserine lactone demonstrating the
highest inhibitory activity (Figure 6A). In bacteria employing AI-2 based QS systems, two
periplasmic binding proteins have been identified as AI-2 receptors thus far, that is, LuxP
in V. harveyi and LsrB in S. typhimurium and E. coli; the former binds to the borate form
of AI-2, (2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran-borate (S-THMF-borate),
while the latter binds to (2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (RTHMF) in S. typhimurium15. There is a limited amount of research to develop
agonists/antagonists of the receptors LuxP and LsrB. Although Lowery et. al have
developed several analogs of DPD55, the precursor of AI-2, none of them were effective
as agonists or antagonists. On the other hand, Ni et. al screened a number of boronic
acids and aromatic diols that would form a complex with boric acid and found that para
substituted boronic acids56 and pyrogallols57 were capable of inhibiting AI-2 based
quorum sensing (Figure 6B).

Interference by other bacterial species and strains
S. aureus uses AIP and AgrCA two-component systems to regulate various
activities, including production of virulence factors and biofilm formation. Among
different strains of S. aureus, the AIP and its receptor AgrC show considerable
intraspecies variations, which account for signal specificity and are used to identify four
major groups of S. aureus strains. Interestingly, while each group AIP activates
expression of virulence in bacteria of its own group, it represses the virulence in other
groups of S. aureus. Mayville et. al studied this phenomenon in a mouse model. Addition
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of AIP II, the AIP signal produced by group II S. aureus, to a lesion infected with group I S.
aureus reduced the infection, as apparent from the reduced size of the lesion58. In
another study, Xavier et. al have shown that, in a mixed species community of bacteria
that are able to produce and/or detect AI-2, one species of bacteria degrades the AI-2
produced by another species, thus interfering in the communication system of the
latter59.

Biosensors
The need of living organisms to recognize and respond to changes in their
environment exemplifies biosensing in nature. Biosensing involves selective and
sensitive molecular recognition between proteins and a target ligand analyte, even
when present at very low concentrations. Researchers have tried to mimic the exquisite
properties found in nature by utilizing naturally occurring recognition elements to
develop biosensing systems for analytical applications. To that end, a biological
recognition element capable of reversible binding to a target ligand analyte is coupled to
a transducer element that converts the recognition event into a readable/measurable
output. Several biological recognition elements, including proteins, nucleic acids, cell
organelles, and intact cells, have been used as sensing elements in biosensors for
applications in environmental, biological, pharmaceutical, and clinical analysis60,61.
Proteins with high specificity for analytes of interest have been extensively used in the
development of biosensors. These proteins include enzymes, antibodies, and binding
proteins, among others. For instance, glucose oxidase catalyzes oxidation of β-D-glucose
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to D-glucono-1,5-lactone, which is further hydrolyzed to gluconic acid26. A range of
commercially available biosensors for blood glucose monitoring and diabetes
management use glucose oxidase as the sensing element coupled to appropriate
mediators and transducers6. Antibodies have exquisite specificity for their cognate
antigens. In an immunosensor62, antibodies are used as recognition elements coupled
with a variety of detection methods, including, electrochemical, piezoelectric,
fluorescence, bioluminescence, absorbance, and surface plasmon resonance; labeled
secondary antibodies can also be used in a different format for detection of target
analytes.
A variety of sensing systems have also been developed by using hinge motion
binding proteins (HMBPs), for example periplasmic binding proteins and the messenger
protein calmodulin, with an incorporated signal-generating reporter molecule63. In
general, these proteins have extraordinary selectivity to their corresponding ligand
and/or analyte, with affinities, KD, typically in the sub-micromolar range—in some cases
as low as in the nanomolar range—and undergo conformational changes upon binding
to their ligands. As representative examples of periplasmic binding proteins 64, the KD of
the sulfate-binding protein is 10 nmol L−1 whereas that of the glucose-binding protein is
20 nmol L−1. Specifically, upon ligand binding, two protein domains bend around a
“hinge” region of the protein. Such conformational change can be used to quantify a
target analyte and/or ligand by measuring the change in signal intensity of the
transduction molecule, which can either be an environmentally sensitive fluorescent
probe strategically conjugated to the protein or a reporter protein genetically fused to
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the HMBP. The advantages of this type of protein-based biosensor are their high
specificity toward their ligand analyte, thus resulting in high selectivity, low limits of
detection, rapid response times, and amenability to incorporation into various analytical
devices. Potential disadvantages of protein-based biosensors can be their storage
conditions, transport, and shelf life. In most cases, protein biosensors must be stored
and transported refrigerated, which limits their utility and compromises their shelf life
when used at room temperature.
Intact cells, including bacterial, yeast, and mammalian cells, are used as sensing
elements in biosensing systems. Bacterial cell-based biosensing systems use genetically
engineered bacteria capable of generating a signal on selective recognition of the
analyte or class of analytes of interest. The ability to produce dose-dependent
detectable signals in response to the analyte, as described in the next section, enables
selective determination of the bioavailable analyte or class of analytes present in a given
sample. Cell-based sensing systems are relatively easy and inexpensive to prepare and
store, and are robust: they tend to be stable to environmental changes, for example
variations in temperature or pH. In addition, these sensing systems can provide
physiologically relevant data and evaluate the bioavailability of the analyte of interest,
because the target chemical must enter the cells to trigger a response. Moreover, by
using different recognition element–reporter protein pairs, multiple analytes can be
detected simultaneously in a sample. Cell-based biosensing systems have highthroughput features because they are amenable to miniaturization and incorporation
into high-density analytical devices, thus enabling assay of large numbers of samples in a
22

single analytical run. This is a distinct advantage over conventional physicochemical
analytical methods. However, a whole-cell biosensing system is not without limitations.
In whole-cell biosensing systems, analytes must enter the bacteria by diffusion, which
may, depending on the rate of diffusion, result in a slow sensor response. Additionally,
because the cell biochemical machinery must be activated to produce the reporter
protein, the response of a whole-cell sensing system is slow compared with that of
protein-based biosensors, which is of the order of seconds or minutes. Additional
drawbacks include potential interference with the sensor’s response by components of
the bacterial cell and high background signal when fluorescent proteins are used as
reporters, because of the presence of fluorescent molecules in the cell. Cell batch-tobatch variability, which is intrinsic to living organisms, is a further aspect that may have
to be taken into consideration65.

Bacterial whole-cell-based biosensing systems
Bacterial biosensing systems can be categorized into two different types,
depending on the mode of expression of the reporter protein66. Expression of the
reporter can either be constitutive or inducible. In constitutive expression systems, the
reporter is expressed at high basal levels. An increase in the amount of compounds that
are toxic to the cell causes its death, thus reducing the reporter protein expressed and
its generation of signal. Whole-cell biosensing systems based on constitutive expression
have been used to measure the general toxicity of a sample or test compound. A wellknown example is Microtox® toxicity testing7, a standardized, commercially available
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toxicity testing system that uses the spontaneously bioluminescent marine bacteria V.
fischeri as bacterial sensor for detection of toxic compounds in water samples. When V.
fischeri in the test kit is exposed to a sample containing toxic compounds, a dosedependent reduction in bioluminescence is observed, indicating the toxicity level of the
sample. The second class of whole-cell bacterial biosensing systems comprises inducible
expression systems in which the cells are genetically engineered to contain a plasmid in
which an inducible promoter fused to a reporter gene controls its expression66. In the
absence of analyte/inducer, the reporter gene is expressed at very low basal levels,
while in the presence of analyte/inducer it is expressed in a dose-dependent manner.
Inducible expression systems can be further classified as stress inducible or chemically
inducible, depending on the mechanism of activation of the response. In stress inducible
cell-based biosensing systems, the reporter gene is placed under the control of a
promoter that is activated by stressful conditions, for example heat shock and osmotic
stress. Several structurally unrelated compounds can activate these response
mechanisms; therefore, such sensing systems are not specific to target compounds and
are defined as semi-specific. On the other hand, chemically inducible cell-based systems
harbor a plasmid that contains a specific promoter and the genes for regulatory and
reporter proteins. The presence of an analyte or class of analytes activates the
promoter, triggering the expression of the regulatory and the reporter proteins in a
specific manner. The mechanism by which this occurs involves binding of the analyte to
the recognition/regulatory protein, which then undergoes a change in conformation,
subsequently activating expression of the reporter gene. Reporter gene expression can
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be negatively or positively regulated. In negative regulation (Figure 7A), the regulatory
protein is bound to the operator/promoter region of an operon and inhibits expression
of downstream genes, including the reporter gene. When the analyte is present, it binds
to the regulatory protein, which is then removed from the operator/promoter region,
thus enabling expression of the reporter gene. In positive regulation (Figure 7B), the
analyte first binds to the regulatory protein and the complex then binds to the
operator/promoter region, triggering expression of the reporter gene. The reporters
used in whole-cell sensing systems are typically proteins that can be detected by optical,
i.e.,

colorimetry,

fluorescence,

bioluminescence,

and

chemiluminescence,

or

electrochemical methods. Although the recognition component is important in
determining the selectivity, the reporter is crucial in determining the sensitivity of the
bacterial sensor. A wide variety of reporter genes have been used in several
applications, including gene expression, gene transfer, and cell signaling. The reporter
proteins encoded by such genes have also been used as signal-transduction elements in
bacterial sensors. These proteins include β-galactosidase67,68, bacterial luciferase69,
firefly luciferase70, and the green fluorescent protein and its variants. Table 2 lists
reporters that are commonly used in whole-cell sensing systems, with their catalyzed
reactions and methods of detection.

Miniaturization of cell-based biosensing systems
Cell-based bioluminescent biosensing systems have still to reach their fullest
potential. Attractive technologies where these systems could find applications include
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rugged, compact portable sensing platforms and instrumentation for on-site
measurements of environmentally and clinically relevant analytes. To date, several
important strides toward miniaturization have been achieved. An example of the
progress made towards constructing miniaturized systems includes the whole-cell
bioluminescent-bioreporter integrated circuit device developed by Simpson et al.71 In
this system, a toluene-selective genetically engineered Pseudomonas putida bioreporter
strain was incorporated onto a chip provided with an optical application-specific
integrated circuit (Figure 8). Upon interaction with toluene vapor, a bioluminescence
signal was generated and measured by the integrated circuit, allowing detection of
toluene concentrations down to 50-10 ppb, depending on the signal integration time.
The main advantage of this system lies in the direct coupling of the bioluminescent
bioreporter cells to an integrated circuit designed for detecting, processing and
reporting of the light signal. This eliminates the need for large detection
instrumentation and optical components for light collection and transfer, thus providing
a self-contained portable device suitable for on-site applications.
Miniaturized cell-based biosensing systems have also found application in
genome-wide transcription analysis. In a study performed by Van Dyk72 et al.,
sequenced random segments of E. coli DNA were inserted into plasmids as gene fusions
with Photorhabdus luminescens luxCDABE gene cassette and transformed into host cells.
A group of functional gene fusions known as Lux Array 1.0 was selected, which
contained a total of 689 diverse reporter strains. These strains were printed on a porous
nylon membrane (8 cm x 10 cm) at 16 spots cm-2 by means of a commercially available
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automated workstation. During and after this process the membrane was kept in
contact with LB growth media in a culture dish. These reporter strains were employed
for simultaneously evaluating gene expression in the presence of nalidixic acid, an
antibiotic that induces DNA damage stress response by causing a change in gene
regulation. Specifically, in the described reporter gene assay, upregulation of certain
genes translated to increased bioluminescence signals. This system showed the
feasibility of obtaining high-density bioluminescent reporter cell arrays and suggests
their potential use for analytical purposes. Notably, a further increase in the density of
the arrays may be limited due to cross-illumination from neighboring spots.
In another attempt towards miniaturization, fiber optic based systems have been
designed and developed in which whole-cell biosensing bacteria were immobilized onto
an exposed core of a fiber-optic73,74. In one case, reporter cells containing a gene fusion
of the genotoxicant-inducible recA promoter of E. coli to the P. luminescens luxCDABE
reporter were constructed74. These sensing cells emitted light in a dose-dependent
manner in the presence of DNA damaging (genotoxic) agents, such as mitomycin C,
which can react with the DNA structure, destabilize it and potentially cause deadly
genetic mutations. The optical fiber was treated with acid for proper cleaning. The
sensing cells were mixed with a polymeric solution, such as sodium alginate, and the
fiber optic tip was dipped into the mixture containing the cells (Figure 9). Further
treatment with calcium chloride solution was performed to harden the cell-alginate
matrix onto the fiber-optic core. When the cell-deposited fiber-optic tip was exposed to
solutions of mitomycin C at various concentrations, a dose-dependent bioluminescence
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response was triggered, and then measured by the fiber optic system. Notably, this
fiber-optic system was able to achieve the same detection limit, in a shorter period of
time, as its larger scale counterpart. In another work by Gil et al.75, genetically
engineered constitutively bioluminescent bacteria were deposited on an optical fiber,
employing a solid matrix of glass beads and agar, to develop a biosensor for the
detection of toxic gases. Specifically, the presence of toxic chemicals reduced the cells'
bioluminescence intensity. Addition of glass beads increased both the porosity of the
cell matrix, which facilitated the diffusion of vapors through the cell matrix layer, and
the contact surface area of the cells with the gases, thus resulting in improved sensing
ability of the bacterial sensor. This sensor is not as specific because it measures cell
death, which can be caused not only by gases but also by other toxic compounds
present in the sample. Technologies such as biological laser printing (BioLP™) have been
reported for the rapid deposition of biomolecules and live bacterial sensing cells onto
various surfaces76. Forward transfer BioLP™ uses laser pulses to transfer material from a
carrier support onto a receiving substrate (Figure 10). The carrier support is an
absorption layer (mostly quartz coated with metal oxides) on which properly grown
bacterial sensing cells are spread prior to printing. In the reported example, the sensing
strain was E. coli harboring a plasmid-borne fusion of the recA gene promoter to the red
fluorescent protein gene from Discosoma, capable of responding to genotoxicants like
nalidixic acid. Then, the sensing cells on the carrier support were printed onto a
receiving surface composed of a LB agar plate or a sterile glass slide with a thin film of
LB agar. The laser pulse was focused on a spot in the absorption layer. The laser28

material interaction produced photo-absorption, propelling a three-dimensional pixel of
biomaterial towards the receiving substrate through photomechanical and/or
photothermal effects. This method of printing was reported to be precise, with an
average spot diameter of 70 ± 6 μm and an approximate volume of 5 pL. An alteration in
the bioluminescence emission was observed and attributed to the genotoxicity caused
by nalidixic acid. This BioLP™ technique may be applied to several diverse sensing cells
to produce miniaturized chip-based sensing systems that can be used in a laboratory
setting or in the field.
During the last two decades, there has been considerable interest in and efforts
made to miniaturize conventional bench-top analytical techniques and incorporate
them into microfluidic chip-based platforms1 as well as to integrate multiple analytical
processes into a single chip77. The physical principles that govern mass transfer and fluid
flow at the microscale level allow for rapid mass transfer and kinetics as well as high
surface-to-volume ratio, which endow microfluidic systems with unique characteristics
when compared to conventional volume analytical systems. Microfluidic devices such as
micro-total analysis systems (µTAS) and lab-on-a-chip platforms have been developed
for several analytical tasks, including whole-ceIl based biosensing. Generally, computer
numerical control (CNC) machining and lithography techniques are used to fabricate
these devices, employing polymeric materials such as poly(methyl methacrylate)
(PMMA), glass and silicon. Various microfluidic structures can be fabricated that
incorporate features such as micro reservoirs, microchannels, mixing devices, filtration,
fractionation and separation devices and microvalves. The choice of structures
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incorporated into a microfluidic device depends on the specific application desired78.
Propulsion of fluids on microfluidic platforms is accomplished by employing varied
instruments such as syringe and peristaltic pumps, or by applying acoustic, magnetic or
centrifugal forces79.
Microfluidic platforms employing centrifugal forces can be designed in the form
and size of a compact disk (CD). This kind of centrifugal microfluidic device has been
used for cell-based detection systems. Specifically, bacterial biosensing cells containing
the gene for green fluorescent protein (GFP) under the transcriptional control of the
promoter and regulatory genes of the ars operon were employed80. The biosensing
system

relies

upon

the

recognition

and

binding

of

the

target

analytes

arsenite/antimonite by the transcription regulatory protein ArsR, and the resulting
expression of the reporter protein GFP inside the cytoplasm. The biosensing cells were
incorporated into a CD microfluidic platform made of PMMA for detection of arsenite
and antimonite. In this application, miniaturization significantly reduced the assay time
(30 min versus < 1 min) along with the volumes of reagents used, while retaining similar
micromolar detection limits and dynamic ranges, when compared to the benchtop
assay. The decrease in detection time is due to faster diffusion of the analyte into the
cells, thus increasing the reaction kinetics. The sensing system proved to be highly
selective for arsenite and antimonite when incorporated into the microfluidic platform.
Owing to precise manufacturing, all the structures have identical physical
characteristics, making these platforms a very attractive solution for multiple parallel
assays with potential for high-throughput screening as well as on-site monitoring. This
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type of sensing platform is suitable for the development of simple instrumentation
based on readily-available, cost effective hardware consisting of a drive motor, a power
supply, a controller, lens optics and compact CCD cameras for the detection and
quantification of emitted light. These components along with software for system
control and data acquisition, processing and analysis can be easily integrated into a
portable system. Figure 11 shows an example of centrifugal CD microfluidic platform.
Multiple structures consisting of an arrangement of reagent reservoirs, burst valves and
microchannels leading to detection reservoirs are shown. Fluid release from the reagent
reservoirs is controlled by burst valves, located a very short distance from the
reservoirs. Sufficient centrifugal force is needed to overcome the capillary force holding
the liquids into the reservoirs and allow their flow to the detection chamber. Such force
is generated by appropriate frequency of rotation (burst frequency) of the disk.
Whole-cell based biosensing systems employing firefly luciferase as a reporter
for the detection of genotoxicants have been integrated into a chip-based threedimensional microfluidic device, which was obtained by placing a silicon substrate
between two poly(dimethylsiloxane) (PDMS) layers. Microchannels (volume 3 µL) in the
two PDMS layers were connected via perforations in the silicon layer that served as
microwells (volume 0.25 µL) to hold the sensing strains, thus forming a threedimensional microfluidic network. The sensor strains were immobilized onto the
microwell array of the silicon chip by gelation upon injection of a cell/agarose mixture
through the microchannels of one of the PDMS chips. Luciferase gene expression was
then induced by passing sample genotoxicant solutions through the microchannels
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present on the second PDMS chip (Figure 12). Bioluminescence was triggered when a
solution of luciferin/ATP was passed through the channels and detected by means of a
CCD camera. The bioluminescence response obtained with this miniaturized microfluidic
system (1 h) was significantly faster than the assay using test tubes (4 h). Low-cost
materials were employed to make these platforms and low volumes of reagents were
consumed, thus rendering the system very cost-effective. In addition, multi-analyte
detection in multiple samples can be performed simultaneously by immobilizing
different sensor bacteria on a single chip.

Paper strip based whole cell sensors
While a number of biosensing systems are available that can detect a number of
analytes by employing various detection principles, most of these biosensing systems
cannot be used outside of the laboratory due to required bulky instrumentation. This is
particularly limiting for on-site environmental and biomedical applications. In addition
to the miniaturized devices described in the previous section, another approach towards
development of biosensors that could be used on site has been demonstrated by
Stocker et. al who created paper strip based biosensing systems to detect arsenic in
polluted water81. β-Galactosidase was employed as a reporter and detected by means of
a chromogenic substrate generating an insoluble colored product that could be
visualized on the paper strips. Five water samples obtained from Bangladesh indicated
arsenic contamination to much higher than permissible levels (10 µg/L) (Figure 13A).
Our group developed paper strip based whole-cell sensors that could be used for on-site
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monitoring of AHLs present in biological and environmental samples 82. E. coli cells
harboring plasmid pSD908, which is based on the lasR/lasI regulatory system of P.
aeruginosa with lac-Z encoding β-galactosidase as the reporter gene, were employed.
These sensing cells were liquid-dried in vacuum on filter paper strips. A dose-dependent
development of color was seen when the paper strips were incubated with various
concentrations of N-dodecanoyl-DL-homoserine lactone followed by addition of the
chromogenic substrate, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal). The
applicability of the sensor was validated by employing the paper strips to detect AHLs
present in saliva of healthy and diseased individual (Figure 13B). The sensor can be
employed not only to detect AHLs in samples, but also to evaluate molecules that
interfere with AHL based QS.

Binding proteins as recognition elements in biosensors
Proteins constitute the working machinery of every living organism. Proteins
perform a variety of tasks, including recognizing specific molecules, transferring
messages across the cell, catalyzing biochemical reactions, and participating in immune
responses. Hinge-motion binding proteins (HMBPs) are a group of proteins with high
selectivity and high binding affinity towards their respective ligands, with Kd values
down to the nanomolar level64. HMBPs are generally composed of two domains
connected by a hinge region, with the ligand binding site present at the interface of
these domains. Ligand binding results in a change in conformation of the protein,
consisting in bending of the two domains around the hinge region. The unbound or
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analyte free conformation is generally referred to as “open” form and the analyte bound
conformation is referred to as “closed” form. Hinge-motion binding proteins include
various types of proteins, such as, periplasmic binding proteins, transcriptional
regulatory proteins, enzymes, and the messenger protein, calmodulin. These proteins
bind to the respective analytes with high specificity and selectivity. This property makes
them appealing for use in sensing applications. As an example of HMBP, in E. coli
glucose is transferred from the periplasmic space to the cytoplasm through binding to
the periplasmic protein, glucose binding protein (GBP). Binding of the sugar to the
protein occurs through various interactions, such as van der Waals, ionic, salt-bridges,
and hydrogen bond formation with amino acids in the binding pocket, which causes the
protein conformation to change from the open to the close form (Figure 14). The
change in the conformation of a protein upon binding to a ligand can be harnessed to
create protein based sensors for target analytes. In order to make a biosensor from a
hinge-motion binding protein, the change in conformation due to ligand binding needs
to be translated into a readable output. This can be achieved by several methods,
including chemical conjugation of an environment sensitive fluorophore near the ligand
binding site, genetic fusion of a fluorescent or bioluminescent protein to either the C or
N terminus of the binding protein, and genetic insertion of the binding protein between
two fragments of a fluorescent or bioluminescent reporter protein to form a molecular
switch. Irrespective of the approach used to create a protein based biosensor, binding of
the ligand to the specific protein generates a dose-dependent change in the reporter
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molecule signal, thus allowing for the biosensor to be utilized for quantitative detection
of the target ligand/analyte.
A commonly used strategy to make protein based biosensors employs strategic
placement

of

environment

sensitive

fluorophores,

such

as,

5-({2-

[(iodoacetyl)amino]ethyl}amino)naphthalene-1-sulfonic acid (IEDANS), 7-diethylamino3-((((2-maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC), acrylodan, and Alexa-fluor
near the ligand binding site of the protein. Conjugation of the fluorophore at a site
within the binding pocket would not be a good choice as it could disrupt analyte
binding. Sites on the protein that experience a substantial conformational change upon
ligand binding are determined from X-ray crystal structure, NMR, and modeling studies.
These sites are ideal for fluorophore conjugation in that the analyte-induced
conformational change is likely to perturb the microenvironment surrounding the
fluorophore. Amino acids in the protein that are amenable to direct conjugation of the
fluorophore include cysteine (through sulfhydryl group), lysine (through amine group),
and aspartic and glutamic acid (through carboxyl group). When such amino acids are not
present at the required fluorophore attachment site, genetic mutations can be
performed to introduce the amino acid of interest. In our lab, a range of such
fluorophore labeled binding proteins have been constructed as biosensing systems to
detect environmental pollutants83 and clinically relevant analytes84.

Salins84 et. al

utilized the glucose/galactose binding protein from E. coli to develop a glucose
biosensor based on the principle outlined above. Specifically, cysteines were introduced
into the structure of GBP via mutagenesis at three different positions. A set of four
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fluorophores were conjugated at these cysteines and evaluated, with MDCC providing
the maximum response and limits of detection in the submicromolar range. More
recently, Siegrist et. al utilized fluorescently labeled glucose recognition polypeptide
elements to detect glucose AT physiologically relevant millimolar levels85. Similar
strategies were used to develop protein biosensors for the detection of environmental
pollutants, such as inorganic phosphates86, nickel87, and sulfates83.
Partial or full protein sequences can be joined together via recombinant DNA
technology resulting in fusion or hybrid proteins. An important application of fusion
protein technology is in the field of protein purification. As an example, GE Healthcare
Life Sciences offers a series of vectors that encode for glutathione-S-transferase (GST).
The DNA of the protein of interest can be cloned in these vectors, thus allowing
expression of a fusion of the GST tag and target protein, which can then be purified by
affinity chromatography88. In fusion protein constructs for sensing, an inherently
fluorescent or bioluminescent protein is attached to either the N or C terminus of a
binding protein. When the analyte binds to the binding protein, a change in
conformation of the binding protein leads to altered light emission from the reporter
protein. Using this principle, Dikici89 et. al developed a fusion protein using calmodulin
(CaM) as the recognition element to detect phenothiazine, and enhanced green
fluorescent protein (eGFP) as the reporter protein. When excited at a wavelength of 488
nm, eGFP emits at 510 nm. CaM is a calcium binding protein and when it binds to
calcium, a change in conformation of CaM exposes a hydrophobic pocket that interacts
with the antidepressant phenothiazine. When CaM binds to antidepressants, a further
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change in conformation of CaM induces a change in microenviroment of eGFP, thus
altering the emission intensity in a dose-dependent manner. Dikici et. al demonstrated a
system that serves as model to develop binding assays that employ binding proteins as
drug-recognition element. Based on the concept of fusion protein, a few fluorescence
resonance energy transfer (FRET) based biosensors have been reported90-93, in which
the binding protein is sandwiched between two fluorescent proteins acting as members
of a FRET donor-acceptor couple. Analyte binding leads to the fluorescence resonance
energy transfer between the two proteins.
Another approach in engineering protein based sensors is the development of
molecular switches. A protein molecular switch is comprised of a binding protein with
two fragments of a reporter protein fused to either end. In the absence of the analyte,
the two split fragments of the reporter protein stay apart and the switch is in “off”
mode, while in the presence of the analyte the binding protein undergoes a
conformation change that brings the two fragments of the reporter protein together,
thus forming an active protein and turning on the switch readout signal. A novel
molecular switch for detecting glucose was designed and developed by Teasley
Hamorsky et. al, employing the photoprotein aequorin as the reporter94. In brief, by
using genetic engineering tools, aequorin was split in two fragments and each of the
two fragments was fused to either the N or C terminus of GBP. In the presence of
glucose, the change in the conformation of the binding protein allowed the two
fragments of the aequorin to come together and triggered a dose-dependent light
emission in the presence of coelenterazine and calcium (Figure 15).
37

Miniaturization of protein-based biosensing systems
Efforts have been made to further augment the utility of protein based
biosensing systems by incorporating them in miniaturized devices, thus facilitating onsite applications. An approach to incorporate protein-based biosensing systems into
miniaturized devices was demonstrated by Puckett95 et. al. A fusion protein comprised
of calmodulin and the enhanced green fluorescent protein was integrated into a
microfluidic compact disk based µTAS (figure 16). This miniaturized device was
employed to detect phenothiazine, an antidepressant, which binds to the protein CaM.
The microfluidic platform contained μL-size reservoirs in which solutions of sensor
protein and analyte were added. When the disk was spun at a certain velocity, the
solutions flew through micro channels into a detection reservoir, due to centrifugal
force. As shown in Figure 16, the phenothiazine solution was contained in reservoir 3,
while the dried sensing protein was contained in reservoir 2. The flow of solutions was
controlled by passive valves, which opened only at a specific angular velocity. By
controlling the angular velocity, water was initially released from reservoir 1 into the
protein chamber to reconstitute the protein, and later, at a higher angular velocity, the
phenothiazine solution and reconstituted protein flew to the detection chamber. The
binding between CaM and phenothiazine resulted in fluorescence emission from the
reporter protein eGFP, which was measured using a fiber-optic based detection system.
Such microfluidic platforms are easy and inexpensive to manufacture, and are amenable
to multiplex and high-throughput analysis in that each disk may contain multiple
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identical microfluidic structures comprised of the required microchannels and
reservoirs.
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Figure 1. General schematic of AHL based quorum sensing system. Upon entering the
bacteria, AHL binds to LuxR type protein, and the LuxR-AHL complex regulates
expression of target genes, including AHL synthase. The label LuxR indicates LuxR types
proteins.
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Figure 2. General schematic of AIP based quorum sensing system. Initially, a precursor
peptide is produced, which undergoes modification to form a mature AIP and
transported out of the bacteria by ABC transporter. AIP is recognized by sensor kinase
protein, and via a cascade of phosphorylation/dephosphorylation steps, quorum sensing
regulated genes are expressed. Adapted from Xavier et al.19
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Figure 3. Autoinducer-2 and quorum sensing circuit in Vibrio spp. (A) Isomers deriving
from DPD cyclization. Copyright from Tavender et al.96 (B) Schematic of AI-2 based
quorum sensing system. Copyright from Vendeville et al. 97
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Figure 4. Natural compounds as quorum sensing inhibitors.
Iberin inhibits AHL based QS in P. aeruginosa

Fatty acids that inhibit AI-2 based QS in V. harveyi
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Figure 5: Inhibition of QSM synthesis.
(A) Compounds that inhibit AHL synthesis.

(B) Compounds that inhibit AI-2 synthesis.
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Figure 6: Interference with QSM receptors.
(A) Analogue of AHL demonstrating inhibitory activity

(B) Analogue of AI-2 demonstrating inhibitory activity
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Figure 7. Chemically inducible whole-cell biosensing systems.
(a) Negative regulation of reporter gene expression. (b) Positive regulation of reporter
gene expression. Adapted from Struss et al.65
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Figure 8. Bioluminescent-bioreporter integrated circuit featuring (i) enclosure containing
bacterial biosensing cells and optical application-specific integrated circuit (OASIC); (ii)
enclosure mounted on the chip; and (iii) the enclosure showing bacterial biosensing cells
on agar plug. A tight seal between chip and enclosure is maintained by using an O-ring.
Figure copyright of Simpson et al.71
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Figure 9. Fiber optic-based miniaturization. An optical fiber is placed in a conical tube
containing the sample solution. The fiber optic tip is coated with an alginate matrix that
incorporates the sensing bacterial cells. Bioluminescence is triggered when the analyte
enters the cells and is recognized by the biosensing element. The bioluminescence
emitted travels to the detector through the optical fiber. Adapted from Polyak et al.74
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Figure 10. Schematic showing a BioLP™ device. A laser beam is focused on a spot at the
interface of the support and absorption layers, causing ejection of the sensing cells
containing material, which is then deposited on the substrate. Figure adapted from
Barron et al.76
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Figure 11. Example of centrifugal CD microfluidic platform. Reagent reservoirs contain
the necessary reagents, which flow through the mixing channels when the platform is
spun at high rpm. Finally the two solutions arrive in the detection reservoir where
measurements are made using a suitable detector. Copyright from Turner et al.98
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Figure 12. Three dimensional microfluidic network. (i) The solution of sensor cells is
immobilized in the wells of chip 1. (ii) Analyte solutions are introduced in channels of
chip 2. (iii) Schematic of the 3 dimensional structure of the platform. Copyright from
Tani et al.99
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Figure 13: Immobilization of whole-cell based biosensing system on paper strips. (A)
Detection of arsenic in water samples from Bangladesh. Total arsenic concentration
(μg/L) measured by atomic fluorescence spectroscopy is indicated in parentheses.
Copyright from Stocker et al.81 (B) Detection of AHLs in saliva samples using the filterpaper-based strip biosensor containing the plasmid pSD908. Samples 1−5 were from five
healthy volunteers and sample 6 was from one patient with Crohn’s disease. Copyright
from Struss et al.82

(A)

(B)
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Figure 14. Crystal structure of GBP without glucose (A, open form; PDB: 2FWO) and with
glucose (B, closed form; PDB: 2FVY).
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Figure 15. Protein biosensor based on molecular switch approach. The reporter protein
aequorin is split into two fragments; each fragment is fused to the two ends of the
recognition protein GBP. In the absence of glucose, the two fragments of aequorin are
separated from each other and no emission of light is observed (off mode). In the
presence of glucose, the two fragments of aquorin are brought close to each other due
to conformational changes in GBP, and emission of light is observed (on mode).
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Figure 16. Microfluidic architecture utilized in the protein-based assay. Copyright from
Puckett et al.95
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Table 1: Quorum sensing molecules utilized by various bacteria. (a) AHLs employed by
Gram-negative bacteria. (b) AI-2: borate diester form employed by V. harveyi and
hydrated form, not containing boron, employed by S. typhimurium. (c) Linear and cyclic
peptides employed by Gram-positive bacteria. The underlined tryptophan residue (W)
in the ComX pheromone indicates isoprenylation.
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Table 2: Reporter proteins commonly used in whole-cell sensing systems. Copyright
Struss et al.65
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STATEMENT OF RESEARCH
Bacteria communicate with members of the same species or other species by
production, secretion, and detection of small signaling molecules termed quorum
sensing molecules (QSMs), whose concentration is proportional to the bacterial cell
density. This system of cell-to-cell communication is named quorum sensing (QS) and
allows bacteria to modulate their behavior in a population-size dependent manner.
When a certain QSM threshold concentration is reached, certain specialized genes are
expressed that are involved in a variety of phenotypes, including, virulence factor
production, biofilm formation, motility, sporulation, and bioluminescence. In general,
Gram-negative bacteria utilize N-acyl homoserine lactones (AHLs), while Gram-positive
bacteria utilize autoinducing peptides (AIPs) as QSMs. Autoinducer-2 (AI-2) is a third
category of molecules that are employed, both, by Gram-negative and Gram-positive
bacteria and are believed to be involved in interspecies communication.
Bacteria have been associated with the pathogenesis of various disorders, such
as, inflammatory bowel disease (IBD), a chronic inflammatory condition of the intestine
with recurrent bouts of acute inflammation. Since QS is known to modulate various
bacterial functions,many of which are critical for bacteria to successfully colonize a host
and evade the host’s defense system, we aimed at studying the role of QS in relation to
bacterial conditions, mainly IBD. Specifically, we hypothesized that QSMs may serve as
biomarkers for the diagnosis and monitoring of bacteria related disorders, as well as for
the evaluation of treatment efficacy. To that end, we designed and developed
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biosensing systems, based on engineered cells and proteins, for the detection of QSMs
in physiological samples from IBD patients and control subjects. Moreover, bacteria are
known to be involved in the spoilage of food by forming biofilms and producing food
degrading enzymes, whose expression is often regulated by QS. Hence, we developed
methods for the detection of QSMs in food samples in order to investigate the
relationship between food spoilage and QS. Finally, we employed the developed
biosensing systems to test target compounds for their ability to disrupt QS and evaluate
their potential use as food preservatives.
In chapter two, we developed an analytical method for the detection of QS AI-2
molecules in saliva, stool, and intestinal samples. For that, we developed a whole-cell
biosensing system, which is based on the QS regulatory circuit of the marine bacterium
Vibrio harveyi and uses the LuxP periplasmic binding protein as the sensing/recognition
element and luxCDABE gene cassette as the reporter element. This method enabled the
quantitative and sensitive detection of AI-2 in the types of clinical samples mentioned
above. To the best of our knowledge this is the first reported cell-based sensing system
for quantitative detection of AI-2 molecules. This analytical approach has significant
advantages over physical chemical methods in terms of simplicity, rapidity, and costeffectiveness.
In chapter three, we developed, optimized, and applied whole-cell biosensing
systems to the detection of QSMs in blood serum. We utilized a panel of three
biosensing systems able to detect short-chain AHLs, long chain AHLs, and AI-2
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molecules, respectively. In order to validate our method, we confirmed the presence of
QSMs in serum by employing a conventional physical chemical technique, LC-MS-MS.
Furthermore, using a mice animal model of colitis, which represents an experimental
model of human IBD, we demonstrated altered serum levels of QSMs in colitic mice as
compared to the controls. This indicates that the QSM levels in serum may reflect the
known altered composition of the intestinal microflora in IBD (less diversity and
modified relative abundance of species), thus supporting our hypothesis of employing
QSMs as biomarkers of disease. To the best of our knowledge this is the first time that
the presence of QSMs in serum has been demonstrated. This is an important finding due
to the ready availability and minimally invasive collection of serum, as well as its
extensive use as the biological fluid of choice for a number of clinical laboratory
investigations.
In chapter four, we developed methods based on whole-cell sensing systems for
the detection of AHLs and AI-2 molecules in food samples. Ground beef and milk were
chosen as representative food matrices. After the method optimization, the biosensing
systems were employed to detect QSMs in simulated spoiled foods, obtained by
artificially contaminating the food samples. A wide variety of microorganisms are
responsible for food spoilage, thus rendering contamination difficult to identify; on the
other hand, QSM production is a feature shared by many bacteria, thus supporting the
use of QSMs as general quantitative markers of bacterial presence. To that end, the
analytical methods developed herein should allow for the early detection and
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prevention of food contamination, thus helping to minimize the related foodborne
illnesses and reduce the costs associated with the waste of degraded food.
In chapter five, we employed the developed whole-cell sensing systems for AHL
and AI-2 detection to test a number of compounds, originating from Generally
Recognized As Safe (GRAS) substances, for their ability to interfere with QS. The GRAS
compounds chosen in this study had previously been demonstrated to possess an
antibacterial effect, although their mechanisms of action had not been elucidated. To
that end, these compounds were evaluated for their effects on the QS circuits of the
sensing bacteria, in terms of ability to induce a sensor’s response and to interfere with
the sensor’s response to cognate QSMs. In addition, effects on the QSM synthesis by
QSM-producing bacteria were analyzed. Quorum sensing inhibition has been proposed
as an alternative approach to combat bacterial infections, especially in light of the
frequent occurrence of antibiotic resistant microorganisms. Along the same lines, the
identification of GRAS compounds with QS inhibitory properties may lead to their safe
and successful employment as food preservatives, in the form of food additives and/or
components of food packaging materials.
In chapter six, we designed and developed a protein based biosensing system for
the detection of AI-2 molecules. A fusion protein, comprised of the LuxP
recognition/binding protein and enhanced green fluorescent protein (EGFP), was
designed using molecular cloning techniques. The sensing system worked on the
principles of Förster Resonance Energy Transfer (FRET) and utilized the fluorophore 7-
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diethylamino-3-[N-(2-maleimidoethyl)carbamoyl]coumarin (MDCC) as donor and EGFP
as acceptor in the FRET pair, based on the ability of MDCC to bind to LuxP. This
biosensing system allowed us to quantitatively detect AI-2 molecules with high
sensitivity, selectivity, and rapidity (3 min incubation time with the analyte). It was then
applied to detect AI-2 in saliva and serum samples. A protein based sensing system
could also be employed as a rapid tool for the investigation and characterization of
agonists and antagonists, with potential to be utilized as QS disruptors.
In chapter seven, we discussed the conclusions and future prospects of the work
presented in this thesis.
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CHAPTER TWO
WHOLE-CELL SENSING SYSTEM FOR DETECTION OF THE QUORUM SENSING UNIVERSAL
SIGNAL AUTOINDUCER-2 IN PHYSIOLOGICAL SAMPLES
Introduction
Bacteria have long been considered as independently living organisms focused
on survival and propagation of single cells. However, in the past few decades it was
discovered that they can communicate with and respond to neighboring bacteria of the
same species or of other species by means of small signaling molecules 12,14. This system
of communication among bacteria is termed quorum sensing (QS). Quorum sensing
allows bacteria to regulate behaviors as diverse as bioluminescence, horizontal transfer
of DNA, sporulation, formation of biofilms, as well as production of pathogenic factors,
antibiotics, and metabolites12,100. Bacteria synthesize quorum sensing signaling
molecules and release them in the surrounding media, where they are recognized by
other bacteria. The signaling molecule concentration increases as a function of cell
density, thus allowing bacteria to sense their population size. When a threshold
concentration of signaling molecules is reached, bacteria express certain specialized
genes and, thus, coordinate their behavior in a cell-density dependent manner.
Interestingly, bacterial communication is often involved in establishing relationships of
bacteria with their respective hosts, both in beneficial and detrimental bacteria-host
interactions. Well-characterized examples of such relationships include the symbiosis
between the bioluminescent marine bacterium Vibrio fischeri and the Hawaiian bobtail
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squid Euprymna scolopes, as well as the pathogenesis caused by the human
opportunistic pathogen Pseudomonas aeruginosa, which colonizes the lungs of
individuals affected by cystic fibrosis101. Furthermore, recent research has shown that
bacterial signaling molecules enable interkingdom communication and are involved, for
instance, in the relationship of the intestinal microbial flora, both commensal and
pathogenic, with human and other mammalian hosts102,103. Bacteria employ various
chemical compounds as signaling molecules for quorum sensing communication. Some
of them are species-specific, while others are used by different species of bacteria.
Quorum sensing signaling molecules can be categorized based on the types of bacteria
that produce them. In general, Gram negative bacteria use N-acyl homoserine lactones
(AHLs) and Gram positive bacteria employ autoinducing peptides (AIPs) as quorum
sensing molecules. AHLs and AIPs are used for communication between bacteria of the
same species. Another group of molecules, collectively called autoinducer-2 (AI-2), are
found in culture supernatants of both Gram positive and Gram negative bacteria and are
used for inter-species communication12.
The term AI-2 refers to a group of interconverting molecules formed from a
common precursor, 4,5-dihydroxy-2,3-pentanedione (DPD), whose production in
bacterial cells is catalyzed by the LuxS enzyme. LuxS has a crucial function as it is
responsible for metabolism of the toxic intermediate S-adenosyl-L-homocysteine (SAH),
which is formed from S-adenosyl-L-methionine (SAM) upon the release of methyl groups
to be employed in the methylation of proteins, nucleic acids and metabolites. A two
step enzymatic conversion of SAH by Pfs and LuxS enzymes produces DPD as a
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byproduct. DPD undergoes spontaneous cyclization to generate either the R or S form of
the

thermodynamically

favorable

compound,

2,4-dihydroxy-2-methyldihydro-3-

furanone (DHMF). In the presence of water and borate, S-DHMF forms S-THMF-borate
(Figure 1), a furanosyl borate diester, which is the form of AI-2 employed for QS
regulation of bioluminescence in Vibrio harveyi104. AI-2 diffuses out of the cells and,
upon entering other cells and binding to the periplasmic binding protein LuxP, triggers a
cascade of phosphorylation/dephosphorylation events ultimately leading to the
expression of luciferase and production of light48.
Bacterial quorum sensing molecules, namely AHLs, have been identified in
physiological samples, such as sputum samples of patients with cystic fibrosis 8,25,26.
Studies have shown that not only quorum sensing molecules activate bacterial virulence
systems and bacterial proliferation at a particular defined cell density, but also modulate
the host immune system to the advantage of bacteria 105. Bacteria are known to play an
important role in many diseases, from infections to chronic inflammation. Therefore,
quorum sensing is involved in a variety of disorders of bacterial origin or where bacteria
play a crucial pathogenic role. One such condition is inflammatory bowel disease (IBD), a
chronic inflammation of the gastrointestinal (GI) tract that includes debilitating diseases
such as ulcerative colitis (UC) and Crohn’s disease (CD). The inflammation in ulcerative
colitis is concentrated in the colon as has a continuous distribution, whereas Crohn’s
disease encompasses inflammation in the ileum and other regions of the alimentary
tract in patches106. Both diseases are characterized by periods of increased
inflammatory activity that can occur against a background of chronic ongoing
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inflammation. The causes of IBD are not fully elucidated. However, studies carried out in
animals and humans have established that gut bacterial flora play an essential role in
these inflammatory states of the bowel. Specifically, IBD appears to be caused by an
overly aggressive immune response to commensal enteric bacteria in genetically
predisposed individuals107. Hence, monitoring of quorum sensing molecules over the
course of time can give an idea of the bacterial load, extent of inflammation and
progress of the disease. Recently, our group has developed whole-cell sensing systems
for the detection of AHLs and shown that these signaling molecules are present at
distinct concentrations in saliva and stool samples from CD patients and infants with
various types of intestinal inflammatory illnesses. These results suggest that quorum
sensing molecules may be potential non-invasive biomarkers of gastrointestinal
inflammatory disease27.
A bioassay based on the V. harveyi strain BB170, which is able to emit
bioluminescence in the presence of AI-2 molecules, was developed by Bassler et al.16.
This bioassay has mainly been employed to screen cell culture supernatants to identify
and investigate bacteria able to produce AI-2; as such, it has not been characterized in
terms of analytical performance and standardized for detection of AI-2 in clinical
samples. Herein, we present the design, development, optimization, standardization,
and characterization of a biosensing system based on V. harveyi BB170, as well as its
application for the quantitative detection of AI-2 in saliva, stool and intestinal samples
from IBD patients and control subjects.
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Experimental Section
Materials: Sodium chloride and anhydrous magnesium sulfate were purchased from
Sigma (St. Louis, MO). Vitamin free casamino acids were purchased from BD Scientific
(Franklin Lakes, NJ). Autoinducer-2 was purchased from Omm Scientific (Dallas, TX).
Reverse osmosis (RO) filtered water (Milli-Q water purification system, Millipore,
Bedford, MA) was utilized for all experiments. Sterile 14-mL culture tubes were
purchased from BD Biosciences (San Jose, CA). 1.5-mL microcentrifuge tubes were
purchased from Eppendorf (Westbury, NY). 96-well polystyrene microtiter plates were
purchased from Costar (Corning, NY). The orbital shaker incubator was from Fisher
Scientific (Fair Lawn, NJ). Bioluminescence measurements were performed using the
FLUOstar Optima microplate reader (BMG Labtech, Durham, NC).
Bacterial Strain and Culture Conditions: V. harveyi strain BB170 was purchased from
ATCC (Manassas, VA). The BB170 strain is genetically modified to express luciferase and
emit light only in response to the autoinducer-216. The autoinducer bioassay (AB) media
described by Greenberg et al. was used to grow cells108. Cells were grown overnight in
AB media in the orbital shaker at 30 °C, 250 rpm and glycerol stocks were prepared by
adding 250 µL glycerol to 750 µL cell culture; the stocks were then stored at -80 °C.
Fresh cell cultures were grown from the glycerol stocks as needed by incubation in the
orbital shaker at 30 °C, 250 rpm until an optical density at 600 nm (O.D. 600nm) of 0.010.02 was reached.
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Sample Collection and Preparation. Saliva, stool and intestinal samples were assayed
for the presence of AI-2 molecules. Saliva and intestinal samples were obtained from
patients with inflammatory bowel disease in the Gastroenterology Clinic of the
University of Kentucky Medical Center (Lexington, KY). Intestinal samples were
comprised of rectal samples, which can be assimilated to stools, and ileal as well as
duodenal washings collected during endoscopy. Saliva samples were also obtained from
healthy volunteers. Additionally, stool samples were obtained from infants in the
Newborn Intensive Care Unit (NICU) of the University of Kentucky Medical Center. Saliva
samples were collected in the morning immediately after brushing the teeth in order to
minimize collection of oral bacteria and debris. They were then processed by
centrifugation in sterile microcentrifuge tubes at 13,000 rpm for 7-8 minutes to facilitate
settling of any debris and particles to the bottom of the tubes. Supernatants were then
stored in sterile tubes at -80 °C till needed. For analysis, saliva samples were diluted 1:10
(v/v) and 1:100 (v/v) using RO filtered water. Stool and intestinal washing samples were
frozen right after collection and stored at -80 °C until assayed. Stool samples were
prepared for analysis by weighing certain amounts of specimens and then suspending
and diluting them in RO filtered water to a final dilution of 1:750 (w/v). Washing
samples were analyzed directly without any sample preparation.
Dose-Response Curves. A commercially available 3.9 mM stock solution of AI-2 in water
was employed. Just before use, the stock solution was serially diluted with RO filtered
water to prepare AI-2 standard solutions at concentrations ranging from 1 × 10 -4 M to
2.5 × 10-8 M. RO filtered water served as blank. 10 µL of each AI-2 standard solution and
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blank was added in triplicate to the microtiter plate wells containing 90 µL of cell culture
grown to an O.D.600nm of 0.010. The plate was incubated in the orbital shaker at 30 °C,
175 rpm for 2.5 hours. Bioluminescence was recorded in the microplate reader and
measurements were expressed as relative light units (RLU) and plotted using Microsoft
Office Excel 2007.
Dose-Response Curves in Saliva and Stool Matrices. Dose-response curves were
generated in saliva and stool matrices. A pool of saliva was prepared by mixing equal
volumes of processed saliva samples obtained from healthy volunteers. Pooled saliva
was then diluted 1:100 (v/v) with RO filtered water. The 3.9 mM stock solution of AI-2
was serially diluted with 1:100 (v/v) pooled saliva to prepare AI-2 solutions at
concentrations ranging from 1 × 10-4 M to 2.5 × 10-8 M. A solution containing 1% RO
filtered water in 1:100 (v/v) pooled saliva served as blank. 10 µL of each AI-2 solution
and blank was added in triplicate to the microtiter plate wells containing 90 µL of cell
culture, and the assay was performed as described above. A dose-response curve
without matrix was also obtained in the same analytical run, which served as a
reference. In order to prepare a pool of stool samples, 10 samples from infants admitted
to the NICU were weighed in equal amounts, mixed together, and then suspended and
diluted 1:750 (w/v) in RO filtered water. The 3.9 mM stock solution of AI-2 was serially
diluted with 1:750 (w/v) pooled stool to prepare AI-2 solutions at concentrations
ranging from 5 × 10-4 M to 5 × 10-8 M. A solution containing 1% RO filtered water in
1:750 (w/v) pooled stools served as blank. 10 µL of each AI-2 solution and blank was
added in triplicate to the microtiter plate wells containing 90 µL of cell culture, and the
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assay was performed as described above. A typical dose-response curve without matrix
was also obtained in the same analytical run as a reference.
Analysis of Physiological Samples. Collection and processing of saliva, stool and bowel
secretion samples is described above. A final volume of 10 µL of each of the processed
samples was added in triplicate to the microtiter plate wells containing 90 µL of cell
culture, and the assay was performed as described above. Each analytical run included a
dose-response curve generated using standard AI-2.

Results and Discussion
Several recent reports implicate intestinal microorganisms in the pathogenesis of
IBD. Studies on animal models have shown that IBD does not occur in germ free
environments and that enteric bacteria are essential for development of colitis109. A
number of bacteria have been postulated to play a role in the pathogenesis of Crohn’s
disease, including Mycobacterium avium subspecies paratuberculosis, Pseudomonas
species, adherent-invasive Escherichia coli, and Streptococci106; however, no definitive
evidence exists to support any specific microorganism as the causative agent of IBD.
Additionally, some Crohn’s patients subjected to prolonged treatment with antibiotics
have shown improvement110, indicating that bacterial flora must play a crucial role in
IBD. Importantly, it has been demonstrated that the bacterial composition of IBD
inflamed intestine differs from that of healthy intestine, with decreased microbial
diversity and increased relative abundance of certain taxa in IBD 111,112.
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The above mentioned reports, along with other published data point to the presence of
bacterial quorum sensing molecules in human samples; however, only a few analytical
studies have been performed to identify and quantify these signaling molecules in
physiological specimens. Kumari et al. have utilized whole-cell based biosensing systems
for detecting and quantifying nanomolar levels of AHL molecules in complex clinical
samples, like saliva and stool27. Sperandio et al. report that fecal filtrates contain AI-2,
although quantitative analysis has yet to be performed 113. Recently, Campagna et al.
have utilized liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS)
to quantify AI-2 molecules in saliva of healthy individuals114. The method required
analyte derivatization, which is time consuming and may result in inaccurate
measurements caused by low efficiency of the derivatization reaction due to the
complex nature of the biological matrix.
Herein we developed, optimized, and characterized a whole-cell sensing system
based on V. harveyi BB170 for the quantitative detection of AI-2 in physiological
samples, i.e., saliva, stool and intestinal fluids, from healthy individuals as well as IBD
patients. The bioluminescent bacterium V. harveyi, in its natural wildtype form has
multiple parallel quorum sensing circuits that regulate bioluminescence. Among those,
there is a circuit that responds to AHLs and another one to AI-2 (Figure 2). The V. harveyi
BB170 variant employed in this study was, in contrast, genetically modified to only
respond to AI-2. When AI-2 enters the cells, it binds to the periplasmic binding protein
LuxP, which undergoes a change in conformation upon binding to AI-2 and initiates the
transcription of the luxCDABE cassette, which codes for bacterial luciferase and other
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enzymes that catalyze the synthesis of the luciferase substrate. Thus, presence of AI-2
triggers the expression of luciferase, its substrate, and ultimately results in the
generation of bioluminescence. In the optimized conditions described in this work, the
light signal derived from the luciferase-dependent reaction is proportional to the AI-2
present in the environment of the sensing cells. Therefore, the whole-cell sensing
system is appropriate for monitoring the levels of AI-2 in saliva, stool, and intestinal
washing samples. It is well established that the concentration of biomolecules and drugs
in saliva reflects their systemic concentration because of the ability of many substances
to reach saliva via intracellular and extracellular routes115. On the other hand, stool and
rectal samples as well as intestinal washings are considered to be representative of the
environment present in the bowel116.
As mentioned above, the V. harveyi strain BB170 has been employed as the
detection element in a bioassay aimed at investigating the ability of a variety of bacterial
species and strains to produce AI-2. For that, the bacteria under examination are grown
for a period of time and the culture supernatants are then exposed to the reporter
strain for induction of bioluminescence due to the presence of AI-2. The conventional
experimental protocol employed in these studies is time-consuming (4 hours) and only
provides qualitative data117,118. In that regard, the goal of this work was to develop a
whole-cell sensing system based on V. harveyi BB170 for the quantitative detection of
AI-2 molecules in physiological samples. To that end, we first developed a sensing
system for the detection of AI-2 quorum sensing molecules. We then optimized and
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standardized the experimental protocol for effective and efficient use of the biosensing
system in clinical applications.
Modifications to the conventional assay protocol allowed for a 40% reduction in
time to perform the entire assay (2.5 h vs. 4 h). By exposing the sensing cells to standard
solutions containing various concentrations of AI-2, we were able to establish a doseresponse curve with a detection limit of 2.5 × 10-8 M AI-2 and a dynamic range of 2.5 ×
10-8 M to 1 × 10-5 M. The limit of detection (LOD) was defined as sum of the average of
the blank signal and three times its standard deviation. The sensing system proved to be
precise and reproducible, with intra- and inter-assay percent relative standard deviation
(%RSD) values less than 8%. It is noteworthy to point out that the limit of detection
obtained with our whole-cell sensor is well below the levels of AI-2 found in human
saliva (244-965 nM) by Campagna et al. using LC-MS/MS119. This further supports the
applicability of the cell-based sensing system to the analysis of physiological/clinical
samples.
When the whole-cell biosensing system was used for detection of AI-2 in stool,
significant quenching of the bioluminescence signal was observed. Dilution studies
were then performed in order to determine a proper stool dilution that did not show
any matrix interference (data not shown). A 1:750 (w/v) dilution of stool with RO
filtered water was found to be required to eliminate matrix effect. A dose-response
curve was constructed in 1:750 diluted pooled stool samples and compared with a
standard dose-response curve (Figure 3). As observed in the figure, the two dose-
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response curves virtually overlapped and exhibited similar analytical characteristics
(Table 1). Thus, a 1:750 (w/v) dilution was chosen to test unknown stool samples. A
matrix effect was also observed when saliva samples were analyzed directly, without
dilution. A dose-response curve was obtained by adding AI-2 solutions at known
concentrations to a pool of saliva samples, which showed signal intensities lower than
those observed when the dose-response curve was generated with known AI-2
standards in water. Optimization studies determined that a 1:100 (v/v) dilution of saliva
was able to eliminate the matrix effect and allowed for the generation of analytically
sound dose-response curves (Figure 4). The analytical parameters of dose-response
curves obtained in different matrices are reported in Table 1.
After optimizing the assay conditions, we employed the whole-cell sensing
system to detect AI-2 levels in individual saliva, stool, and intestinal samples collected
from IBD patients and healthy subjects (Table 2). The obtained data proved that AI-2
was detectable in all three different types of samples. Although only a few samples were
analyzed, it is interesting to observe that distinct levels of AI-2 were detected in the
tested samples. Specifically, AI-2 levels varied considerably in stool samples from IBD
patients, which may support the hypothesis that variations in the concentrations of
QSMs in those samples may reflect perturbation of the microflora in the inflamed
intestine111,112. To the best of our knowledge, this is the first time that the levels of AI-2
are quantified in human stool and intestinal samples. The results obtained point out to
a potential use of our method as a rapid and inexpensive tool for diagnosis and
monitoring of bacterial-related conditions, including IBD, where bacteria is thought to
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play an important role. We postulate that correlation of AI-2 levels in physiological
samples with the status of the disease may have implications in the potential use of AI-2
as a biomarker of disease.

Work toward the verification of this hypothesis by

performing clinical studies is underway in our laboratories.
Conclusion
In conclusion, we have designed, developed and optimized a whole-cell based
biosensing system that allows for quantitative detection of AI-2 quorum sensing
molecules in human samples. When employed for the detection of AI-2 in physiological
specimens, the method proved to be rapid, reproducible, and sensitive, with a detection
limit of 2.5 × 10-8 M. Additional advantages of the method lie in the requirement of
small unprocessed sample amounts (approximately 1 µL of saliva and less than 1 mg of
stool) and the potential for high-throughput analysis which are important for clinical
applications, such as monitoring of IBD patients for their AI-2 levels over a period of
time. This sensing system should also be applicable to other bacteria-related conditions.
Furthermore, the analytical features of this method make it amenable to investigation
of compounds that may act as agonists or antagonists in the AI-2-mediated QS system;
this may lead to the identification of QS inhibitors that could be employed as drugs in an
alternative approach for the treatment of bacteria-related disorders.
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Figure 1. Synthesis of DPD in bacteria. By the action of methyltransferases, Sadenosylmethionine (SAM) is converted to S-adenosylhomocysteine (SAH). SAH is
metabolized to adenine and S-ribosylhomocysteine (SRH) by Pfs enzyme. SRH is the
substrate for the enzyme LuxS catalyzing the synthesis of 4,5-dihydroxy-2,3pentanedione (DPD). (b) DPD undergoes spontaneous cyclization and forms (2R,4S)- and
(2S,4S)-2,4-dihydroxy-2-methyldihydrofuran-3-one (R- and S-DHMF, respectively). Rand S-DHMF undergo hydration to form (2R,4S)- and (2S,4S)-2-methyl-2,3,3,4tetrahydroxytetrahydrofuran (R- and S-THMF, respectively). In the presence of borate,
S-THMF converts to (2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran-borate (STHMF-borate), i.e., the autoinducer-2 form utilized by Vibrio harveyi. R-THMF is the
autoinducer-2 form utilized by other bacteria, such as, Salmonella typhimurium. Figure
copyright from Xavier et al.19
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Figure 2. Quorum sensing regulation of bioluminescence in V. harveyi BB170. System 1,
which uses an AHL as quorum sensing molecule, has been silenced. Therefore,
production of bioluminescence only depends on AI-2 (System 2).
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Bioluminescence Intensity
(RLU)

Figure 3. Standard dose-response curve (black) compared with dose-response curve in
1:750 (w/v) stool (red).
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Figure 4. Standard dose-response curve (blue) compared with dose-response curve in
1:100 saliva (red).
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Table 1. Analytical parameters of the whole-cell biosensing system in buffer and
physiological matrices.
Signal Intensity
with 5 x 10-5 M
AI-2
(× 104 RLU)
Buffer
1:750 (w/v)
Stool
1:100 (v/v)
Saliva

Signal Ratio

7.9

1

7.1

1.11

7.7

1.03
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LOD
(M)

Dynamic Range
(M)

2.5 × 10- 2.5 × 10-8 - 5.0 ×
8
10-5
5.0 × 10- 5.0 × 10-8 - 5.0 ×
8
10-5
2.5 × 10- 2.5 × 10-8 - 5.0 ×
8
10-5

Table 2. Detection of AI-2 in clinical samples from IBD patients (white) and healthy
subjects (gray).
Samples
Stool 1
Stool 2
Ileal washing
Saliva 1
Saliva 2
Saliva 3
Saliva 4
Saliva 5
Saliva 6

Signal Intensity
(× 104 RLU)

%RSD

1.8
3.8
2.5
2.5
2.4
1.9
1.2
1.3
2.3

6
7
7
6
10
1
6
5
6
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CHAPTER THREE
DETECTION OF QUORUM SENSING MOLECULES IN BLOOD SERUM

Introduction
Bacteria are known to cause a variety of disorders from acute and chronic
infection to inflammation, within and on the surface of the human body. Bacterial
infections can be caused by a variety of microorganisms and result in mild to lifethreatening conditions. Furthermore, certain bacteria are involved in chronic diseases,
such as, inflammatory bowel disease (IBD)120 and cystic fibrosis26. A notable feature of
bacteria is their ability to form biofilms. Biofilms were first reported by J. W. Costerton
in 1978; using light and electron microscopy, he demonstrated the presence of biofilms
on inanimate surfaces in an aquatic environment121. The presence of biofilms in cystic
fibrosis lung infections has been shown by Singh et al.25. Bacterial infections are
generally treated by antibiotic administration. Formation of biofilms contributes to
pathogenicity and makes the treatment less effective as bacteria are encased in a matrix
composed of polysaccharides and proteins that reduces the contact between bacteria
and antibacterial agent122. In addition, due to extensive usage of antibiotics, several
pathogenic bacteria have gained antibiotic resistance through mutations and lateral
gene transfer. Indeed, alternative strategies against bacterial infections that involve new
classes of antibiotics are needed more than ever. In that regard, compounds that are
inhibitors of quorum sensing, the mechanism by which bacterial cells communicate and
ultimately leads to biofilm formation, provide with a new approach to combating
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bacterial infection. Other bacterial behaviors such as virulence factor production,
swarming, and motility are also modulated through quorum sensing. Bacterial quorum
sensing circuits operate via synthesis and secretion of small organic molecules, termed
as quorum sensing molecules (QSMs), which are recognized by bacteria of the same
species

(intra-species

communication)

or

of

other

species

(inter-species

communication). Once these molecules enter the bacterial cell, they initiate a cascade
of events leading to the expression of certain target genes. A general schematic of the
quorum sensing circuits in the pathogenic bacterium Pseudomonas aeruginosa is shown
in Figure 1. The expression of the aforementioned genes is regulated in a cell-density
dependent manner. When cell density is low, the amount of QSMs in the environment
around bacteria is low and the expression of genes is repressed. As the cell density
gradually increases, the amount of QSMs in the environment also increases
proportionally and, when a certain QSM threshold concentration is reached, the genes
are expressed12. Gram-negative bacteria utilize N-acyl homoserine lactones (AHLs) and
Gram-positive bacteria utilize autoinducing peptides (AIPs) for intra-species
communication. A third category of molecules, known as autoinducer-2 (AI-2), is used
for interspecies communication as the genes coding for the proteins that either
synthesize or bind AI-2 are present in both Gram-negative and Gram-positive bacteria.
Recently, Sperandio et al. postulated that a new type of QSM, autoinducer-3, is involved
in interkingdom communication between bacteria and their hosts17. Figure 2 lists few
examples of QSMs and the bacteria that synthesize them.
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Reports relating quorum sensing to bacterial infections have emerged in the last
decade. Singh et al. reported the presence of biofilms of the pathogenic bacterium P.
aeruginosa in the lungs of cystic fibrosis patients. It has been demonstrated that the
presence of biofilms reduce the effectiveness of even aggressive antibiotic treatment25.
Two AHLs, N-butyryl-L-homoserine lactone (C-4 HSL) and N-(3-oxododecanoyl)-Lhomoserine lactone (3-oxo-C-12 HSL), used by P. aeruginosa to control biofilm
formation as well as virulence determinant production, were identified in sputum
samples from these patients. The significance of quorum sensing in burnt wound
infections in mice was demonstrated by Rumbaugh et al. who found that mice infected
with mutant strains of P. aeruginosa that were unable to synthesize AHLs had lower
levels of virulence expression as compared to those infected with wild type P.
aeruginosa22. Another study also highlighted the importance of quorum sensing using a
mouse model with ascending urinary tract infections123. These studies demonstrate the
relevance of detecting and quantifying QSMs. If a relationship between levels of QSMs
in physiological specimens and status of the disease is established, QSMs could be used
as biomarkers of bacteria-related disorders.
The most common techniques to detect QSMs include various physical-chemical
methods and biosensing systems. Physical-chemical methods, such as, GC-MS124,125,
HPLC-UV126, and LC-MS-MS127 require extensive sample preparation steps, often
including derivatization119, expensive instrumentation, and specialized laboratory
personnel, along with being time consuming and low throughput. While protein-based
biosensing systems to detect QSMs are rapid, cost-effective, and easy to use, they are
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limited by the stability of the sensing proteins in biological matrices and relatively high
limits of detection128. Our group developed and employed two bioluminescent bacterial
whole-cell biosensing systems based on the recognition and signal generation afforded
by plasmids pSB406 and pSB1075, respectively, to detect with high sensitivity,
selectivity, and reproducibility short and long chain AHLs in human saliva and stool 27.
Bodily fluids such as saliva and blood are known to contain a variety of small molecules
and proteins, many of which have been investigated for potential utility as biomarkers
of diseases. We have previously demonstrated that AHLs are present in saliva and stool
specimens27. However, until now blood has not been studied for the presence of QSMs.
Blood transports oxygen and nutrients to cells and takes metabolic waste away from
cells. In addition, it helps maintain body temperature, regulates pH, and allows
protection against foreign agents by the action of white blood cells. Furthermore, blood
represents one of the most commonly used fluids where clinically relevant molecules
and drug metabolites are detected.
In this study we aimed at investigating blood for the detection of QSMs. To the
best of our knowledge, this is the first time that the presence of AHLs in blood serum is
reported. Moreover, we validated our findings, which were achieved in human blood
serum employing whole-cell sensing systems, by analyzing the serum samples using LCMS-MS. Furthermore, we demonstrated that AHLs can also be detected in animal
serum. Specifically, in order to support the hypothesis of employing QSMs as biomarkers
of disease, we report the results of a pilot study investigating the effects of
experimentally induced colitis on the serum and stool levels of QSMs in mice models.
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Experimental section
Materials. N-hexanoyl-DL-homoserine lactone (C-6 HSL), N-dodecanoyl-DL-homoserine
lactone (C-12 HSL), sodium chloride, anhydrous magnesium sulfate, Luria Bertani (LB)
media, ampicillin, and kanamycin were purchased from Sigma-Aldrich (St. Louis, MO).
Acetonitrile and methylene chloride used in all experiments were of HPLC grade and
were purchased from VWR Scientific (Pittsburgh, PA). AI-2 was purchased from Omm
Scientific (Dallas, TX). The 96-well microtiter plates were purchased from Costar
(Corning, NY). Vitamin free casamino acids were purchased from BD Biosciences
(Franklin Lakes, NJ).
Plasmids, bacterial strains, and culture conditions. The plasmids pSB406 and pSB1075
were originally provided by Dr. Paul Williams (University of Nottingham, Nottingham,
UK) and previously transformed in Escherichia coli JM109 cells. The transformed cells
were then stored at -80 °C as glycerol stocks. Fresh cell cultures were obtained from the
glycerol stocks and grown in LB media (100 µg/mL aAmpicillin) overnight in an orbital
shaker at 37 °C, 250 rpm, refreshed in the morning, and allowed to grow until an optical
density at 600 nm (OD600nm) of 0.45-0.50 was reached. Vibrio harveyi MM32 cells were
purchased from American Type Culture Collection (ATCC), and glycerol stocks were
stored at -80 °C. Fresh cell cultures were obtained by growing cells in autoinducer
bioassay (AB) media with 30 µg/mL of kanamycin overnight in the orbital shaker at 30
°C, 250 rpm, and then refreshing the cultures in the morning to obtain an OD 600nm of
0.01-0.02. The procedure to prepare AB media has been described elsewhere 16,129.
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Dose-response curves. Commercially available N-acyl-homoserine lactones were
dissolved in acetonitrile to obtain 1 x 10-2 M stock solutions, which were serially diluted
with RO filtered water to obtain standard solutions at concentrations ranging from 1 x
10-4 M to 1 x 10-8 M. A 1% (v/v) solution of acetonitrile in RO filtered water (0.1% (v/v)
acetonitrile after adding to the sensing cell suspension) was used as blank. This amount
of acetonitrile was not toxic for the sensing cells. A volume of 10 μL of each of these
solutions was added in triplicate to a 96-well white polystyrene microtiter plate
containing 90 µL/well of the corresponding E. coli cell culture grown to an OD600nm of
0.45-0.50. C-6 HSL solutions were employed for the whole-cell sensor with pSB406,
while C-12 HSL solutions were employed for the whole-cell sensor with pSB1075. The
microtiter plate was then incubated in an orbital shaker at 37 °C at 175 rpm for two
hours. Commercially available aqueous AI-2 solution (3.7 × 10-3 M) was serially diluted
using RO filtered water to obtain solutions at concentrations ranging from 1 × 10 -4 M to
1 × 10-8 M. RO filtered water was used as blank. A 10 µL volume of each AI-2 solution
and blank in triplicate was incubated with 90 µL of V. harveyi MM32 cell culture grown
to an OD600nm of 0.01-0.02, in a microtiter plate. The produced bioluminescence from all
the sensing systems was then measured using the FLUOstar Optima microplate reader
(BMG Labtech, Durham, NC). The light intensity was expressed in relative light units
(RLU).
Human blood serum samples. Blood serum samples were obtained from IBD patients
and healthy volunteers (Division of Gastroenterology, Department of Medicine,
University of Miami Miller School of Medicine). Individual serum samples were stored at
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-80 °C until analyzed. To prepare a pool of serum for matrix effect studies, equal
volumes of serum samples from various healthy individuals were mixed together in a
14-mL tube and vortexed for 5 minutes. Several aliquots of pooled serum were prepared
and stored at -80 °C until needed.
Serum dilution study. One aliquot of pooled serum was removed from -80 °C, thawed,
and equilibrated to room temperature. To test for potential matrix effect, the serum
was serially diluted with RO filtered water to obtain 1:10, 1:100, and 1:1000 dilutions.
Each standard QSM (C-4 HSL, C-12 HSL, or AI-2) was added to aliquots of undiluted and
diluted serum to achieve a final 1 × 10-6 M concentration. A 10 µL volume of each of
these spiked and non-spiked serum samples at various dilutions was added in triplicate
to 90 µL of the appropriate sensing cells, and the assay was performed as described
above. A dose-response curve with the respective QSM was also included in each
analytical run.
Dose-response curves in serum matrix. 1 × 10-2 M stock solutions (prepared in
acetonitrile) of C-6 HSL and C-12 HSL were serially diluted with 1:10 serum/water
solution to obtain AHL concentrations ranging from 1 × 10 -4 to 1 × 10-8 M. Acetonitrile at
1% in the 1:10 serum/water solution was used as blank. Similarly, the available stock of
AI-2 (aqueous solution at 3.7 × 10-3 M) was serially diluted with 1:10 serum/water
solution to obtain AI-2 concentrations ranging from 1 × 10-4 to 1 × 10-8 M. A 10 µL
volume of each of these solutions was added in triplicate to the wells of a microtiter
plate, followed by addition of 90 µL of cell culture of the respective biosensing system.
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The assay was then performed as described above. A reference dose-response curve
was included in each analytical run.
Serum storage study. Aliquots of pooled serum were spiked with C-6 HSL to obtain final
concentrations in serum of 1 × 10-6 M and 1 × 10-7 M. Three sets of spiked serum
samples were prepared; the first set was assayed immediately, the second set was kept
at room temperature for six hours and then assayed, and the third set was kept at room
temperature for two hours, later stored at -80 °C for 48 hours, and then assayed. Final
concentration of Serum containing RO filtered water, instead of C-6 HSL solution, was
used as blank for each storage condition. Aqueous solutions of C-6 HSL at 1 × 10-6 M and
1 × 10-7 M concentrations served as controls. The serum samples were diluted 1:10 using
RO filtered water, 10 µL of each diluted sample was added in triplicate to a microtiter
plate containing 90 µL/well of the whole-cell biosensing system bearing pSB406, and the
assay was carried out as described above.
Analysis of human serum samples. After optimizing the experimental conditions,
individual serum samples were diluted 1:10 using RO filtered water. A 10 µL volume of
each diluted sample was added in triplicate to the wells of a microtiter plate and
incubated with 90 µL of cell culture of each of the biosensing systems for detection of
short chain AHLs, long chain AHLs, and AI-2, respectively. The assays were performed as
described above.
LC-MS-MS analysis of serum samples.
Preparation of AHL standard solutions. Commercially available standard N-acylhomoserine lactones were dissolved in acetonitrile to obtain 1000 μg/mL solutions.
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Twenty microliters of each of these 1000 μg/mL solutions of N-butyryl-DL-homoserine
lactone (C-4 HSL), N-hexanoyl-DL-homoserine lactone (C-6 HSL), N-(3-oxohexanoyl)-DLhomoserine lactone (3-oxo-C-6 HSL), N-octanoyl-DL-homoserine lactone (C-8 HSL), Ndecanoyl-DL-homoserine lactone (C-10 HSL), N-dodecanoyl-DL-homoserine lactone (C12 HSL), and N-tetradecanoyl-DL-homoserine lactone (C-14 HSL) was added to 860 μL of
methanol/water (35:65, v/v) with 0.1% formic acid, in order to obtain a stock mixture
solution containing 20 μg/mL of each of the seven AHLs. From this stock solution, AHL
standard mixture solutions, which contained 50, 25, 10, 5, 1, and 0.5 ng/mL of each AHL,
respectively, were prepared for calibration. N-heptanoyl-DL-homoserine lactone (C-7
HSL) was used as an internal standard (since C-7 HSL is not produced by bacteria) for all
the standard mixtures. A specific volume of 1 μg/mL solution of C-7 HSL in
methanol/water (35:65, v/v) with 0.1% formic acid was added to each of the standard
mixture solutions to achieve a final internal standard concentration of 25 ng/mL. These
standard mixture solutions with the added internal standard served as laboratory
control spike (LCS) solutions. Similarly, a specific volume of 1 μg/mL internal standard
solution was added to water to obtain a final C-7 HSL concentration of 25 ng/mL. The
resulting solution served as blank.
Extraction of AHLs from serum samples. An extraction protocol similar to that used by
Kumari et al. to extract AHLs from saliva samples130 was employed with modifications in
this study. Briefly, an equivalent volume of acetonitrile was added to a pool of serum to
precipitate the proteins out. The precipitate formed was centrifuged and the
supernatant separated. The supernatant was then extracted using methylene chloride,
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evaporated to dryness, reconstituted using mobile phase to about 100 µL and C-7 HSL
was added as internal standard. The LC-MS-MS analysis was performed at the
Environmental Research Training Laboratories (ERTL) of the University of Kentucky as
previously described130.
Animal Study. Wild type C57BL/6 mice were purchased from Jackson Laboratories (Bar
Harbour, Maine). A total of nine mice, between 13 and 17 weeks of age, were used. In
the course of study, mice were fed manufacturer prescribed diet (LabDiet® 5K52/5K67).
Over a period of seven days, five mice were given a 3% aqueous solution of dextran
sulfate sodium (DSS) through drinking water (5 mL per day) to experimentally induce
colitis. Four mice that received equivalent amount of water, without DSS, served as
controls. Serum and stool samples were collected from both animal groups on day 0
(before DSS administration) and on day 7. Serum and stool samples were frozen at -80
°C immediately upon collection. Serum samples were processed and analyzed as
described above for human serum. Stool samples were processed by following the
procedure described by Kumari et al.27. Briefly, a 20 mg/mL suspension of stool was
prepared using 25:75 acetonitrile/water solution and diluted using RO filtered water to
obtain a 1:1600 stool suspension. For analysis, a 10 µL volume of this stool suspension in
triplicate was then incubated with 90 µL of cell culture of each of the whole-cell sensing
systems. The assays were performed as described above.

Results and Discussion
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A biosensing system consists of a biological recognition component coupled to a
transducer component. A whole-cell biosensing system consists of the intact bacteria as
the recognition component; the bacteria are genetically engineered to generate a
readable output upon selective recognition of the analyte. The biosensing system
produces a dose-dependent readable output in response to the analyte. The whole-cell
biosensing systems carrying plasmids pSB406 and pSB1075 respond to short and long
chain AHLs, respectively. Plasmid pSB406 contains the gene rhlR, which codes for the
recognition/regulatory protein RhlR, and the reporter gene cassette luxCDABE, which is
under the transcriptional control of promoter PrhlI. Similarly, plasmid pSB1075 bears the
gene lasR, which codes for the recognition/regulatory protein LasR, and the reporter
gene cassette luxCDABE, which is under the transcriptional control of promoter PlasI. The
gene cassette luxCDABE encodes for the bioluminescent enzyme luciferase and enzymes
that catalyze the synthesis of the luciferase substrate. In the presence of AHLs, the
reporter is expressed in a dose-dependent manner and the produced bioluminescent
signal is proportional to the AHL concentration present inside the cell. In a similar
manner, the whole-cell biosensing system based on V. harveyi MM32 responds to AI-2
by producing bioluminescence in a dose-dependent fashion. V. harveyi is a
spontaneously bioluminescent marine microorganism that controls light emission
through various quorum sensing systems, which employ various QSMs. Specifically, the
bacterium uses QS circuits that utilize N-3-hydroxybutanoyl homoserine lactone (HAI-1),
(S)-3-hydroxytridecan-4-one (CAI-1), AI-2, and recently discovered nitric oxide (NO). V.
harveyi strain MM32 is genetically modified in such a way that it only emits
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bioluminescence in response to AI-2. Additionally, it lacks the gene luxS encoding for
LuxS protein, which synthesizes AI-215; in this way the cells do not produce their own AI2 and they can only produce bioluminescence in response to exogenous AI-2. Therefore,
this strain can be employed as a sensor that responds with emission of light to AI-2
present in the environment of the cells. In this work we optimized, characterized, and
utilized E. coli pSB406 and pSB1075 based whole-cell biosensing systems, and V. harveyi
MM32 based whole-cell biosensing systems, to detect AHLs and AI-2, respectively, in
blood serum samples.
In our studies, we collected individual blood serum samples from healthy
volunteers and mixed them together to obtain a pool of serum in order to take in
account possible variations between samples.

Serum electrolytes, antibodies,

hormones, and exogenous substances can affect the performance of biosensing
systems, and therefore, serum needs to be evaluated in terms of its potential matrix
effect on the determination of the AHLs in this sample. For that, dilution studies were
undertaken by preparing serial dilutions of serum with water followed by spiking studies
in which a known concentration of analyte was added to serum. Serum 1:10, 1:100, and
1:1000 dilutions were prepared using RO filtered water and incubated with the wholecell biosensing systems employed in this study. RO filtered water served as control.
When undiluted pooled serum was incubated with the whole-cell biosensing systems,
reduced bioluminescence was observed as compared to that of the control; the control
bioluminescence was due to the background signal of the sensing cells. However, signals
equivalent to that from the control were obtained from all the serum dilutions tested,
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which showed that the quenching/inhibiting matrix effect was eliminated at even a very
low dilution of the serum, i.e., 1:10 dilution of serum in water. These data were
confirmed by spiking the undiluted serum and above serial serum dilutions with a
known concentration of QSM and employing the corresponding whole-cell biosensing
system to detect the AHLs as described in the Methods Section. As an example, Figure 3
shows the results of the matrix effect studies performed using the whole-cell biosensing
system containing pSB406. Dose-response curves using 1:10 dilution of the serum were
then obtained. Standard solutions of QSMs were prepared by serial dilution in either
1:10 serum or water and incubated with the sensing cells. As shown in Figure 4 for
detection of short chain AHLs with the pSB406-based sensing system and AI-2 with the
V. harveyi MM32-based sensing system, the two dose-response curves of each sensing
system overlap, thus confirming that a 1:10 dilution of serum eliminates the matrix
effect. Similar results were obtained with the sensing systems for detection of long
chain AHLs. Limits of detection of 1 × 10-9 M for short and long chain AHLs, and of 5.0 ×
10-8 M for AI-2 were obtained in 1:10 diluted serum.
Following optimization and characterization of the sensing systems for use in
serum by evaluating and eliminating matrix effect through serum dilution, and defining
the analytical parameters of the sensing systems in serum, we analyzed the blood serum
samples obtained from IBD patients and control individuals. Inflammatory bowel
disease is a chronic inflammatory condition of the intestine, which is characterized by
recurrent acute inflammation episodes (flare-ups) over chronic persistent inflammation.
The most common forms of IBD are Crohn’s disease (CD), which mainly affects the small
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intestine as well as other parts of the gastrointestinal tract, and ulcerative colitis (UC),
which affects the colon. The causes of IBD are not well understood; it is believed that
several factors, including bacteria, play a role in the etiology of the disease. Specifically,
there is evidence that an overly aggressive immune response towards the intestinal
microflora occurs in genetically predisposed individuals131. Additionally, altered gut
bacterial composition, with less diversity and changed relative abundance of species,
has been demonstrated in IBD patients as compared to healthy subjects132. For this
study, we obtained 6 samples from control individuals, 10 samples from UC patients,
and 8 samples from CD patients. The serum samples were analyzed after a 1:10 dilution
with RO filtered water. When the whole-cell biosensing system containing plasmid
pSB406 was employed, short chain AHLs were detected in a number of samples.
Specifically, all control samples, except one, exhibited undetectable levels of AHLs; on
the other hand, AHLs were detected in the majority of IBD samples, with UC patient
samples showing a trend of higher bioluminescence signal intensities as compared to CD
patient samples (Figure 5). Each sample was tested at least twice to confirm the above
observation; consistent results were achieved, with good reproducibility as expressed by
percent relative standard deviation (%RSD) values ranging from less than 1% to 10%.
Although a limited number of samples were analyzed as proof of principle, the obtained
data suggest that the differences in intestinal bacterial composition between IBD and
healthy subjects, as reported in the literature, may be revealed by differences in QSM
levels in physiological samples. This would support the use of QSMs as biomarkers of
bacteria-related diseases. However, more samples derived from larger numbers of IBD
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patients and controls need to be analyzed in order to confirm the observed trend. When
the whole-cell biosensing system containing plasmid pSB1075 was employed, long chain
AHLs were not detected in any of the tested samples. Additionally, when samples were
analyzed using the MM32-based sensing system, none of them showed AI-2 levels in our
detection range. One could speculate that this may be due to limited stability of certain
QSMs, e.g., AI-2 in serum. On the other hand, stability of long chain AHLs in human
serum should not be an issue, as shown by the LC-MS-MS study discussed below.
Further investigations are required to clarify the obtained data.
Since no studies have previously reported the presence of QSMs in serum, we
deemed it necessary to confirm our findings using a conventional physical-chemical
technique, such as LC-MS-MS. Recently, our group developed an LC-MS-MS method to
detect AHLs in saliva130. In this work, using HPLC coupled to tandem mass spectrometry
and the above protocol with slight modifications, we were able to separate and
quantitate AHLs present in standard mixture solutions, with nanomolar limits of
detection. We subsequently analyzed pooled serum samples. Unlike saliva, serum forms
an emulsion if methylene chloride is used for AHL extraction. Therefore, we first
precipitated the proteins from serum by adding acetonitrile. This step ensured that AHLs
were solubilized in acetonitrile. After separating supernatant from precipitate,
methylene chloride extraction was performed; the extract was then evaporated, dried,
and reconstituted with mobile phase to run the sample on LC-MS-MS. As shown in
Figure 6, C-8 HSL, C-10 HSL, C-12 HSL, and C-14 HSL were detected in extracted serum
samples. The daughter ion analysis (Table 1) further confirmed the identity of AHLs that
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were present in serum. These results are significant because they support that AHLs are
actually present in serum and validate the use of whole-cell sensing systems for
detection of AHLs in this type of physiological sample.
Sample storage conditions are crucial when collecting and analyzing clinical
samples. To that end, we carried out a study where we spiked pooled serum samples
with C-6 HSL to obtain two final concentrations of, 1 × 10-6 M and 1 × 10-7 M, and then
stored these spiked samples in various conditions before assaying them with the wholecell biosensing system containing pSB406. The storage conditions tested were meant to
represent those actually employed when collecting patient serum samples in hospital
settings. After spiking, sets of serum samples were either assayed immediately, or after
being kept at room temperature for 6 hours, or after being kept at room temperature
for 2 hours followed by storage at -80 °C for 48 hours. We found that (Figure 7), among
these spiked serum samples, only those that were assayed immediately showed a
bioluminescence signal intensity similar to that of the control (same AHL concentrations
in water. This indicates that AHLs rapidly degrade in serum at room temperature; hence,
serum samples should not be left at room temperature and should rather be frozen as
soon as possible after collection.
While no reports are available with regard to stability of AI-2 in blood, few
studies have indicated that blood of mammals carries enzymes, known as paraoxonases
(PONs), which are capable of degrading AHLs133-136. In humans, three kinds of
paraoxonases have been identified – PON1, PON2, and PON3. PON1 and PON3 are
synthesized in the liver and secreted into the blood. PON2, which has the highest
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activity for AHLs hydrolysis, is expressed in many tissues, including brain, kidney, liver,
and testis, but not in blood. While PON1 and PON3 are mostly involved in hydrolysis of
organophosphates, both of them are active lactonases, although with activity much less
than that of PON2134,136. The presence of PON1 and PON3 in blood may affect the
stability of lactones, including AHLs, and thus affect the amount of AHLs detected.
Interestingly, one report has indicated reduced levels of PON1 enzymes in the serum of
CD and UC patients as compared to controls137. This reduced lactonase activity may
explain, at least in part, the higher levels of short chain AHLs that we observed in IBD
patients with respect to controls. In healthy individuals, higher levels of PON enzymes
may degrade AHLs more effectively, while in IBD patients lower levels of PON enzymes
are unable to degrade AHLs effectively, leading to accumulation in serum.
In order to further test the hypothesis that intestinal inflammation may be
associated with changes in the gut microflora, which can be detected by changes in
QSM production, we employed a well-established animal model of colitis and monitored
the QSM levels. Specifically, we used mice that were orally administered dextran sulfate
sodium (DSS) for 7 days to induce colitis40,138. DSS-induced murine colitis represents an
experimental model for human IBD. A group of five mice were treated with DSS, while a
group of 4 mice served as control. Serum and stool samples from all mice were collected
at day 0 and day 7. Serum samples were analyzed by using the protocol developed in
this work. Stool samples were analyzed by using a protocol that was previously
developed in our lab27. Figure 8 shows the comparison of long chain AHL levels between
day 0 samples and day 7 samples in control and DSS treated mice. At day 0, before the
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beginning of DSS treatment, the bioluminescence signals were nearly the same for most
samples, without distinctions between the two groups of animals, as expected. At day 7,
the control mice samples exhibited bioluminescence signals either at the same level or
higher than those at day 0. On the other hand, four out of five DSS treated mice showed
a marked decrease in bioluminescence signals. Further, it is important to note that a
similar trend was observed in all animals, with the exception of mouse DSS4, when
comparing the changes in AHL levels in stool and serum samples; for example, if the
serum AHL levels increased between day 0 and day 7 in a certain mouse, the stool AHL
levels also increased in that same mouse. These results further support the feasibility of
analyzing serum samples for AHL molecules. Although a very limited number of mice
were employed in this study, the data clearly suggested that, under the conditions of
colitis, changes in the levels of AHLs occurred that might be related to changes in
bacterial flora.

Conclusion
In conclusion, we successfully utilized whole-cell biosensing systems to detect
AHL molecules in serum samples of IBD patients and animal models. The method was
standardized using a pool of serum and 1:10 dilution allowed to overcome the serum
matrix effect. Nanomolar limits of detection were obtained in water as well as in 1:10
diluted serum. Similar slopes of the dose-response curves obtained in water and 1:10
diluted serum, indicating that whole-cell biosensing systems can be utilized to detect
AHLs in serum samples without loss of analytical performance. While we did not yet
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analyze a substantial number of samples, doing so may enable us to confirm our
observation that there is a difference between the levels of AHLs in control and IBD
samples, and between the levels of AHLs in the two types of IBD conditions, UC and CD.
As we analyze more serum samples, a relationship between the levels of AHLs in serum
and the status of the disease may be established, thus pointing out at the potential of
employing AHLs as biomarkers of IBD. Additionally, the ability to detect AHLs in serum
may also serve in studies aimed at investigating the role and relationship between the
levels of AHLs in serum and the concentration and activity of paraoxonase enzymes in
individuals suffering from IBD, which have been suggested to have quorum-quenching
activity137. These studies should aid in understanding the role of bacteria and, in general,
the microbiome in IBD.
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Figure 1. Schematic of LasI/LasR and RhlI/RhlR quorum sensing circuits in P. aeruginosa.
LasI catalyzes synthesis of 3-oxo-C-12 HSL (triangle), which accumulates in the
environment. At a threshold level, 3-oxo-C-12 HSL binds to LasR; 3-oxo-C-12 HSL bound
LasR activates transcription of several virulence genes along with the rhlR gene, which
encodes for RhlR, thus initiating the RhlI/RhlR quorum sensing circuit. RhlI catalyzes
synthesis of C-4 HSL (pentagon), which accumulates in the environment and, at a
threshold level, binds to RhlR. C-4 HSL bound RhlR activates transcription of target genes
including a subset of virulence genes. Adapted from Miller et al.12.
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Figure 2. Quorum sensing molecules. (A) N-acyl-homoserine lactones. (B) Autoinducer-2.
(C) Quinolone signaling molecule. (D) Autoinducing peptides (AIPs).
(A)

(B)

(C)
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Figure 3. Undiluted and diluted serum samples were incubated with whole-cell
biosensing system containing plasmid pSB406 (yellow). Undiluted and diluted serum
samples were spiked with 1 × 10-7 M C-6 HSL and incubated with whole-cell biosensing
system containing plasmid pSB406 (green). Blank 1 contains RO filtered water. Blank 2
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Figure 4. Comparison of dose-response curves in clinical samples with standard doseresponse curve. (A) Using solutions of C-6 HSL, a dose-response curve was obtained in
pooled serum (red) and compared with that obtained in water (black) in the same
analytical run. C-6 HSL solutions were incubated with whole-cell biosensing system
containing plasmid pSB406. (B) Using solutions of AI-2, a dose-response curve was
obtained in pooled serum (red) and compared with that obtained in water (black) in the
same analytical run. AI-2 solutions were incubated with V. harveyi MM32-based wholecell biosensing system.
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Figure 5. Analysis of serum samples from IBD patients and controls. Yellow – Serum
samples obtained from healthy volunteers. Red – Serum samples obtained from UC
patients. Green – Serum samples obtained from CD patients. Short chain AHLs were
detected using the whole-cell sensing system containing plasmid pSB406. The reported
signal values are blank-subtracted.
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Figure 6. LC-MS-MS analysis of serum. (A) A standard mixture of AHLs (1 ng/mL each).
(B) Mobile phase alone. (C) Pooled serum was extracted using acetonitrile/methylene
chloride followed by reconstituting in the mobile phase.
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Figure 7. Stability of C-6 HSL in serum stored under various conditions. Serum was
spiked with (1) 1 × 10-6 M C-6 HSL (yellow) and (2) 1 × 10-7 M C-6 HSL (blue). Control 1 is
serum spiked with 1 × 10-6 M C-6 HSL and control 2 is serum spiked with 1 × 10 -7 M C-6
HSL.
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Figure 8. Mice treatment with colitis inducing agent dextran sulphate sodium (DSS). (A)
Comparison of long chain AHL levels in serum samples before DSS treatment (green)
and after a 7 day DSS treatment (red). The plotted values are blank-subtracted.
Horizontal lines indicate the cutoff for each set of values. The cutoff is determined as
the signal corresponding to 3 standard deviations of the blank. (B) Comparison of long
chain AHL levels in stool samples before DSS treatment (green) and after a 7 day DSS
treatment (red). The plotted values are blank-subtracted. Horizontal lines indicate the
cutoff for each set of values. The cutoff is determined as the signal corresponding to 3
standard deviations of the blank.
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Table 1. LC-tandem MS detection of AHLs
AHLs
C-7 HSL
3-oxo-C-8 HSL
C-8 HSL
C-10 HSL
C-12 HSL
C-14 HSL

[M + H-101]+ (m/z)
113
141
127
155
183
211

[M – H2O]+ (m/z)
196
224
210
238
266
294
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CHAPTER FOUR
DETECTION OF BACTERIAL QUORUM SENSING MOLECULES IN FOOD MATRICES
Introduction
Foodborne illnesses are a major health issue affecting over 15% of the US
population and resulting in 3000 deaths each year 139. Most of these diseases are due to
infections caused by viruses, bacteria, and parasites, which enter into the
gastrointestinal tract by consumption of contaminated food. While diseases caused by
pathogens, such as Yersinia, Escherichia coli O157:H7, and Listeria have decreased over
the past few years, those caused by Salmonella and Vibrio have been on the rise140.
None of these bacterial-related foodborne illnesses have been eradicated, and rather,
multistate foodborne outbreaks have increased consistently over the past several
years10.
Food contamination can occur at any stage, from farms and slaughter houses to
distribution at restaurants and shopping centers. The list of edibles that are known to
carry bacterial contamination includes milk and milk products (such as cheese, yogurt,
and ice cream), meat products (such as beef, pork, chicken, and turkey), vegetables
(such as broccoli, lettuce, tomato, and sprouts), eggs, and sea products. In the past, the
time lag between food production and consumption was relatively short, and therefore,
chances of food contamination were limited. Current market demands that food be
stored for longer durations of time. To limit bacterial growth, a number of food
preservation techniques have emerged. For example, milk is pasteurized by heating to
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high temperatures for short periods of time, and vegetables and meat are packaged
under a variety of controlled conditions.
Initial processing by heat treatments reduces the initial bacterial content
considerably, and the recontamination thereafter determines shelf-life. The most
commonly employed approach to improve shelf-life of foods involves focusing on
packaging techniques that extend the viability of the food. Various methods are
employed that utilize air, vacuum, or modified atmosphere packaging of food. A method
is chosen depending on the food product and market requirements. For example,
packaging with high oxygen content helps preserve the color of retail cut meat;
however, shelf-life is only slightly improved141. On the contrary, storage of meat
products in 100% carbon dioxide ensures maximum shelf life, but can cause
discoloration142. Furthermore, different packaging methods differently affect the growth
of various species of bacteria. In aerobic packaging a variety of bacteria can grow,
including Pseudomonas spp., Brochothrix thermosphacta, Lactobacillus spp., and many
Enterobacteriaceae, while in vacuum and anaerobic packaging a few bacteria can
survive, the most common being Lactobacillus spp. Other factors impacting the growth
of bacteria include temperature and pH. Many foods are amenable to storage at low
temperatures, which, in most cases, extends the shelf-life by decreasing the rate of
bacterial growth. Temperature studies involving Jalapeño peppers143, shell eggs144,
pork145, and minced beef146 have shown that the bacterial count was lower when food
was stored at low temperature as compared to when it was stored at higher
temperatures. Moreover, while a decrease in pH may favorably reduce the growth of
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certain bacteria, that is not the case for the Lactobacillus spp. , which produce lactic
acid, and thus, contribute to a reduction of the pH147.
The economic and health consequences, caused by food spoilage, have fueled
efforts to detect early food spoilage and contamination. The bacterial count is one of
the indicators that food may either be spoiled or prone to spoilage. The number of
bacteria is often counted by determining the colony forming units (cfu) per gram of food
under consideration; when the cfu value from a food sample is higher than that of
standard/unspoiled food, it is indicative of potential food spoilage. The determination of
cfu has been used in a number of applications, ranging from evaluation of food spoilage
to assessment of the effectiveness of an agent for prevention of food spoilage 148,149.
However, cfu determination cannot be considered accurate as it neglects the bacterial
population that cannot grow under the conditions of the cfu assay. Hence, other ways
to count bacteria are employed, which include epifluorescence, an ATP bioluminescence
assay,

impedance

measurements,

and

spectroscopic

methods.

When

using

epifluorescence, bacteria present in the food sample are concentrated on a filtration
membrane, stained with a fluorescent dye, and enumerated using epifluorescence
microscopy150,151. Indirect measurement of bacterial load in the sample can be obtained
by measuring ATP concentration. Highly sensitive ATP determination is achieved using
firefly luciferase, which in the presence of adenosine 5’-triphosphate (ATP), converts the
substrate luciferin to oxyluciferin emitting a photon of light. Non-microbial ATP present
in food is first removed either by enzymatic degradation152 or by filtration153, and
microbial ATP is then detected.
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The bacterial load can also be estimated by measuring the change in current in
the microbiological media as bacteria grow, consume nutrients, and release such highly
charged molecules as fatty acids, amino acids, and organic acids. Impedance
measurements have been used to measure bacteria in raw milk154, frozen vegetables155,
meat156, and fish157. Bacteria also release a range of volatile compounds during their
growth that are different depending on the bacterial species.

Thus, the volatile

compounds can be considered a fingerprint of the type of bacteria present in a sample;
by using an array of sensors responsive to various volatile compounds, Blixt et al.
evaluated the degree of spoilage of vacuum packaged beef158. Methods such as Fourier
transform infrared (FT-IR) and short-wavelength-near-infrared (SW-NIR) spectroscopy
have been used to discriminate among pathogens159 and to detect overall food
spoilage160, respectively. Furthermore, molecular methods, such as the polymerase
chain reaction (PCR)161 and real-time PCR162, have been employed to detect food
spoilage caused by specific microorganisms.
Bacteria are known to communicate with one another by producing, releasing,
and responding to small signaling molecules14. When these molecules reach a critical
threshold concentration corresponding to a given cell density, certain specialized genes
are expressed. This type of cell-to-cell communication, termed quorum sensing (QS),
enables bacteria to regulate specialized phenotypes, including virulence factors
production and biofilm formation, depending on their population size. Among the
quorum sensing molecules (QSMs) employed for bacterial chatter are N-acyl
homoserine lactones in Gram-negative bacteria, autoinducing peptides (AIPs) in Gram114

positive bacteria, and autoinducer-2 (AI-2) in both Gram-negative and Gram-positive
bacteria.
Bacteria are involved in the spoilage of food by producing food degrading
enzymes, whose synthesis and release are regulated by the QS circuitry in many
bacteria. Hence, bacterial QS might play a crucial role in food spoilage. Another
significant QS regulated function is biofilm formation, which enables bacteria to
propagate and establish themselves on the contaminated surfaces by generating
complex three-dimensional structures where bacteria are included and protected from
other bacteria and antibiotics163. A biofilm is defined as “microbially derived sessile
community characterized by cells that are irreversibly attached to a substratum or
interface or to each other, are embedded in a matrix of extracellular polymeric
substances that they have produced, and exhibit an altered phenotype with respect to
growth rate and gene transcription”164. In the biofilm mature state, the extracellular
matrix is composed of exopolysaccharides, proteins, dead bacteria, and DNAs. Biofilms
can be comprised of single bacterial species; however, mixed species biofilms dominate
under most environmental conditions165,166. Some features of biofilms include primitive
homeostasis, metabolic cooperation, exchange of genetic material, and circulatory
systems to facilitate waste disposal. Such biofilms can be present on the surface of
foods as well as on food processing surfaces and equipment. Examples of food-related
biofilm-forming bacteria include Bacillus spp. from dairy processing plants167 and
Salmonella from poultry processing plants168, among others. In few foodborne
pathogens, biofilm formation has been linked to quorum sensing. Specifically, wild type
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Hafnia alvei, a milk and meat pathogen that employs the AHL-based QS signaling for
communication, regularly forms biofilms, while a mutant from the same bacterial
species Hafnia alvei that is unable to synthesize AHLs, cannot form biofilms169.
In light of the evident important role that QS plays in food contamination and
spoilage, we deemed necessary to further explore the relationship between food
spoilage and QS. Methods that can detect QSMs in food samples should allow for the
early detection and prevention of food contamination. Conventional physical-chemical
methods, such as separation techniques coupled to various detection principles, are
cumbersome, time-consuming, and often not sufficiently sensitive to detect QSMs at
low concentrations. In addition, most of these techniques require extensive sample
preparation, expensive instrumentation, and specialized technical personnel 170. On the
other hand, whole-cell biosensing systems are sensitive, with limits of detection in the
micromolar to nanomolar ranges27, rapid, easy to use, cost-effective, and require simple
instrumentation and minimal or no sample preparation. Furthermore, they are
amenable to multiplexing and high-throughput analysis, as well as on-site monitoring
when incorporated into portable devices.
To that end, we utilized cell-based biosensing systems to develop an analytical
method for the quantitative detection of QSMs in food matrices such as milk and
ground beef. Specifically, we employed Vibrio harveyi MM32-based whole-cell
biosensing system for the detection of AI-2, and two E. coli-based whole-cell biosensing
systems, one containing plasmid pSB406 and the other containing plasmid pSB1075, for
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the detection of short chain AHLs and long chain AHLs, respectively. Most food products
are either in liquid or solid form. We chose milk as an example of a liquid food, and
ground beef as an example of a solid food. Initially, the whole-cell biosensing systems
were optimized for use in these food matrices. The effect of the sample matrix on the
performance of the sensing system’s response was evaluated by performing recovery
studies. In addition, the limit of detection, dynamic range, and reproducibility afforded
by the sensing system in the two food samples were determined. In order to simulate
food spoilage conditions, we employed food contaminating bacteria that naturally
produce QSMs. For this purpose, we contaminated milk and ground beef samples with
Escherichia coli AB1157 strain and Hafnia alvei 718 strain. The former communicates
through and produces AI-2, while the latter employs the short chain AHL regulatory
system. To demonstrate the validity of our proposed method in the detection of
bacterial contamination, we then employed our cell-based biosensing systems in the
quantitative determination of both types of quorum sensing molecules in milk and
ground beef.
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EXPERIMENTAL SECTION
Materials. AHLs, N-hexanoyl-DL-homoserine lactone (C-6 HSL) and N-dodecanoyl-DLhomoserine lactone (C-12 HSL), ampicillin, and kanamycin were purchased from Sigma
(St. Louis, MO). AI-2 was purchased from Omm Scientific (Dallas, TX). Luria Bertani (LB)
broth, nutrient broth, and vitamin free casamino acids were purchased from Difco
(Sparks, MD). Acetonitrile used in all experiments was of HPLC grade and was from VWR
Scientific (Pittsburgh, PA). The 96-well microtiter plates were purchased from Costar
(Corning, NY). Lean ground beef (93% lean), fat free milk (skim milk), 2% fat milk, and
whole milk were purchased from a local grocery store. Reverse osmosis (RO) filtered
water (Milli-Q water purification system, Millipore, Bedford, MA) was utilized in all
experiments as needed.
The microcentrifuge was purchased from Eppendorf (Westbury, NY). The orbital
shaker incubator was purchased from Fisher Scientific (Fair Lawn, NJ). Bioluminescent
measurements were performed using the FLUOstar OPTIMA microplate reader (BMG
Labtech, Durham, NC). The Spectronic 21D spectrophotometer used to measure optical
density of the bacterial cultures was purchased from Artisan Scientific (Champaign, IL).
Plasmids, bacterial strains, and culture conditions. The plasmids pSB406 and pSB1075
were originally provided by Dr. Paul Williams (University of Nottingham, Nottingham,
UK) and previously transformed in E. coli JM109 cells. The transformed AHL-sensing cells
were then stored at -80 °C as glycerol stocks. Fresh cell cultures were obtained from the
glycerol stocks, grown in LB media (100 µg/mL ampicillin) overnight, in the orbital
shaker at 37 °C, 250 rpm, and then refreshed and allowed to grow until an optical
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density at 600 nm (OD600nm) of 0.45-0.50 was reached. V. harveyi MM32 (AI-2-sensing
strain), E. coli AB1157 (AI-2-producing strain), and H. alvei 718 (AHL-producing strain)
were purchased from American Type Culture Collection (Manassas, VA). Cultures of V.
harveyi MM32 cells were setup in autoinducer bioassay (AB) media containing 30 µg/mL
kanamycin and grown overnight in the orbital shaker at 30 °C, 250 rpm. Overnight
cultures were then diluted 1:100 to obtain an OD 600nm of 0.01-0.02. The procedure to
prepare AB media has been described elsewhere129. E. coli AB1157 cells were grown in
LB media (no antibiotic) at 37 °C, 250 rpm, while H. alvei 718 cells were grown in
nutrient media (no antibiotic) at 30 °C, 250 rpm, in the orbital shaker.
Dose-response curves. Commercially available N-acyl-homoserine lactones were
dissolved in acetonitrile to obtain 1 x 10-2 M stock solutions, which were serially diluted
with RO filtered water to obtain standard solutions at concentrations ranging from 1 x
10-4 M to 1 x 10-8 M. A 1% solution of acetonitrile in RO filtered water was used as blank
(upon addition to the bacterial culture, the acetonitrile final concentration of 0.1% did
not result toxic for the sensing cells). A volume of 10 μL of each of these solutions was
added in triplicate to a 96-well white polystyrene microtiter plate containing 90 µL/well
of cell culture grown to an OD600nm of 0.45-0.50. C-6 HSL solutions were employed for
the whole-cell sensor with pSB406, while C-12 HSL solutions were employed for the
whole-cell sensor with pSB1075. The microtiter plate was then incubated in the orbital
shaker at 37 °C, 175 rpm for two hours. The produced bioluminescence was then
measured using the microplate reader. The light intensity was expressed in relative light
units (RLU).
119

AI-2 aqueous stock solution (3.7 × 10-3 M) was serially diluted with RO filtered
water to prepare AI-2 standard solutions at concentrations ranging from 1 × 10-4 M to 1
× 10-8 M. RO filtered water was used as blank. A volume of 10 μL of each of these
standard solutions and blank was added in triplicate to a 96-well black polystyrene
microtiter plate containing 90 µL/well of V. harveyi MM32 cell culture at an OD600 nm of
0.01-0.02. The microtiter plate was then incubated in the orbital shaker at 30 °C, 175
rpm for three hours. The produced bioluminescence was then measured using the
microplate reader. The light intensity was expressed in relative light units (RLU).
Food sample collection and processing. Food samples used in this study were lean
ground beef (93% lean), fat free milk, milk with 2% fat, and whole milk. They were
purchased from a local grocery store. The ground beef sample was further ground, with
slow addition of water, using a high performance blender to form a uniform suspension.
The volume of water was then adjusted to prepare a 10% w/v suspension, which was
stored as 20 mL aliquots at -80 °C. When needed, beef suspension aliquots were thawed
at room temperature and diluted using RO filtered water. For simplicity, 10% w/v beef
suspension is referred to as beef suspension in the rest of the manuscript. All milk
samples were stored at -80 °C in 15 mL aliquots. When needed, milk aliquots were
thawed at room temperature and diluted using RO filtered water.
Food sample dilution study. To test for potential matrix effect of the food samples on
the whole-cell sensing systems response, an aliquot of 10% w/v beef suspension was
serially diluted with RO filtered water to obtain 1:10, 1:100, and 1:1000 dilutions. At
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each dilution step, proper care was given to vortex the suspensions thoroughly to avoid
settling of meat particles. Similarly, a fat free milk aliquot was serially diluted with RO
filtered water to obtain 1:10, 1:100, and 1:1000 dilutions. To test the beef and skim milk
samples with the E. coli whole-cell biosensing systems containing plasmids pSB406 or
pSB1075, a 10 µL volume of the above beef suspensions and milk solutions was added in
triplicate to a microtiter plate followed by addition of 90 µL/well of the sensing bacterial
cells grown to an OD600nm of 0.45-0.50. Similarly, to test the beef and skim milk samples
with the V. harveyi MM32 whole-cell biosensing system, a 10 µL volume of the above
beef suspensions and milk solutions was added in triplicate to a microtiter plate
followed by addition of 90 µL/well of the sensing bacterial cells at an OD 600nm of 0.010.02. A reference dose-response curve with the respective QSM was included in each
analytical run. The assays were performed as described above for standard doseresponse curves.
Evaluation of food matrix effects in the presence of QSMs. Beef suspensions and skim
milk solutions at various dilutions, prepared as described above, were spiked with a
fixed concentration of QSM, namely 1 × 10-6 M C-6 HSL, 1 × 10-6 M C-12 HSL, or 1 × 10-5
M AI-2. A 10 µL volume of each of these spiked samples was added in triplicate to a
microtiter plate followed by addition of 90 µL/well of the corresponding sensing cell
suspension. The assays were then performed as described above.
Dose-response curves in sample matrix. Acetonitrile 1 × 10-2 M stock solutions of C-6
HSL and C-12 HSL were serially diluted with 1:10 beef suspension or undiluted skim milk
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to obtain AHL solutions of concentrations ranging from 1 × 10-4 to 1 × 10-9 M. A 1%
acetonitrile solution in each of the above food sample dilution was used as blank.
Similarly, 3.7 × 10-3 M aqueous stock solution of AI-2 was serially diluted with 1:10 beef
suspension or undiluted skim milk to obtain AI-2 solutions of concentrations ranging
from 1 × 10-4 to 1 × 10-9 M. 1:10 beef suspension and undiluted skim milk served as
blanks. A 10 µL volume of each of the obtained solutions and blanks was added in
triplicate to a microtiter plate followed by addition of 90 µL/well of cell culture of the
respective biosensing system. The assays were performed as described above. A
reference dose-response curve was included in each analytical run.
Monitoring of QSM production by E. coli AB1157 and H. alvei 718. E. coli AB1157 was
grown in LB media (no antibiotic) overnight, in the incubator shaker at 37 °C, 250 rpm.
H. alvei 718 was grown in nutrient media (no antibiotic) overnight, in the incubator
shaker at 30 °C, 250 rpm. Overnight cultures were diluted 1:100 and 1:15, respectively,
with fresh media and allowed to grow in the above conditions. One-milliliter fractions of
culture media were collected at each hour for 8 hours, followed by collection of an
overnight fraction. The collected fractions were centrifuged at 13,000 rpm for 5 minutes
at room temperature and the supernatants were stored at -20 °C until analyzed. To
measure the QSMs produced, 10 µL of each supernatant sample was added in triplicate
to the wells of a microtiter plate followed by addition of 90 µL of the proper sensing cell
suspension, prepared as described above. For E. coli AB1157 culture media fractions, V.
harveyi MM32 sensing cells were used, while for H. alvei 718 culture media fractions,
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the whole-cell sensing systems containing pSB406 and pSB1075 were employed. The
assays were performed as described above.
Food contamination study. To investigate QSM production in food matrices, we
contaminated beef and skim milk with AHL producing H. alvei 718 and AI-2 producing E.
coli AB1157, respectively. An overnight grown culture of E. coli AB1157 was added into
10% w/v beef suspension to obtain a 1:100 dilution of the original culture and allowed
to grow in the incubator shaker at 37 °C, 250 rpm. Similarly, an overnight grown culture
of H. alvei 718 was added into 10% w/v beef suspension to obtain a 1:15 dilution of the
original culture and allowed to grow in the incubator shaker at 30 °C, 250 rpm.
Procedures similar to those used for contaminating beef suspension were employed to
contaminate skim milk. One-milliliter fractions of media from each of the contaminated
food samples were collected at each hour for 8 hours, followed by collection of an
overnight fraction. The collected fractions were centrifuged at 13,000 rpm for 5 minutes
at room temperature and the supernatants were stored at -20 °C until analyzed. To
measure the QSMs produced, the supernatant samples were assayed using the
respective whole-cell biosensing systems as described above.
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Results and discussion
The purpose of our work was to demonstrate the feasibility of employing wholecell biosensing systems to detect bacterial presence as a measure of spoilage and
contamination of foods. Three different specific biosensing systems were employed in
the determination of two different classes of quorum sensing molecules, AI-2 and AHLs
(long and short chain), in ground beef and milk. The AI-2 quorum sensing regulatory
system is used by both Gram-negative and Gram-positive bacteria, while AHL-based
communication is employed by Gram-negative bacteria. The role of QS in food spoilage
was validated by identification of QSMs in spoiled foods171,172. For example, bacterial
presence and AHL molecules were detected in vacuum packed meat samples 171. In
addition, AI-2 has been identified in food samples such as fish, tomato, carrots, tofu, and
milk172. The methods employed in both of the above studies were qualitative and time
consuming due to a need for processing steps and the fact that detection relied on color
development by reporter cells upon exposure to AHLs171. To the best of our knowledge,
this is the first application of cell-based biosensing systems in the quantitative detection
of QSMs in food samples aimed at aiding in the early detection of food contamination
and prevention of food spoilage.
In this work, we employed E. coli whole-cell biosensing systems containing
plasmids pSB406 and pSB1075 to detect short and long chain AHLs, respectively. For AI2 detection, we used a whole-cell biosensing system that is based on V. harveyi MM32.
The plasmids pSB406 and pSB1075 bear recognition and regulatory elements that are

124

originally derived from Pseudomonas aeruginosa AHL-dependent RhlR/RhlI and
LasR/LasI QS systems23. Plasmids pSB406 and pSB1075 carry the promoters PrhlI and PlasI,
respectively, as well as the genes rhlR and lasR, encoding for the recognition/regulatory
proteins RhlR and LasR, respectively. In addition, both plasmids contain the luxCDABE
cassette that is under transcriptional control of the respective promoters. The luxCDABE
genes encode for bioluminescent bacterial luciferase and the enzymes catalyzing the
synthesis of the luciferase substrate (Figure 1a). The plasmids are lacking the rhlI and
lasI genes that code for the AHL synthase enzymes, thus, exogenous AHLs need to be
supplied in order for the sensing cells to produce bioluminescence. When AHLs are
present in the environment of the sensing cells, they bind to the recognition/regulatory
proteins, triggering the expression of luciferase and other enzymes part of the luxCDABE
cassette. This results in the production of bioluminescence in a manner proportional to
the concentration of AHLs present. The whole-cell biosensing systems based on plasmid
pSB406 and pSB1075 had been previously characterized in our laboratory and employed
to detect AHLs in saliva and stool samples27. V. harveyi MM32 is a mutant of wild-type V.
harveyi BB120, a marine bioluminescent bacterium that controls light emission through
multiple QS systems. Strain MM32 was genetically modified to only emit
bioluminescence in response to AI-2 and not to produce its own AI-215; therefore, light
emission is only triggered by AI-2 present in the environment of the cells. When AI-2
binds to its recognition element, the periplasmic binding protein LuxP, the binding event
triggers a cascade of phosphorylation and de-phosphorylation processes in a number of
proteins that control the expression of luxCDABE, responsible for bioluminescence,
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along with other genes (Figure 1b). Thus far, V. harveyi MM32 has been used as a
reporter strain in bioassays for a number of applications – to evaluate QS regulated
functions173, to screen compounds for agonistic and antagonistic activities 57, and to
identify bacteria that produce AI-2174. Herein, we employed V. harveyi MM32 to develop
a whole-cell biosensing system for quantitative detection of AI-2. Due to the high
sensitivity and selectivity demonstrated by the above whole-cell biosensing systems for
AHL and AI-2 detection, we utilized them as sensitive and rapid tools for the analysis of
QSMs in various food matrices. The levels of QSMs should correlate with the extent of
bacterial contamination and serve as indicators of food spoilage.
In our study, milk and ground beef were chosen as food representative models
to investigate whether whole-cell biosensing systems could be used with liquid as well
as solid foods. Initially, the analytical parameters of the biosensing systems were
determined using standard solutions of QSMs in RO water (Table 1). The limits of
detection for each analyte were found to be 1 × 10-9 M. In addition, dynamic ranges of
at least three orders of magnitude were obtained with all biosensing systems. At least
three sets of experiments were performed to verify reproducibility, both with standard
solutions and in food matrix.
Next, we evaluated the effect exerted by the food sample matrices on the
whole-cell biosensing systems response. Being solid, ground beef was mixed with RO
filtered water and using a grinder, a 10% w/v suspension (referred to as beef
suspension) was prepared. As can be seen from Figure 2a-2c, when beef suspension was
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incubated with whole-cell biosensing systems, bioluminescence signals lower than those
of the controls were observed. Such decrease was probably due to components of the
sample matrix diminishing the ability of the system to emit bioluminescence. The matrix
effect was eliminated when beef suspension was diluted 1:10, 1:100, and 1:1000. At
these dilutions, bioluminescence signals were similar to those of the controls,
confirming that dilution was necessary and that a 1:10 dilution was sufficient to
eliminate the matrix effect. Recovery studies were performed by spiking the beef
suspension with a known concentration of a QSM standard solution. A complete signal
recovery was observed when employing a 1:10 dilution of beef suspension (Figure 3a3c).
To evaluate the performance of the biosensing systems in the beef matrix at
various concentrations of QSMs, dose-response curves using a 1:10 dilution of the beef
suspension were obtained and compared to the dose-response curves obtained in water
during the same analytical run (Figure 4). The slopes of the dose-response curves
obtained in the 1:10 beef suspension were nearly identical to those of the reference
dose-response curves for all three sensing systems. Therefore, we concluded that short
chain AHLs in the range of 1 × 10-5 M to 1 × 10-9 M, long chain AHLs in the range of 1 ×
10-6 M to 1 × 10-9 M, and AI-2 in the range of 1 × 10-5 M to 1 × 10-9 M can be detected in
1:10 beef suspension using our whole-cell biosensing systems. The results obtained
prove that these biosensing systems could be employed to detect QSMs in solid foods,
such as beef, with minimal sample processing.
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Similar studies were carried out to investigate the effect of matrix on QSM
detection in skim milk. When undiluted skim milk was incubated with the whole-cell
biosensing systems, we observed an emission of bioluminescence signal similar to that
of the controls. Further, dilutions of skim milk did not alter the bioluminescence signals
(Figure 5). However, when milk was spiked with fixed concentrations of QSMs, followed
by incubation with the respective sensing cells, increases in bioluminescence were
observed in spiked milk samples as compared to the controls; the controls consisted of
aqueous solutions with the same fixed QSM concentrations (data not shown). Doseresponse curves obtained in skim milk also showed higher bioluminescence emission
than those obtained with reference dose-response curves in the same analytical run
(Figure 6). The observed increase in bioluminescence could be due to the presence of
very small amounts of fat (<0.5%) and slight acidity of the skim milk, which might
increase the solubilization and stability of the QSMs. Fatty acids present in the milk may
help better solubilize AHLs, thus enhancing their bioavailability to the sensing cells. This
effect would be more pronounced as the hydrophobicity of AHLs increases. This
conforms to our observation that a larger increase in bioluminescence was observed
with long chain AHLs than with short chain AHLs.
To further evaluate the effect of fat content in milk, we spiked and analyzed two
additional types of milk (whole milk, 2% fat milk), along with skim milk, which differ in
fat content. We observed that as the fat percentage increased, bioluminescence also
increased, thus supporting improved AHL solubility and bioavailability in the presence of
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fat. As the pH effect is concerned, lower pH values are known to enhance the stability of
AHLs, by reducing lactonolysis175.
To further prove that our whole-cell biosensing systems can be employed in food
analysis, the next step of the study was to detect QSMs in simulated spoiled food
samples that were subjected to bacterial contamination. We chose E. coli AB1157 and H.
alvei 718 as model organisms, given that they produce AI-2 and AHLs, respectively, to
artificially contaminate skim milk and beef suspension. First, we characterized the two
bacterial strains in order to find out the amount of time required for maximum
production of QSMs. When grown in LB media at 37 °C, E. coli AB1157 produces
maximum concentration of AI-2s in six hours, while maximum production of AHLs in H.
alvei 718 was observed after five hours growth in nutrient media at 30 °C.
To perform spoilage studies, overnight separate cultures of E. coli AB1157 and H.
alvei 718 were added into a beef suspension and skim milk, respectively. A 1 mL-volume
sample was collected hourly, centrifuged to remove debris, and the supernatant
analyzed for the presence of QSMs using the whole-cell biosensing systems. The results
obtained with beef suspension contaminated with H. alvei 718 indicating the ability of
the employed sensing system to detect the produced short chain AHLs are shown in
Figure 7a. Only minor production of long chain AHLs was observed, which is consistent
with the fact that H. alvei produces and uses short chain AHLs as QSMs171. Similarly,
when the beef was contaminated with AI-2 producing E. coli AB1157, our V. harveyi
MM32 whole-cell biosensing system was able to detect the AI-2 produced in beef
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(Figure 7b). The same trend was observed when skim milk was contaminated with E. coli
AB1157 and H. alvei 718, respectively. In sum, these data demonstrate that the wholecell biosensing systems can be successfully utilized to detect different QSMs in various
contaminated food matrices.

Conclusion
The incidences of food spoilage and foodborne illnesses have been on the rise,
with more multistate outbreaks reported each year. There are numerous bacteria
responsible for the outbreaks and foods that spread the illnesses, thus making the
source of contamination difficult to identify. However, a feature common to many
bacteria, including foodborne pathogens, is the production of QSMs. Herein, we
investigated the feasibility of employing QSMs as quantitative markers of bacterial
presence in foods. To that end, we have developed an analytical method to detect
QSMs for early detection of food contamination and prevention of food spoilage in two
different food matrices, namely beef and milk. The proposed method is based on the
use of whole-cell biosensing systems that are sensitive, easy to use, rapid cost-effective,
and amenable to miniaturization, thus exhibiting potential for high throughput and onsite analysis. The optimized method allowed for detection of QSMs in a sensitive
manner with limits of detection down to nanomolar levels. Additionally, food spoilage
studies proved that our whole-cell biosensing systems can be successfully employed to
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detect QSMs in spoiled food, thus suggesting potential usefulness in the early detection
of food spoilage and prevention of foodborne illnesses.
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Figure 1. (A) Plasmids pSB406 and pSB1075 contained in E. coli-based whole-cell sensing
systems for detection of short and long chain AHLs, respectively. (B) V. harveyi AI-2based quorum sensing regulatory pathway. V. harveyi MM32 lacks LuxS, thus not
producing its own AI-2 and only responding to exogenous AI-2.
(A)

(B)
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Figure 2. Beef suspension (BS) and its dilutions were incubated with whole-cell based
biosensing systems. Data shown is the average ± one standard deviation (n=3).
(A) Whole-cell biosensing system containing plasmid pSB406 for detection of short chain
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(C) V. harveyi MM32-based whole-cell biosensing system for detection of AI-2.

Figure 3. Effect of beef matrix on the whole-cell sensing systems response in the
presence of QSMs. Beef suspension and its dilutions containing 1 × 10 -6 M of C-6 HSL, 1
× 10-6 M of C-12 HSL, or 1 × 10-5 M of AI-2 were incubated with whole-cell biosensing
system containing pSB406, whole-cell biosensing system containing pSB1075, or V.
harveyi MM32 biosensing system, respectively. Data shown is the average ± one

standard deviation (n=3).
(A) Whole-cell biosensing system containing plasmid pSB406 for detection of short
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(B) Whole-cell biosensing system containing plasmid pSB1075 for detection of long
chain AHLs.
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(C) V. harveyi MM32-based whole-cell biosensing system for detection of AI-2.

Figure 4. Standard dose-response curve (black) compared with dose-response curve in
1:10 beef suspension (red) obtained using (A) whole-cell biosensing system containing
plasmid pSB406, (B) whole-cell biosensing system containing plasmid pSB1075, and (C)
V. harveyi MM32-based whole-cell biosensing system.
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Figure 5. Skim milk and its dilutions were incubated with whole-cell based biosensing
systems. Data shown is the average ± one standard deviation (n=3).
(A) Whole-cell biosensing system containing plasmid pSB406 for detection of short
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(B) Whole-cell biosensing system containing plasmid pSB1075 for detection of long chain
AHLs.

600

400

200

140

1:
10
00

M

ilk

ilk
M
1:
10
0

M
ilk
1:
10

ilk
M
nd
ilu
te
d
U

on
tr
ol

0

C

Bioluminescence Intensity
(RLU)

(C) V. harveyi MM32-based whole-cell biosensing system for detection of AI-2.

Figure 6. Standard dose-response curve (black) compared with dose-response curve in
undiluted skim milk (red) obtained using (A) whole-cell biosensing system containing
plasmid pSB406, (B) whole-cell biosensing system containing plasmid pSB1075, and (C)
V. harveyi MM32-based whole-cell biosensing system.
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Figure 7. Contamination of food matrix with QSM producing bacteria.
(A) Short chain AHL production in beef suspension contaminated with H. alvei 718,
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monitored with V. harveyi MM32 whole-cell biosensing system.

Table 1. Analytical parameters of the whole-cell biosensing systems.
Biosensing system

Limit of detection (M)

Dymanic range (M)

E. coli pSB406

1 × 10-9

1 × 10-5 - 1 × 10-9

E. coli pSB1075

1 × 10-9

1 × 10-6 - 1 × 10-9

V. harveyi MM32

1 × 10-9

1 × 10-5 - 1 × 10-9
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CHAPTER FIVE
INTERFERENCE OF GENERALLY RECOGNIZED AS SAFE (GRAS) COMPOUNDS WITH
BACTERIAL QUORUM SENSING
Introduction
The discovery of bacterial communication was paradigm shifting in terms of
bacteria being viewed as organisms that exert their effects as a community, not as
independent single cell organisms. Cell-to-cell communication occurs via the synthesis
and release of small signaling molecules, termed quorum sensing molecules (QSMs) that
are transported out of the cell and can be detected by bacteria of the same (intraspecies communication) or different species (inter-species communication). Such QSMs
include N-acyl homoserine lactones (AHLs), autoinducing peptides (AIPs), and
autoinducer-2 (AI-2), which are utilized by Gram-negative, Gram-positive, and both
Gram-negative and Gram-positive bacteria, respectively. This system of communication,
which bacteria employ to modulate their behavior in a cell-density dependent manner,
is termed quorum sensing (QS). Specifically, when the cell population reaches a critical
size reflected by a critical threshold QSM concentration in the environment surrounding
the cells, certain specialized genes are expressed. Hence, this communication process
allows a population of bacteria to change the community behavior in response to
changes in its size. More recently, it has been reported that certain QSMs not only
mediate

bacterial

communication,

but

also

interkingdom

communication

–

communication between microorganisms and their hosts17,103. Figure 1(a) depicts the
aforementioned QS phenomenon. QS is utilized by both pathogenic and non-pathogenic
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Gram-positive and Gram-negative bacteria25,176,177. Employing QS, bacteria regulate
various functions such as sporulation, swarming motility, biofilm formation, and
production of virulence factors and antibiotics. Among these phenomena, QS regulation
of virulence in human pathogens such as Staphylococcus aureus, Pseudomonas
aeruginosa, and enterohaemorrhagic Escherichia coli, has been well documented178.
Bacterial infections are generally treated with antibiotics; however abuse of use
of antibiotics in humans and animals that humans consume has caused the emergence
of a number of antibiotic resistant bacteria179. This has created the need for the
identification of classes of new antibacterial compounds that are efficient in attacking
the aforementioned resistant bacteria. To that end, the discovery of compounds that
may interfere with bacterial communication may provide with a potential alternative to
current classes of antibacterial drugs52,180. Molecules that can interfere with QS should
be able to mislead the bacteria about their surrounding environmental conditions, and
therefore, affect their growth and behavior181. In the past few years, a number of such
molecules have been identified. For instance, some synthetic analogs of AI-2 were found
to act as agonists in Vibrio harveyi, while others were antagonists in P. aeruginosa182.
More recently, modified imidazolines have been reported to inhibit QS33. The list of such
interfering compounds is extensive and there are several possible mechanisms of
interference as pointed out in a recent review by Ni et al.52 One of the most significant
advantages of using QS interfering molecules as a means to limit bacterial growth and
pathogenicity is that QS interfering molecules, unlike antibiotics, do not directly kill the

146

bacteria and, therefore, do not add evolutionary pressure to develop resistance against
interfering molecules183,184.
To date several molecules that interfere with QS have been identified, but their
use in practical applications is limited because of potential side-effects on human
health. An approach to address this issue is to test compounds that are safe to consume,
or known to improve the quality of food products, as QS interfering agents 185-187. The
United States Department of Food and Drug Administration maintains a list of food
additives that are considered safe and approved suitable for consumption. These
substances are classified as Generally Recognized As Safe (GRAS). Sources of GRAS
substances include angelica, basil, bergamot, chamomile roman, chamomile german,
cinnamon bark, citrus rind (all), clary sage, clove, coriander, dill, eucalyptus,
frankincense, galbanum, geranium, ginger, grapefruit, hyssop, juniper, jasmine, bay
laurel, lavender, lemon, lemongrass, lime, melissa (lemon balm), marjoram, myrrh,
myrtle, nutmeg, orange, oregano, patchouly, pepper, peppermint, petitgrain, pine,
rosemary, rose, savory, sage, sandalwood, spearmint, spruce, tarragon, tangerine,
thyme, valerian, vetiver, and ylang ylang, among others.
Phenolic compounds, which are known to protect the plants from pathogens188,
constitute a key ingredient of a number of GRAS substances. The three major classes of
phenolic compounds are tannins, flavonoids, and lignins. Among them, flavonoids have
a variety of beneficial biological properties and, therefore, are the most studied among
all189. To date, a limited number of compounds originating from GRAS substances have
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been shown to affect QS. For example, Niu et al. have reported that cinnamaldehyde, an
ingredient of cinnamon, inhibited the bacterial growth in sub-millimolar ranges36. In
addition, tannic acid, which is abundant in oak bark, antagonized QS in
Chromobacterium violaceum as well as reduced biofilm formation in Proteus mirabilis190.
In another study, garlic extract and p-coumaric acid were proven to act as antagonists in
the QS systems of various bacteria such as Escherichia coli, Chromobacterium violaceum,
Agrobacterium tumefaciens, Pseudomonas putida, and Pseudomonas chlororaphis191.
Phenolic compounds originating from GRAS substances are under investigation
at the College of Agriculture of the University of Kentucky; some of them have been
shown to possess antimicrobial properties192 and are being considered for use as food
preservatives. However, the mechanism of action of these compounds is not known. We
postulated that they may act by interfering with bacterial QS. There are a number of
ways in which a molecule can interfere with QS; Figure 2 represents some of them.
Specifically, we hypothesized that test GRAS compounds 1) may affect the
concentration of QSMs produced by food contaminating bacteria or 2) may act as
agonists or antagonists in the QS systems of bacteria. The former may occur if QSM
synthesis is inhibited. In order to test this hypothesis, we selected 12 compounds that
had shown antimicrobial effect, and incubated each of them with cultures of QSM
producing bacteria. QSM production was then monitored in the culture media at
different time intervals using a panel of bacterial whole-cell sensing systems designed to
quantitatively respond to AI-2, short chain AHLs, and long chain AHLs, respectively.
These experiments allowed us to detect the amount of QSMs that the cultured bacteria
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produced and verify if GRAS compounds affected the QSM synthesis. To test the latter,
we performed experiments to determine if the GRAS compounds had an effect on the
QS response of the above sensing bacteria, both, in the presence and absence of QSMs.
These studies provided insight into the mode of action of GRAS compounds based on
their effects on the QS sensing/regulatory elements of the whole-cell biosensing
systems.

Materials and methods
Materials. AHLs, N-hexanoyl-DL-homoserine lactone (C-6 HSL) and N-dodecanoyl-DLhomoserine lactone (C-12 HSL), ampicillin, kanamycin, and compounds originating from
GRAS substances, namely curcumin, capsaicin, thymol, thymoquinone, coumarin,
ascorbic acid, p-coumaric acid, t-cinnamic acid, tannic acid, eugenol, quercetin, and odianisidine, were purchased from Sigma (St. Louis, MO). AI-2 was purchased from Omm
Scientific (Dallas, TX). Luria Bertani (LB) broth, nutrient broth, and vitamin free casamino
acids were purchased from Difco (Sparks, MD). Acetonitrile used in the experiments was
of HPLC grade and was purchased from VWR Scientific (Pittsburgh, PA). The 96-well
microtiter plates were purchased from Costar (Corning, NY). The microcentrifuge was
purchased from Eppendorf (Westbury, NY). The orbital shaker incubator was purchased
from Fisher Scientific (Fair Lawn, NJ). Bioluminescent measurements were performed
using the FLUOstar OPTIMA microplate reader (BMG Labtech, Durham, NC).
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Plasmids, bacterial strains, and culture conditions. The plasmids pSB406 and pSB1075
were originally provided by Dr. Paul Williams (University of Nottingham, Nottingham,
UK) and previously transformed in E. coli JM109 cells. The transformed AHL-sensing cells
were then stored at -80 °C as glycerol stocks. Fresh cell cultures were obtained from the
glycerol stocks, grown in LB media (100 µg/mL ampicillin) overnight, in the orbital
shaker at 37 °C, 250 rpm, and then refreshed and allowed to grow until an optical
density (OD) at 600 nm of 0.45-0.50 was reached. V. harveyi MM32 (AI-2-sensing strain),
E. coli AB1157 (AI-2-producing strain), and Hafnia alvei 718 (AHL-producing strain) were
purchased from American Type Culture Collection (Manassas, VA). Cultures of V. harveyi
MM32 cells were setup in autoinducer bioassay (AB) media containing 30 µg/mL
kanamycin and grown overnight in the orbital shaker at 30 °C, 250 rpm. Overnight
cultures were then diluted 1:100 to obtain an OD (600 nm) of 0.01-0.02. The procedure
to prepare AB media has been described elsewhere129. E. coli AB1157 cells were grown
in LB media (no antibiotic) at 37 °C, 250 rpm, while H. alvei 718 cells were grown in
nutrient media (no antibiotic) at 30 °C, 250 rpm, in the orbital shaker.
Dose-response curves. Commercially available N-acyl homoserine lactones were
dissolved in acetonitrile to obtain 1 x 10-2 M stock solutions, which were serially diluted
with RO filtered water to obtain standard solutions at concentrations ranging from 1 x
10-4 M to 1 x 10-8 M. A 1% solution of acetonitrile in RO filtered water was used as blank
(upon addition to the bacterial culture, the acetonitrile final concentration of 0.1% did
not result toxic for the sensing cells). A volume of 10 μL of each of these solutions was
added in triplicate to a 96-well white polystyrene microtiter plate containing 90 µL/well
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of cell culture grown to an OD (600 nm) of 0.45-0.50. C-6 HSL solutions were employed
for the whole-cell sensor with pSB406, while C-12 HSL solutions were employed for the
whole-cell sensor with pSB1075. The microtiter plate was then incubated in the orbital
shaker at 37 °C, 175 rpm for two hours. The produced bioluminescence was then
measured using the microplate reader. The light intensity was expressed in relative light
units (RLU).
AI-2 aqueous stock solution (3.7 × 10-3 M) was serially diluted with RO filtered
water to prepare AI-2 standard solutions at concentrations ranging from 1 × 10-4 M to 1
× 10-8 M. RO filtered water was used as blank. A volume of 10 μL of each of these
standard solutions and blank was added in triplicate to a 96-well black polystyrene
microtiter plate containing 90 µL/well of V. harveyi MM32 cell culture grown to an OD
(600 nm) of 0.01-0.02. The microtiter plate was then incubated in the orbital shaker at
30 °C, 175 rpm for three hours. The produced bioluminescence was then measured
using the microplate reader. The light intensity was expressed in relative light units
(RLU).
Monitoring of QSM production by E. coli AB1157 and H. alvei 718. E. coli AB1157 was
grown in LB media (no antibiotic) overnight, in the incubator shaker at 37 °C, 250 rpm.
H. alvei 718 was grown in nutrient media (no antibiotic) overnight, in the incubator
shaker at 30 °C, 250 rpm. Overnight cultures were diluted 1:100 and 1:15, respectively,
with fresh media and allowed to grow in the above conditions. One-milliliter fractions of
culture media were collected at each hour for 8 hours, followed by collection of an
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overnight fraction. The collected fractions were centrifuged at 13,000 rpm for 5 minutes
at room temperature and the supernatants were stored at -20 °C until analyzed. To
measure the QSMs produced, 10 µL of each supernatant sample was added in triplicate
to the wells of a microtiter plate followed by addition of 90 µL of the proper sensing cell
suspension, prepared as described above. For E. coli AB1157 culture media fractions, V.
harveyi MM32 sensing cells were used, while for H. alvei 718 culture media fractions,
the whole-cell sensing systems containing pSB406 and pSB1075 were employed. The
assays were performed as described above.
Solubility study and preparation of GRAS compounds solutions. While the selected
GRAS compounds are soluble in several solvents, the cell based biosensing systems
employed in this work have been characterized in terms of behavior in the presence of
water and acetonitrile. Therefore, when solubility properties allowed, we prepared
solutions of GRAS compounds in either of the two solvents. Tannic acid, eugenol, and
ascorbic acid were dissolved in RO filtered water to obtain 10 mg/mL stock solutions. A
set of 10 mg/mL stock solutions of coumarin, p-coumaric acid, t-cinnamic acid,
capsaicin, thymoquinone, and thymol were prepared in acetonitrile. Curcumin was not
completely soluble either in water or acetonitrile at 10 mg/mL; therefore, a 1 mg/mL
stock solution in acetonitrile was prepared. A 10 mg/mL stock solution of o-dianisidine
was prepared in dimethyl sulfoxide (DMSO). Quercetin was dissolved in 0.1 N NH 4OH to
obtain a 10 mg/mL stock solution. The GRAS compound stock solutions were serially
diluted with RO filtered water to obtain the desired range of concentrations. Table 1
lists the GRAS compounds, their structures, solvents used to dissolve them, and the
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concentration ranges that were tested. All of the GRAS compound solutions were
evaluated in the experiments described below along with the respective controls. For
each compound, the control was comprised of a RO filtered water solution containing
an amount of solvent equivalent to that present in the solution of GRAS compound at
the highest concentration tested.
Effect of GRAS compounds on the response of the bacterial sensing systems in the
absence of QSMs. A 10 µL volume of the GRAS compound solutions at various
concentrations and of the respective controls was added in triplicate to 90 µL of cell
culture of each of the sensing systems, prepared as described above, in a microtiter
plate. The assays were performed as described above for standard QSM solutions. A
matched standard dose-response curve was included in each analytical run.
Effect of GRAS compounds on the response of the bacterial sensing systems in the
presence of QSMs. A fixed concentration of QSM was added to each of the GRAS
compound solutions at various concentrations and to the respective controls.
Specifically, 2 × 10-6 g/mL C-6 HSL, 2.8 × 10-7 g/mL C-12 HSL, or 1.9 × 10-6 g/mL AI-2 was
added to each sample. A 10 µL volume of the obtained GRAS compound solutions at
various concentrations and of the respective controls, containing a fixed concentration
of QSM, was added in triplicate to 90 µL of cell culture of the corresponding sensing
system, prepared as described above, in a microtiter plate. The assays were performed
as described above for standard QSM solutions. A matched standard dose-response
curve was included in each analytical run.
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Effect of GRAS compounds on the production of QSMs by E. coli AB1157 and H. alvei
718. E. coli AB1157 produces AI-2 molecules, while H. alvei 718 produces AHL
molecules. The two bacterial strains were grown overnight, and the overnight cultures
were then diluted 1:100 with fresh LB media (E. coli AB1157) and 1:15 with fresh
nutrient media (H. alvei 718), respectively, as described above. Volumes of 100 µL of
GRAS compound solutions at various concentrations and of the respective controls were
added in triplicate to 1-mL aliquots of diluted cell cultures in 14 mL culture tubes; cells
were then allowed to grow in proper conditions, as described above, for a period of six
hours (time needed for maximum production of QSMs by bacteria). At the end of this
time period, the cultures were centrifuged at 12,000 rpm for 5 minutes at room
temperature. The supernatants were stored at -20 °C until analyzed. The QSMs
produced were measured in the supernatant samples following the protocol described
above for monitoring of QSM production by bacteria.
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Results and discussion
Bacterial QS plays a major role in the survival of bacteria and their success in
colonizing various environments. Since QS is utilized by a number of bacteria,
interference with QS could be employed as a general tool to mitigate bacterial growth
and pathogenicity. To that end, a variety of natural and synthetic compounds have been
investigated and shown to be able to disrupt the bacterial chatter 52. The compounds
that we selected in our study were initially evaluated for antimicrobial properties at the
College of Agriculture of the University of Kentucky. Specifically, phenolic compounds of
GRAS origin were tested against some of the most common Gram-positive and Gramnegative foodborne pathogens to determine their minimum inhibitory concentration
(MIC) values192. Compounds that exhibited antimicrobial properties were chosen to be
tested as QS interferants (Table 1). For that, we utilized whole-cell based biosensing
systems that can quantitatively detect QS signaling molecules, namely AHLs and AI-2. E.
coli based whole-cell biosensing systems either containing plasmid pSB406 or plasmid
pSB1075 detect short-chain AHLs and long-chain AHLs, respectively. These
bioluminescent cell-based sensors have been previously optimized, characterized, and
employed as analytical tools in our lab to detect AHLs in physiological samples 27 and to
assess QS-interfering characteristics of antibiotics193. V. harveyi MM32 is derived from
spontaneously bioluminescent marine bacterium V. harveyi, which controls light
emission by means of various QS systems; in strain MM32, bioluminescence is only
triggered by AI-2 since the other QS regulatory systems have been silenced 15. Recently,
we developed a whole-cell biosensing system based on V. harveyi MM32 for
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quantitative detection of AI-2 (this dissertation, Chapter 5). All three biosensing systems
contain genetic modifications so that the sensing cells cannot produce their own QSMs
and, therefore, emit bioluminescence only in response to the QSMs present in the
environment. Examples of QSMs detected by these biosensing systems are shown in
Figure 1(b).
Initial solubility tests were performed to select a suitable solvent for each of the
GRAS compounds, while making sure that it did not have harmful effects on the
bacterial sensing cells. A range of solutions of GRAS compounds were prepared after
dissolving each compound in appropriate solvent by serially diluting the stock solution
with RO filtered water. In order to test the effect of GRAS compounds on the response
of the whole-cell biosensing systems, these solutions were then incubated with the
biosensing cells in the absence as well as in the presence of a fixed concentration of the
respective QSM.
GRAS compounds, curcumin, capsaicin, eugenol, quercetin, p-coumaric acid,
thymol, and o-dianisidine did not alter the bioluminescence emitted by all of the sensing
cells, both, in the absence and presence of the QSM. Namely, the compounds alone did
not trigger a response in the sensing systems and, when incubated along a fixed
concentration of QSM, they did not affect the sensing systems’ responses to the
respective QSMs. As an example, Figure 3 shows the response of the whole-cell sensing
system that harbors pSB406 to various concentrations of p-coumaric acid (from 1 × 10-4
g/mL to 1 × 10-9 g/mL), in the absence and presence of 2.0 × 10-7 g/mL C-6 HSL.
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Decreased signal intensities with 1 × 10-4 g/mL p-coumaric acid were likely due to the
cell toxicity of the compound. In addition, when the above mentioned GRAS compounds
were incubated with AHL producing H. alvei 718 cells and AI-2 producing E. coli AB1157
cells, no change in the QSM production profile of these bacteria was observed. Hence,
we concluded that these compounds did not interfere with QS, at least through the
investigated mechanisms, that is, interaction with QS recognition/regulatory proteins
and effect on QSM synthesis.
Thymoquinone is known to inhibit the formation of bacterial biofilms 194;
however, its mechanism of action is not known. A potential mechanism may involve
interference with bacterial QS. Therefore, we employed whole-cell biosensing systems
to investigate if thymoquinone interferes with QS. In our study, we found that
thymoquinone affected the bioluminescence response of the biosensing system
harboring plasmid pSB1075, both, in the absence and presence of C-12 HSL (Figure 4).
The increase in bioluminescence observed with 1 × 10-5 g/mL of thymoquinone alone
(Figure 4a) indicates that the compound induces a response in the sensor and may be
recognized by the LasR QS recognition/regulatory protein present in the sensing cells,
thus suggesting potential for interference with QS. The observed decrease in
bioluminescence, when both 1 × 10-5 g/mL thymoquinone and C-12 HSL are present
(Figure 4b), suggests that thymoquinone may interfere with the binding between C-12
HSL and the receptor protein LasR. Based on the overall results, one could speculate
that thymoquinone may bind to LasR, although causing a less effective response as
compared to C-12 HSL. The hydrophobic binding pocket of LasR, being more
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hydrophobic than that of RhlR, may interact with thymoquinone. This might help explain
the effect on the pSB1075 based whole-cell biosensing system. Further experiments and
molecular modeling studies are underway to investigate and elucidate the observed
effects. Thymoquinone did not alter the bioluminescence emitted by the E. coli pSB406based and V. harveyi MM32-based whole-cell biosensing systems, both, in the absence
and presence of the respective QSMs. Additionally, when thymoquinone was incubated
with AHL and AI-2 producing bacteria, no effect was observed on the QSM production.
Ascorbic acid has been previously reported to reduce bioluminescence of the AI2 reporter strain V. harveyi BB170195. Therefore, we studied ascorbic acid with the V.
harveyi MM32-based whole-cell biosensing system. In our study, ascorbic acid solutions
were incubated with V. harveyi MM32 sensing cells in the presence and absence of AI-2.
We observed that, in both conditions, ascorbic acid at concentrations from 1 × 10 -3 g/mL
to 1 × 10-8 g/mL did not influence the bioluminescence response of the biosensing cells.
Similarly, ascorbic acid did not induce a response in the developed FRET biosensing
system for AI-2 detection (this dissertation, Chapter 6). Therefore, we may conclude
that ascorbic acid does not bind to the LuxP protein. On the other hand, in both
experiments, with and without AI-2, a sharp decrease in bioluminescence signal was
observed with 1 × 10-2 g/mL of ascorbic acid, which may be attributed to general toxicity
of ascorbic acid to the sensing cells (data not shown). Next, ascorbic acid solutions (1 ×
10-2 g/mL to 1 × 10-8 g/mL) were incubated with AI-2 producing E. coli AB1157 cells, and
cell culture supernatants were analyzed with V. harveyi MM32 sensing cells to measure
the levels of AI-2 produced. Increased levels of bioluminescence, corresponding to
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increased AI-2 concentrations, were detected in supernatant samples derived from E.
coli AB1157 cultures incubated with ascorbic acid at concentrations from 1 × 10-5 g/mL
to 1 × 10-3 g/mL (Figure 5). These data suggest that ascorbic acid seems to enhance the
production of AI-2 by E. coli AB1157 cells, although there are currently no clear
indications that the ascorbic acid metabolic pathway is linked to the AI-2 synthetic
pathway. Further studies are required to clarify if ascorbic acid acts through a specific
effect on the QS regulatory system or a general effect on the cell metabolism. Ascorbic
acid at the concentrations tested did not affect the response of the whole-cell
biosensing systems containing plasmids pSB406 or pSB1075, both, in the absence and
presence of the respective AHLs. In addition, ascorbic acid did not influence the AHL
production by H. alvei 718.
When t-cinnamic acid at concentrations of 1 × 10-3 g/mL to 1 × 10-9 g/mL was
incubated with the whole-cell biosensing systems containing pSB406 or pSB1075, in the
absence of AHLs, a significant increase in bioluminescence was observed at 1 × 10 -4
g/mL and 1 × 10-5 g/mL of t-cinnamic acid (Figure 6). The effect was dose-dependent, at
least for the sensor bearing pSB1075. These data indicate that t-cinnamic acid may be
able to bind to the AHL receptors. No data are available at this time to confirm whether
t-cinnamic acid binds to the AHL-binding site or to other binding pockets on the AHL
receptors. If the binding was to occur in the AHL-binding site, the fact that the receptors
have higher affinity for their cognate AHLs would explain why a much higher
concentration of t-cinnamic acid (1 × 10-5 g/mL) is needed to obtain a detectable
response, as compared to the cognate AHLs that induce a response at nanomolar levels.
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t-Cinnamic acid at the concentrations tested did not affect the response of the wholecell biosensing systems containing plasmids pSB406 or pSB1075 in the presence of the
respective AHLs, as well as the response of V. harveyi MM32 sensing system, both, in
the presence and absence of AI-2. In addition, t-cinnamic acid did not influence either
the AHL production by H. alvei 718 or AI-2 production by E. coli AB1157.
Recently, the anti QS activity of tannic acid was reported by Taganna et al.196,
who demonstrated that tannin-rich methanolic leaf extract of Terminalia catappa
(tropical almond) inhibited AHL-dependent QS regulated violacein production in
Chromobacterium violaceum. The same extract also inhibited AHL-dependent biofilm
maturation in P. aeruginosa. Further, tannic acid and its derivatives are known to inhibit
biofilm formation in E. coli139 and Proteus mirabilis190. Our studies have confirmed that
tannic acid interferes with AHL based quorum sensing; however, we observed that the
sensors bioluminescence response increased as the concentration of tannic acid
increased. This trend was observed when tannic acid solutions were incubated with
whole-cell biosensing systems containing plasmid pSB406 or pSB1075 (Figure 7), both, in
the presence and absence of C-6 HSL or C-12 HSL, respectively. In addition, tannic acid
also interfered with the AI-2 based QS system as evident by increased bioluminescence
signals obtained when tannic acid was incubated with V. harveyi MM32-based wholecell biosensing system, both, in the presence and absence of AI-2 (data not shown).
Tannic acid does not have any structure similarities with either AHLs or AI-2. However, it
has been shown that certain compounds can interfere with QS by binding to the QSM
recognition proteins in a non-agonistic manner52,140. Therefore, we speculate that tannic
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acid may interact with the AHL or AI-2 recognition proteins by binding to a site other
than the ligand binding pocket. No effect was observed on the AHL production by H.
alvei 718 or AI-2 production by E. coli AB1157. Since tannic acid interferes with QS
systems of both Gram-negative and Gram-positive bacteria, it may potentially be used
as a universal molecule to fight bacterial infections.
Although coumarin is not a GRAS compound, we analyzed it due to its known
antimicrobial properties. In a study by Ojana et al., coumarin exhibited antimicrobial
activity against E. coli, P. aeruginosa, and S. aureus197. In addition, coumarin, alone and
in combination with antibiotics, significantly reduced incidence of local peritoneal
infections in animal models198. In our study, coumarin did not show any effect on the
biosensing system with plasmid pSB406, both, in the presence and absence of C-6 HSL,
as well as on the biosensing system with plasmid pSB1075, both, in the presence and
absence of C-12 HSL. However, when coumarin solutions were incubated with V. harveyi
MM32-based whole-cell biosensing system, both, in the presence and absence of AI-2,
bioluminescence signals higher than those of the controls (no coumarin) were obtained
between 1 × 10-4 g/mL and 1 × 10-5 g/mL of coumarin (Figure 8). Additionally, when
coumarin was incubated with E. coli AB1157, higher levels of bioluminescence,
corresponding to higher AI-2 concentrations, were measured in supernatant samples
from cultures of E. coli AB1157 exposed to 1 × 10-8 g/mL to 1 × 10-6 g/mL of coumarin.
No effect on AHL production by H. alvei 718 was observed. The data obtained supports
that coumarin is capable of interfering with AI-2 dependent bacterial QS, both, by
interacting with the QS regulatory system and affecting the synthesis of AI-2.
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Conclusion
We evaluated twelve compounds for their effect on bacterial QS. Although some
of them did not exert an effect that we could measure using our whole-cell biosensing
systems, other compounds, such as, thymoquinone, t-cinnamic acid, ascorbic acid,
tannic acid, and coumarin affected the bioluminescence response of the bacterial
biosensing systems. In these biosensing systems, bioluminescence depends on
activation of QS regulated circuits; therefore, a molecule that causes a change in
bioluminescence in the sensors may have an effect on the QS systems of naturally
occurring bacteria. While some of the compounds that influenced bioluminescence are
structurally related to QSMs, for instance, ascorbic acid and AI-2 are both furanones,
others are not. Therefore, there must be various ways by which these compounds
interfere with QS. Further investigation is essential to elaborate on the mechanisms of
action of the tested compounds. Moreover, animal studies using these GRAS
compounds should provide further insight into the feasibility of employing them as
alternatives to antibiotic treatment and as food preservatives.
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Figure 1. (a) General schematic of quorum sensing in bacteria. For intra-species
communication, Gram-negative bacteria utilize AHLs and Gram-positive bacteria utilize
AIPs. For inter-species communication, AI-2 molecules are utilized by both Gramnegative and Gram-positive bacteria. (b) Chemical structures of AI-2, C-6 HSL, and C-12
HSL.
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(b)
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Figure 2. Interference with QS. Possible interference mechanisms include (1)
interference with the binding between QSM and its cognate recognition protein, (2)
interference with activation of gene expression, including genes encoding QSM
synthases, and (3) degradation of QSM.
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Figure 3. (a) p-Coumaric acid solutions were incubated with the whole-cell biosensing
system containing plasmid pSB406 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL p-coumaric
acid) contains 1% acetonitrile (v/v). (b) p-Coumaric acid solutions containing 2.0 × 10-6
g/mL C-6 HSL were incubated with the whole-cell biosensing system containing plasmid
pSB406 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL p-coumaric acid) contains 1%
acetonitrile (v/v), along with 2.0 × 10-6 g/mL C-6 HSL. Upon addition to the biosensing
cells, the final concentration of C-6 HSL is 2.0 × 10-7 g/mL.
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Figure 4. (a) Thymoquinone solutions were incubated with the whole-cell biosensing
system containing plasmid pSB1075 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL
thymoquinone) contains 1% acetonitrile (v/v). (b) Thymoquinone solutions containing
2.8 × 10-7 g/mL C-12 HSL were incubated with the whole-cell biosensing system
containing plasmid pSB1075 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL thymoquinone)
contains 1% acetonitrile (v/v), along with 2.8 × 10-7 g/mL C-12 HSL. Upon addition to the
biosensing cells, the final concentration of C-12 HSL is 2.8 × 10-8 g/mL.
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Figure 5. Ascorbic acid solutions, from 1 × 10-2 g/mL to 1 × 10-8 g/mL, were added to
cultures of AI-2 producing E. coli AB1157 cells. After 6 hours (time required for
maximum AI-2 production) the cell cultures were centrifuged, and the supernatants
were analyzed for AI-2 content using the V. harveyi MM32 based whole-cell biosensing
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system. Blank (0 mg/mL ascorbic acid) contained RO filtered water.

Figure 6. (a) t-Cinnamic acid solutions were incubated with the whole-cell biosensing
system containing plasmid pSB406 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL t-cinnamic
acid) contains 1% acetonitrile (v/v). (b) t-Cinnamic acid solutions were incubated with
the whole-cell biosensing system containing plasmid pSB1075 for 2 h at 37 °C, 175 rpm.
Blank (0 mg/mL t-cinnamic acid) contains 1% acetonitrile (v/v).
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Figure 7. (a) Tannic acid solutions were incubated with the whole-cell biosensing system
containing plasmid pSB1075 for 2 h at 37 °C, 175 rpm. Blank (0 mg/mL tannic acid)
contains RO filtered water. (b) Tannic acid solutions containing 2.8 × 10-7 g/mL C-12 HSL
were incubated with the whole-cell biosensing system containing plasmid pSB1075 for 2
h at 37 °C, 175 rpm. Blank (0 mg/mL tannic acid) contains RO filtered water, along with
2.8 × 10-7 g/mL C-12 HSL. Upon addition to the biosensing cells, the final concentration
of C-12 HSL is 2.8 × 10-8 g/mL.
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Figure 8. (a) Coumarin solutions, from 1 × 10-6 g/mL to 1 × 10-2 g/mL, were incubated
with the V. harveyi MM32 based whole-cell biosensing system for 3 h at 30 °C, 175 rpm.
Blank (0 mg/mL t-cinnamic acid) contains 1 % acetonitrile (v/v). (b) Coumarin solutions,
from 1 × 10-6 g/mL to 1 × 10-2 g/mL, containing 2.0 × 10-6 g/mL AI-2 were incubated with
the V. harveyi MM32 based whole-cell biosensing system for 3 h at 30 °C, 175 rpm.
Blank (0 mg/mL t-cinnamic acid) contains 1 % acetonitrile (v/v), along with 2.0 × 10-6
g/mL AI-2. Upon addition to the biosensing cells, the final concentration of AI-2 is 2.0 ×
10-7 g/mL.
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Table 1. GRAS compounds and their properties.
GRAS
compounds

Structure

Solubility

Curcumin

Acetonitrile

Capsaicin

Acetonitrile

Thymol

Water

Thymoquinon
e

Acetonitrile

Coumarin

Acetonitrile

Ascorbic acid

Water

p-Coumaric
acid

Acetonitrile
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Table 1 (continued)
t-Cinnamic
acid

Acetonitrile

Eugenol

Water

Quercetin

0.1 N ammonium
hydroxide

o-Dianisidine

DMSO

Tannic acid

Water
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CHAPTER SIX
BREAKING INTO THE BACTERIAL QUORUM SENSING CIRCUITS: DETECTION OF THE
AUTOINDUCER-2 VIA A FLUORESCENCE BIOSENSING SYSTEM

Introduction

Bacteria, both Gram-positive and Gram-negative modulate the expression of
certain genes in a cell-density dependent manner via the production, release, and
sensing of small signaling molecules known as quorum sensing molecules (QSMs). This
phenomenon, termed quorum sensing (QS), is known to regulate a diverse array of
functions including the production of virulence factors 9,199,200 and antibiotics142,201,
biofilm formation202, and motility203. Specifically, specialized genes involved in the above
functions are expressed when a QSM threshold concentration representative of a
certain population size is reached. The most common types of QSMs are N-acyl
homoserine lactones (AHLs), autoinducing peptides (AIPs), and autoinducer-2 (AI-2).
Gram-negative and Gram-positive bacteria employ AHLs and AIPs, respectively, for
communicating with members of the same species. AI-2 molecules are used by both
types of bacteria and also involved in communication between species 204. Bacteria are
not limited to the use of just one type of QSM or QS circuit, and many bacteria utilize
multiple QS circuits to regulate their various functions205-207. In that regard, Vibrio
harveyi, a marine bacterium, employs multiple QS systems to regulate multiple
functions, such as siderophores208 and metalloproteases production209, type III
secretion210, biofilm formation211, and bioluminescence205. These QS circuits are based
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on the use of different QSMs (Figure 1A), namely, N-(3-hydroxybutanoyl) homoserine
lactone (HAI-1), (Z)-3-aminoundec-2-en-4-one (CAI-1), (2S, 4S)-2-methyl-2,3,3,4tetrahydroxytetrahydrofuran-borate (BAI-2), and nitric oxide (NO), which was recently
shown to participate in QS regulation of bioluminescence through a newly discovered
QS pathway212. HAI-1 is found only in V. harveyi and its close relative Vibrio
parahaemolyticus, CAI-1 is mostly present in the Vibrio species, while the class of AI-2
molecules is found in a wide variety of bacterial species and genera 211. This suggests
that HAI-1 is involved in intra-species communication, CAI-1 in intra-genera
communication, and AI-2 in inter-bacterial communication amongst different species
and genera.
The class of AI-2 molecules, including borated autoinducer-2 (BAI-2), is
composed by a family of compounds that originate from the precursor 4,5-dihydroxy2,3-pentanedione (DPD). In V. harveyi, DPD is formed as a by-product of an enzymatic
reaction part of a bacterial metabolic pathway. Specifically, the essential coenzyme Sadenosyl methionine (SAM) is converted into S-adenosyl homocysteine (SAH) upon
transfer of methyl groups to DNA, RNA, and proteins48. SAH is toxic to cells as it inhibits
SAM-dependent methyltransferases213 and is metabolized to S-ribosyl homocysteine
(SRH) by 5′-methylthioadenosine-SAH nucleosidase as a first step to dampen its toxic
effects. SRH is subsequently converted into homocysteine by the enzyme LuxS, with
DPD being formed as a by-product of this enzymatic reaction. DPP is then employed by
the bacterial quorum sensing circuit to produce AI-2. The biosynthesis of AI-2 from DPD
is illustrated in Figure 1B. Under aqueous conditions, DPD undergoes spontaneous
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cyclization to generate various interconverting hydrated forms, (2R,4S)- and (2S,4S)-2,4dihydroxy-2-methyldihydrofuran-3-one (R- and S-DHMF, respectively), as well as
(2R,4S)- and (2S,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (R- and S-THMF,
respectively). In the presence of borate, S-THMF is converted into (2S,4S)-2-methyl2,3,3,4-tetrahydroxytetrahydrofuran-borate (S-THMF-borate), i.e., BAI-2104. Two of
these AI-2 molecules, BAI-2 and R-THMF, are known to be utilized as QSMs by Vibrio
harveyi and Salmonella typhimurium, respectively, while other forms of AI-2 are used by
other bacterial species15.
AI-2 serves a vital role in QS-regulated pathways in a number of human and
foodborne pathogens, including S. typhimurium and various pathogenic E. coli
strains15,214. Thus, detection of AI-2 in physiological samples may be critical in the early
detection of bacterial infections and monitoring of the efficacy of antibacterial therapy.
To that end, we have developed a rapid, highly sensitive, and selective protein-based
biosensing system aimed at the detection of AI-2 molecules in physiological samples.
In V. harveyi, the periplasmic binding protein LuxP is responsible for recognition
and binding of the BAI-2 molecule. Similar to other periplasmic binding proteins94,215,
LuxP undergoes a change in conformation when it binds BAI-2, a property that has been
employed by researchers to create protein biosensing systems for AI-2 detection. For
example, Rajamani et al. developed a Förster Resonance Energy Transfer (FRET)-based
system128 in which the gene sequence of the LuxP protein was inserted between that of
two different variants of the Green Fluorescent Protein, Cyan Fluorescent Protein (CFP)
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and Yellow Fluorescent Protein (YFP) to create a hybrid CFP-LuxP-YFP fusion protein.
Upon excitation at 440 nm, CFP emits at 485 nm, while YFP excitation and emission
wavelengths are 485 nm and 527 nm, respectively. Thus, excitation of the CFP-LuxP-YFP
fusion protein at 440 nm causes emission of CFP at 485 nm, which, in turn leads to
fluorescence resonance energy transfer (FRET) from CFP to YFP, resulting in YFP
fluorescence emission at 527 nm. When BAI-2 is present in the environment, it binds to
the LuxP part of the fusion protein, changes its conformation, and alters the
fluorescence emission at 527 resulting from the FRET between CFP and YFP.
Specifically, addition of BAI-2 caused a dose-dependent decrease in FRET of the sensing
CFP-LuxP-YFP fusion protein that was used to detect the levels of the QSM. This
biosensing system responded selectively to BAI-2 with an apparent Kd of 270 nM. In
another approach, Zhu et al. modified the LuxP protein with environmentally sensitive
fluorophores216, such as, 6-acryloyl-2-dimethylaminonaphthalene (acrylodan), 6bromoacetyl-2-(dimethylamino) naphthalene (badan), N,N’-didansyl-L-cystine (DDC),
and Dapoxyl (2-bromoacetamidoethyl)sulfonamide (Dapoxyl). The fluorophores were
chemically conjugated to Cysteines near the ligand binding site so that upon analyte
binding, change in the microenvironment surrounding the fluorophore would lead to a
change in the fluorescence emission. These systems were able to detect BAI-2 at
micromolar levels.
The biosensing systems developed by Rajamani et al. and Zhu et al. exhibited a
selective response to BAI-2, but the detection limits were not sufficient for their use in
clinical samples, such as saliva and stool. Data obtained by us (this dissertation, chapter
177

3) and others119,217, suggests that AI-2 is present in a sub-micromolar to low nanomolar
range. Physicochemical methods, such as GC-MS124 and LC-MS-MS119, have also been
employed to detect DPD with limits of detection of 5.6 nM and 0.23 nM, respectively.
However, DPD must be derivatized with the proper chemical moiety before analysis can
be performed, negating the usefulness of these methods for direct quantitative
detection without prior pre-treatment of any physiological sample.
In order to address the current need for systems that can detect QSMs in
physiological samples in a quantitative manner, we designed and developed a
fluorescecce-based sensing system that takes advantage of the exquisite molecular
recognition properties of the LuxP protein to its ligand, AI-2, coupled with the sensitive
detection afforded by fluorescence resonance energy transfer methods. The design of
our system is based on a combination of genetic fusion methods with site-selective
incorporation of a fluorophore into selected the amino acids of LuxP. Specifically, we
prepared a fusion protein between LuxP and enhanced green fluorescent protein
(EGFP). This LuxP-EGFP fusion protein was capable of emitting fluorescent light upon
excitation at 485 nm, and the fluorescence produced was not significantly altered by the
presence of AI-2.

This characteristic of the system inspired us to design a FRET

biosensing system for AI-2 detection that involved labeling the LuxP part of the LUxPEGFP fusion protein with a fluorophore. In particular we utilized the fluorophore 7diethylamino-3-[N-(2-maleimidoethyl)carbamoyl]coumarin (MDCC) and the fusion of
the LuxP protein with EGFP as the donor-acceptor pair for FRET. MDCC, when excited at
425 nm, transferred energy to EGFP in the LuxP-EGFP fusion protein, causing EGFP
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excitation and consequent emission with a peak at 507 nm. Addition of BAI-2 caused a
dose-dependent decrease in FRET, which translated in a lower fluorescence emission
signal at 507 nm. The biosensing system developed was selective to AI-2 molecules, had
detection limits in the sub-micromolar range, and its utility was validated by
determining the concentration of AI-2 molecules in human saliva and blood serum.

Materials and Methods

Materials
Plasmid pGEX-4T-1-LuxP was kindly provided by Dr. Bonnie Bassler (Princeton
University). Plasmid pEGFP and ExTaq DNA polymerase were purchased from Clontech
(Mountain View, CA). Plasmid pET28a(+) was purchased from EMD Millipore (Billerica,
MA). Chemically competent Escherichia coli cells BL21 (DE3) were purchased from
American Type Culture Collection (Manassas, VA). Pfu DNA polymerase was purchased
from Promega (Madison, WI). The TOPO TA cloning kit, MDCC, and Microcon YM-10
centrifugal device were purchased from Invitrogen (Carlsbad, CA). Restriction
endonuclease enzymes, NheI and BamHI, Calf Intestinal Alkaline Phosphatase, and T4
DNA ligase were purchased from New England Biolabs (Ipswich, MA). The QIAprep
Miniprep DNA extraction kit and Nickel-NitriloTriAcetic acid (Ni-NTA) agarose were
purchased from Qiagen (Valencia, CA). Primers were purchased from Operon
(Huntsville, AL). AI-2 was purchased from Omm Scientific (Dallas, TX). Isopropyl-β-Dthiogalactoside (IPTG) was purchased from Gold Biotechnology (Houston, TX). The
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Bradford protein assay kit was purchased from Bio-Rad Laboratories (Hercules, CA).
Polystyrene petri dishes and culture tubes were purchased from BD Biosciences (Sparks,
MD). Boric acid was purchased from Fisher Scientific (Pittsburgh, PA). Sodium Dodecyl
Sulfate (SDS) was purchased from Curtin Mathesin Scientific (Houston, TX). Luria Bertani
(LB) media and 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulphonic acid (HEPES) were
purchased from VWR International (Bridgeport, NJ). Ampicillin, kanamycin, and sodium
chloride were purchased from Sigma (St. Louis, MO). All solutions were prepared using
deionized reverse osmosis filtered water (Milli-Q Water Purification System, Millipore,
Bedford, MA).
Apparatus
Cell cultures were grown using an orbital shaker incubator purchased from
Forma Scientific (Marietta, OH). Cells were harvested using a Beckman J2-MI centrifuge
(Palo Alto, CA). DNA amplification and overlap Polymerase Chain Reaction (PCR)
reactions were performed using an Eppendorf Mastercycler personal thermal cycler
(Hauppauge, NY). Bacterial colonies were grown on agar plates using an Isotemp
incubator from Fisher Scientific (Pittsburgh, PA). Fluorescence studies were performed
using a PTI Laserstrobe™ Fluorescence Lifetime Spectrofluorometer (Birmingham, NJ).
The optical density of bacterial cultures was measured using a Spectronic 21D
spectrophotometer (Artisan Scientific, Champaign, IL).
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Isolation and cloning of DNA
The plasmids pGEX-4T-1-LuxP and pEGFP, respectively, were transformed and
maintained in E. coli BL21 (DE3) cells. Cultures of pGEX-4T-1-LuxP and pEGFP containing
cells were grown overnight in LB media supplemented with 100 µg/mL of ampicillin
using an orbital shaker incubator set at 37 °C and 250 rpm. The DNA from each culture
was harvested using the Qiagen DNA extraction kit. LuxP DNA was amplified from pGEX4T-1-LuxP by PCR using primers 5’-GCTAGCACACAAGTTTTGAATGGGTACTGG-3’ and 5’TATTCAGATAATTCAGGTGGAGGTGGATCA-3’. EGFP DNA was amplified from pEGFP by
PCR

using

primers

5’-TCAGGTGGAGGTGGATCAGTGAGCAAGGGC-3’

and

5’-

CTCGGCATGGACGAGCTGTACAAGGGATCC-3’. By using these primers, a site for the
nuclease NheI was introduced at the beginning of the LuxP DNA sequence and a site for
the nuclease BamHI was introduced at the end of the EGFP DNA sequence. An overlap
PCR

reaction

was

then

carried

TATTCAGATAATTCAGGTGGAGGTGGATCA-3’

out

using

the
and

primers

5’5’-

TCAGGTGGAGGTGGATCAGTGAGCAAGGGC-3’. A high fidelity Pfu polymerase was used
for the above PCR reactions. The overlap PCR product was further incubated with ExTaq
polymerase to introduce A (adenine) overhangs at the 3’ terminus of the amplified DNA.
The obtained DNA product was then cloned into the TA vector using a TA cloning kit.
The plasmid ligation product was transformed and maintained in the TOP10F’ cells
supplied with the TA cloning kit. The primers used enabled creation of a fusion between
the DNAs of LuxP and EGFP connected by a linker corresponding to the peptide Ser-HysHys-Hys-Hys-Ser. Using the restriction enzymes, NheI and BamHI, the LuxP-EGFP DNA
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was cloned into vector pET28a(+) to obtain plasmid pET28a(+)-LuxP-EGFP, which was
transformed and maintained in E. coli BL21 (DE3) cells.
Purification of LuxP-EGFP fusion protein
A culture of E. coli BL21 (DE3) cells containing plasmid pET28a(+)-LuxP-EGFP was
grown overnight in LB media supplemented with 30 µg/mL kanamycin using an orbital
shaker incubator set at 37 °C and 250 rpm. A 4 mL volume of overnight grown culture
was added to 500 mL of fresh LB media (30 µg/mL kanamycin) and allowed to grow at
37 °C, 250 rpm until an optical density (600 nm) of 0.40 to 0.50 was reached. The culture
was moved to an orbital shaker incubator that was set at 16 °C, 250 rpm, and protein
expression was induced by adding IPTG at a final concentration of 10 mM. The following
day, the fusion protein was harvested and purified using a Ni-NTA resin drip column.
The purified protein was analyzed using SDS-PAGE and dialyzed extensively (16 buffer
changes over 2 days) using a buffer containing 50 mM HEPES and 150 mM NaCL (pH
7.0). The concentration of the purified protein was determined using the Bradford
protein assay according to the manufacturer’s instructions.
DNA and protein sequence analysis
DNA was isolated from a culture of E. coli BL21 (DE3) cells containing plasmid
pET28a(+)-LuxP-EGFP using QIAprep miniprep kit and sent for sequencing at the
University of Kentucky Advanced Genetic Technologies Center. The fusion protein was
expressed, purified, and analyzed by SDS-PAGE, as reported above. The gel band of the
protein was digested with trypsin, and LC-ESI-MS-MS analysis was performed using a
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ThermoFinnigan LTQ linear ion trap instrument at the University of Kentucky Mass
Spectrometry Facility. The resulting MS-MS spectra were searched in the Swiss-Prot
protein sequence database using the Mascot search engine to confirm the presence of
both proteins, LuxP and EGFP.
Method optimization for FRET signal detection
The fluorophore MDCC was dissolved in anhydrous dimethyl sulfoxide (DMSO) to
obtain a 1 × 10-4 g/mL stock solution, which was serially diluted with 50 mM HEPES, 150
mM NaCl buffer (pH 7.0) to obtain 1 × 10-5 to 1 × 10-9 g/mL MDCC solutions. LuxP-EGFP
solutions, ranging from 1 × 10-6 M to 1 × 10-10 M, were prepared by serial dilution of the
purified fusion protein solution using 50 mM HEPES, 150 mM NaCl buffer (pH 7.0). The
excitation and emission peak wavelengths of MDCC were 425 nm and 475 nm,
respectively. The excitation and emission peak wavelengths of EGFP in the fusion
protein were 488 nm and 507 nm, respectively. The overlap between the emission
spectrum of MDCC and absorption spectrum of the fusion protein, which contained
EGFP, was determined by using a Varian Cary Eclipse Spectrophotometer. A 900 µL
volume of MDCC solution, at a fixed concentration, was incubated with 100 µL of fusion
protein solutions at various concentrations for 15 minutes. The obtained solutions were
excited at 425 nm and the emission spectra were recorded from 450 nm to 600 nm. The
optimal FRET, i.e., the maximum transfer of energy from MDCC to the fusion protein, as
demonstrated by the emission intensity at 507 nm, was observed when 2.5 × 10 -7 M

183

MDCC was used in combination with 5 × 10-9 M fusion protein. The resulting FRET
donor-acceptor solution was referred to as FRET complex.
Dose-response curve using BAI-2
The FRET complex contained 90% (v/v) MDCC at 2.5 × 10 -7 M concentration and
10% (v/v) fusion protein at 5 × 10-9 M concentration. A 1 × 10-3 M solution of boric acid
was prepared in 50 mM HEPES, 150 mM NaCl buffer (pH 7.0). The commercially
available AI-2 aqueous solution was serially diluted using the 1 × 10-3 M boric acid
solution to obtain standards of the borate isomeric form (BAI-2) ranging in
concentration from 1 × 10-4 M to 1 × 10-10 M. A 180 µL volume of the FRET complex was
incubated with 1.8 µL of BAI-2 solutions at various concentrations in triplicate for a
period of 3 minutes. The incubation was performed in a 300 µL quartz microcuvette. The
samples were then excited at 425 nm and the emission spectra were recorded from 450
nm to 600 nm. A 180 µL volume of the FRET complex with 1.8 µL volume of 1 × 10 -3 M
boric acid solution in 50 mM HEPES, 150 mM NaCl buffer (pH 7.0) served as blank.
Selectivity studies
The compounds tested included AI-2, ascorbic acid, and 4-hydroxy-2,5-dimethyl3(2H)-furanone (DMHF). AI-2 (3.7 × 10-3 M) and ascorbic acid (1 × 10-3 M) stock solutions
were prepared in water, while DMHF stock solution (1 × 10-3 M) was prepared in
ethanol. These stock solutions were serially diluted with 50 mM HEPES, 150 mM NaCl
buffer (pH 7.0) to obtain 1 × 10-4 M to 1 × 10-10 M solutions. A 1.8 µL aliquot of each
solution in triplicate was incubated with 180 µL of FRET complex and fluorescence
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measurements were performed as described above. A 1.8 µL volume of 50 mM HEPES,
150 mM NaCl buffer (pH 7.0) served as blank.
Dose-response curves in saliva and blood serum
Saliva samples were obtained from healthy volunteers. Each saliva sample was
centrifuged to remove debris and the supernatant was stored at -80 °C until needed. A
pool of saliva was obtained by mixing equal volumes of individual saliva sample
supernatants followed by 5 min of vortexing. BAI-2 standard solutions, ranging in
concentration from 1 × 10-3 M to 1 × 10-9 M, were prepared as described above. A 10 µL
aliquot of each BAI-2 solution was added to 90 µL of pooled saliva to obtain spiked saliva
samples ranging from 1 × 10-4 M to 1 × 10-10 M BAI-2 concentration. A 1.8 µL volume of
the spiked saliva samples was incubated in triplicate with the FRET complex as described
above. A 10 µL volume of 1 × 10-3 M boric acid solution in 50 mM HEPES, 150 mM NaCl
buffer (pH 7.0) was added to 90 µL of pooled saliva to serve as a blank.
Blood serum samples were obtained from healthy volunteers. A pool of serum
was prepared by mixing equal volumes of individual serum samples followed by
vigorous vortexing. A 10 µL aliquot of each BAI-2 solution, ranging in concentration from
1 × 10-3 M to 1 × 10-9 M, was added to 90 µL of pooled serum to obtain spiked serum
samples ranging from 1 × 10-4 M to 1 × 10-9 M BAI-2 concentration. A 1.8 µL volume of
the spiked serum samples was incubated in triplicate with the FRET complex as
described above. Because a serum matrix effect was observed, similar spiking studies
were repeated by diluting the pooled serum 1:10, 1:25, 1:50, 1:75, and 1:100 with 50
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mM HEPES, 150 mM NaCl buffer (pH 7.0). A 10 µL volume of 1 × 10-3 M boric acid
solution in 50 mM HEPES, 150 mM NaCl buffer (pH 7.0) was added to 90 µL of undiluted
and diluted pooled serum to serve as a blank.
Detection of AI-2 in saliva and blood serum samples
Saliva samples were obtained from healthy volunteers and processed as
described above. A 1.8 µL volume of each saliva sample was added in triplicate to the
FRET complex and fluorescence measurements were performed as described above.
Serum samples were obtained from patients with inflammatory bowel disease (IBD) and
diluted 1:100 using 50 mM HEPES, 150 mM NaCl buffer (pH 7.0). A 1.8 µL volume of
each 1:100 diluted serum sample was added in triplicate to the FRET complex and
fluorescence measurements were performed as described above. A total of 10 saliva
and 10 serum samples were analyzed. A dose-response curve was included in each
analytical run and data were plotted using GraphPad Prism 5. AI-2 concentrations in
samples were calculated after interpolating the FRET ratio values and multiplying by the
dilution factor.
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Results and discussion

In this work, we designed and developed a biosensing system to detect the
quorum sensing autoinducer-2, AI-2, class of molecules. The biosensing system was
based on the principles of fluorescence resonance energy transfer, FRET, by employing
a fluorophore attached to a recognition protein as the donor of a donor-acceptor pair
where the acceptor is a fluorescent protein part of a LuxP-EGFP fusion protein.
Specifically, MDCC is the donor and EGFP the acceptor. LuxP undergoes a
conformational change upon binding BAI-2128,218. The X-ray crystal structure analysis of
LuxP without BAI-2, i.e., apoLuxP and with bound BAI-2, i.e., holoLuxP revealed
differences in the protein conformation (Figure 2). Hence, we postulated that we could
detect BAI-2 with high sensitivity and selectivity by employing an appropriate reporter
system to monitor this conformational change.
EGFP and its variants are traditionally used as reporter elements in fusion
protein constructs

219,220

. Employing overlap PCR, the two genes, luxP and egfp, were

joined together at the 3’- terminus of luxP. The two genes were separated by 18 bases
that encoded for a six-amino acid peptide linker, to allow for enough flexibility so that
BAI-2 binding to LuxP was not hindered by EGFP. In addition, to ease the purification
process, nucleotides encoding for six-His residues to be employed as an affinity
chromatography tag to bind a Ni-NTA resin column were incorporated at the N-terminus
of the protein. The luxP-egfp construct was cloned into the pET28a(+) vector and placed
under the control of a lac operon, which enabled overexpression of the fusion protein.
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The use of the fluorophore MDCC, a coumarin derivative, as donor in the FRET
system was based on our observation that coumarin caused an increase in the
bioluminescence response of a V. harveyi MM32-based whole-cell biosensing system for
AI-2 detection (Thesis Chapter 5). In this sensing system, the binding of AI-2 to the
recognition element, LuxP, triggers a cascade of phosphorylation and dephosphorylation events that lead to the expression of the luxCDABE cassette and
production of bioluminescence. One possible reason for the observed effect of
coumarin is that it may act as an agonist and bind to the LuxP protein at the BAI-2
binding site or bind to another binding pocket on the protein. Therefore, we
hypothesized that MDCC, which is structurally related to coumarin, may also bind to the
LuxP protein. Additionally, since EGFP is connected to LuxP, it may be in close enough
proximity to MDCC so that FRET between MDCC and EGFP may occur. Furthermore,
MDCC was excited at 425 nm, and the emission spectrum was recorded. An absorption
spectrum for the fusion protein LuxP-EGFP was also obtained. We confirmed that the
emission of MDCC overlaps with the absorption of the fusion protein, thus deeming it
suitable as a donor for use in our proposed FRET system (Figure 3).
In order to optimize the experimental conditions, various molar ratios of MDCC
and fusion protein were tested; upon exciting at 425 nm, the emission intensities of
MDCC at 475 nm and LuxP-EGFP at 507 nm were measured. The LuxP-EGFP construct
alone exhibited background emission at 507 nm when excited at 425 nm; however, in
the presence of MDCC, the emission intensity of the construct increased. Figure 4 shows
the emission spectra from three different concentrations of the fusion protein, with and
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without a fixed concentration of MDCC. An increase in emission intensity of the fusion
protein was observed with increases in its concentration, both, in the presence and
absence of MDCC. Protein concentrations greater than 5 × 10-8 M did not show any
improvement in the FRET ratio, i.e., the ratio of the emission intensities of acceptor and
donor. Further, we found that a solution of MDCC and fusion protein, at final
concentrations of 2.5 × 10-7 M and 5 × 10-9 M, respectively, resulted in the highest FRET
ratio. This solution of LuxP-EGFP and MDCC, which was used in all subsequent
experiments, is referred to as “FRET complex”. Incubation times longer than 15 min did
not improve the FRET ratio from the fusion protein-MDCC solution. Therefore, all
experiments were performed by incubating the FRET complex for a period of 15 min.
The FRET complex was then incubated with solutions of BAI-2 at concentrations
ranging from 1 × 10-5 M to 1 × 10-12 M. The BAI-2 standard solutions were prepared
using 1 × 10-3 M boric acid in 50 mM HEPES, 150 mM NaCl buffer, pH 7.0. It has been
previously reported that in the biosynthesis of BAI-2, a 4 equivalent amount of borate,
with respect to the starting material S-ribosylhomocysteine, was sufficient to obtain a
borate isomer of AI-2104. Hence, we ensured that boric acid was in sufficient excess
while preparing our BAI-2 standards. The presence of boric acid did not affect the pH of
the solution221, thus not affecting the properties of the fluorophore and the
conformation of the LuxP-EGFP fusion. As shown in Figure 5, as the concentration of
BAI-2 increased, the acceptor emission peak at 507 nm decreased, while the donor
emission peak at 475 nm increased; this caused a dose-dependent decrease in the FRET
ratio. The biosensing system developed herein allowed us to detect BAI-2 at sub189

nanomolar levels with a limit of detection (LOD) of 1 × 10 -10 M, which is the lowest limit
of detection reported for a LuxP protein-based biosensing system128,216. The limit of
detection was defined as the analyte concentration that produced a signal lower than
the average of the blank minus three standard deviations of the blank. In addition, a
dynamic range of five orders of magnitude and linear response over three orders of
magnitude was observed (Figure 6).
To test our hypothesis, which postulates direct binding of MDCC to the LuxP
protein in the FRET process followed by an observed FRET signal and not to a direct
interaction of MDCC with EGFP, we performed experiments using MDCC and
commercially available EGFP.

While maintaining all the experimental conditions

described above, various concentrations of EGFP were incubated with 2.5 × 10 -7 M
MDCC. When the solutions were excited at 425 nm, no changes in the emission intensity
of EGFP were observed as compared to EGFP alone, thus showing that the EGFP
emission intensity was independent of the presence of MDCC. This clearly indicates that
there are no interactions taking place between MDCC and EGFP that could result in a
FRET signal. Further, when standard solutions of BAI-2 were added to the solution
containing MDCC and EGFP, no changes in the emission intensities of MDCC and EGFP
were observed (data not shown). These results point to the requirement for MDCC to
bind to LuxP in order to be in close proximity of EGFP for the energy transfer to occur.
One of the limitations of the previously reported LuxP protein-based sensors is
their inability to respond to non-borate forms of AI-2128,216. As noted in the introduction,
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the BAI-2 precursor, DPD, generates various hydrated non-containing boron isomeric
forms that exist in equilibrium. Rather recently, Globisch et al. reported the existence of
an additional isomer of DPD222, although currently, only two forms of AI-2 are known to
take part in QS, namely BAI-2 in V. harveyi and R-THMF in S. typhimurium. Nevertheless,
it is speculated that other isomeric forms might also be involved in the quorum sensing
regulatory pathways of certain bacteria222. To that end, we tested the ability of our
sensing system to respond to the hydrated forms of DPD. A dose-response curve for
DPD was obtained by incubating various concentrations of DPD with the sensing system.
The dose-response curve had a dynamic range of over three orders of magnitude with a
limit of detection of 1 × 10-9 M (Figure 6). The ability to detect both forms of AI-2 is
significant as the sensor can be utilized in applications where samples might contain
borate free as well as borated AI-2.
The selectivity of our protein biosensing system was evaluated by exposing it to
(5R)-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one (ascorbic acid) and 5methyl-4-hydroxy-3(2H)-furanone (MHF). The reason for choosing furanone derivatives
was because of literature reports claiming that furanones affect the AI-2 bacterial
quorum sensing circuitry, although the mechanisms of action have not been
elucidated195,223,224. Solutions of these compounds at concentrations ranging from 1 ×
10-5 M to 1 × 10-12 M, were incubated with the protein biosensing system and the
potential emission due to FRET was observed. Ascorbic acid did not elicit a change in the
concentration range tested. On the other hand, MHF induced a response in the protein
biosensing system at concentrations of 1 × 10-6 M and 1 × 10-5 M. Due to solubility
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constraints, higher concentrations of MHF could not be tested. Based on these
observations, we conclude that the biosensing system is able to respond to the AI-2
class of compounds and to structurally related furanones. However, it is important to
point out that the biosensing system responded to MHF at concentrations at least three
orders of magnitude higher than that of AI-2 molecules. The response of the sensing
system to various concentrations of BAI-2, DPD, MHF, and ascorbic acid is shown in
Figure 6.
Next we explored the feasibility of employing our sensing system for the
detection of AI-2 in saliva and blood serum. For that, we investigated potential matrix
effects by creating pools of saliva and serum samples, respectively, and spiking them
with various concentrations of BAI-2 to obtain dose-response curves in these matrices.
As shown in Figure 7, the slope of the dose-response curve obtained in saliva was nearly
identical to the slope of the dose-response curve obtained in buffer and both curves can
be superimposed. Serum, on the other hand, caused a shift of over 25 nm in the MDCC
emission peak. Therefore, serum dilution studies were performed that showed that
1:100 dilution was necessary in order to effectively eliminate the matrix effect
mentioned above. As it can be seen from Figure 7, the dose-response curve in 1:100
diluted serum overlapped with the dose-response curve obtained in buffer.
We then employed the biosensing system to detect AI-2 molecules in individual
saliva and serum samples. AI-2 was not detected in any of the 10 blood serum samples
tested. These results conform to those of our previous study where, using a V. harveyi
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MM32-based whole-cell biosensing system, we were not able to detect AI-2 in serum
samples (this dissertation, chapter three). While it is possible that serum does not
contain levels of AI-2 that are detectable by protein or whole-cell biosensing systems,
physical-chemical methods119 may be employed to confirm the presence or absence of
AI-2 in serum. On the other hand, three out of ten saliva samples showed distinct levels
of AI-2, varying between approximately 1 × 10-8 M and 1 × 10-10 M (Table 1). The
presence of AI-2 in saliva was also demonstrated in another study using a whole-cell
biosensing system (this dissertation, Chapter 2). Analysis of additional samples is
necessary to potentially establish the method developed herein as an analytical tool for
detection of AI-2 to be employed in the diagnosis and monitoring of bacterial-related
conditions.
Conclusion
We designed and developed a FRET protein-based sensing system for AI-2
detection, which employed the LuxP protein as the recognition element along with the
fluorophore MDCC and the photoprotein EGFP, genetically fused to LuxP, as the FRET
donor-acceptor pair. The biosensing system proved to be rapid, in that it required an
incubation time with the analyte of only 3 min to obtain a dose-dependent response;
this represents a significant improvement as compared to conventional physicochemical methods. Furthermore, the protein biosensing system described in this work
has a lower limit of detection for BAI-2 (1 × 10-10 M) than previously reported protein
biosensing systems employing LuxP combined with synthetic fluorophores216 (1 × 10-6
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M) or yellow and cyan fluorescent proteins as reporters128 (> 1 × 10-8 M BAI-2). One of
the main advantages of our biosensing system lies in its ability to respond to non-borate
forms of AI-2. This broadens the scope of the biosensing system for use in applications
where detection of non-borate forms of AI-2 is required; for instance, human
pathogens, such as S. typhimurium, are known to employ non-borate forms of AI-2 for
QS regulation. Detection of QSMs in clinical samples has attracted attention, especially
in bacteria related conditions such as cystic fibrosis25 and Crohn’s disease170. We
demonstrated that the developed biosensing system can be applied to the detection of
QS AI-2 molecules in saliva and blood serum. In conclusion, our FRET-based protein
biosensing system offers rapid, sensitive, selective, and quantitative detection of AI-2
molecules, and has potential to be used in clinical applications.
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Figure 1(A). Quorum sensing signaling molecules of V. harveyi. (a) HAI-1, (b) CAI-1, (c)
BAI-2, and (d) NO. (B) Biosynthesis of BAI-2.
(A)
(a)

(b)

(c)

(d)
N≡O

(B)
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Figure 2. The 3-D crystal structures of apo-LuxP, without bound AI-2, (left) and holoLuxP, with bound AI-2, (right). Protein data bank structures 1ZHH (apo-LuxP) and 2HJ9
(holo-LuxP).
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Figure 3. The emission spectrum of MDCC (blue) overlaps with the absorption spectrum
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Figure 4. Emission spectra of the LuxP-EGFP fusion protein. LuxP-EGFP at 1 × 10-10 M
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Figure 5. FRET response of construct to BAI-2. A decrease in FRET signal with increase in
concentration of BAI-2 was observed. The solutions were excited at 425 nm; the
emission peak wavelengths of MDCC and LuxP-EGFP are 475 nm and 507 nm,
respectively. The FRET complex contained 2.5 × 10 -7 M MDCC and 5 × 10-8 M LuxP-EGFP.
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Figure 6. Dose-dependent response of the protein biosensing system to BAI-2 (red), DPD
(blue), MHF (black), and ascorbic acid (green).
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Figure 7. Comparison of dose-response curves obtained in buffer (red), undiluted saliva
(blue), and 1: 100 diluted blood serum (black).
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Table 1. Analysis of clinical samples using FRET based biosensing system.
Sample

AI-2 concentration (M)

%RSD

Saliva 1
Saliva 2
Saliva 3

2.5 × 10-10
4.2 × 10-10
6.9 × 10-9

2
6
3
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CHAPTER SEVEN
CONCLUSION AND FUTURE STUDIES
Similar to higher organisms, bacteria have the ability to communicate with each
other. This phenomenon, termed quorum sensing (QS), enables bacteria to coordinate
their behavior in a cell-density dependent manner. Bacteria synthesize small molecules,
known as quorum sensing molecules (QSMs), which are transported out of the cell and
can enter other bacteria. By monitoring these molecules, bacteria can monitor the cellpopulation density since the QSM concentration in the surrounding environment is
proportional to the number of bacterial cells. At a certain population size, several genes
that are under the control of QS regulation are expressed. In many species of bacteria,
QS controls behaviors such as biofilm formation, antibiotic and virulence factor
production, swarming motility, and sporulation.
Inflammatory Bowel Disease (IBD), which includes Crohn’s disease (CD) and
ulcerative colitis (UC), is a chronic gastrointestinal inflammatory condition with
unknown etiology. The involvement of bacteria in IBD is supported by the identification
of serological markers against microbial antigens and improvement in patient health
after treatment by antibiotics. In addition, the bacterial flora has been shown to be
different in healthy individuals and patients with IBD, with less diversity and modified
relative abundance of species in IBD. Given that QSMs are bacterial products involved in
the regulation of functions involved in bacterial pathogenicity, we hypothesized that
monitoring of the levels of QSMs in physiological samples might provide information on
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the bacterial load and on the status of the disease, thus offering a non-invasive
diagnostic tool that can be used for management of IBD as well as other bacteria related
conditions.
The first step towards achieving this goal is to develop tools and methods that
can detect QSMs in physiological samples in a sensitive and selective manner.
Physiological samples such as saliva, stool, and bowel secretions might contain QSMs at
concentrations that represent their systemic level. To that end, we developed a method
to detect QS autoinducer-2 (AI-2) molecules in these physiological samples by
employing a Vibrio harveyi based biosensing system. Whole-cell biosensing systems
offer several advantages; for instance, they can withstand a variety of environmental
conditions (ionic strength of media, wide range of pH) and provide information about
the analyte bioavailability. Due to their sensitivity and selectivity, whole-cell biosensing
systems have been used in a variety of environmental and biomedical applications. The
V. harveyi based whole-cell biosensing system developed in this work encompasses a QS
regulatory system as recognition element and the bioluminescent luxCDABE gene
cassette as reporter element. The biosensing system produces bioluminescence in
response to the presence of AI-2 molecules. Most importantly, the bioluminescence
produced is proportional to the amount of AI-2 present in the environment of the
sensing cells. Therefore, by measuring bioluminescence we can quantitate the amount
of AI-2 present in a sample. By employing the developed method, we obtained limits of
detection of 25 nM and 50 nM in saliva and stool matrices, respectively. In addition,
analysis of physiological samples obtained from IBD patients revealed the presence of
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AI-2. Specifically, different levels of AI-2 were observed in stool samples from different
individuals; this observation supports the hypothesis that changes in the microflora of
the inflamed intestine may result in changes in the levels of AI-2. To our knowledge, this
is the first attempt to quantify AI-2 levels in saliva, stool, and bowel secretion samples
from IBD patients.
Furthermore, we investigated blood serum for the presence of QSMs. Saliva and
stool samples are advantageous to use since they are collected non-invasively; however,
blood samples only require minimally invasive collection and are commonly employed
to detect a variety of biomarkers pertaining to several diseases. Additionally, blood is
also routinely collected from IBD patients to determine various parameters, including
inflammation status and presence of specific antibodies, and to differentiate between
CD and UC. Since we were able to detect QSMs, both, N-acyl homoserine lactones
(AHLs) and AI-2 in saliva and stool samples, we hypothesized that these molecules may
also enter the blood stream. To that end, we developed analytical methods for the
detection of QSMs in blood serum by utilizing whole-cell biosensing systems for AHL and
AI-2 molecules, respectively. E. coli based whole-cell biosensing systems containing
plasmid pSB406 or pSB1075 were employed to detect short and long chain AHL
molecules, respectively, while a V. harveyi based biosensing system was used to detect
AI-2 molecules. The developed methods allowed us to achieve nanomolar limits of
detection in serum with all three sensors. Most importantly, the analysis of blood serum
samples from IBD patients and controls revealed differing levels of short-chain AHLs.
Serum samples of healthy individuals exhibited undetectable levels of short chain AHLs,
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while IBD samples showed the presence of short chain AHLs with slightly higher levels in
UC patients as compared to CD patients. Since no previous reports existed that could
support the presence of AHLs in serum, we deemed it necessary to employ a
conventional analytical method to validate our findings. To that end, we confirmed the
presence of AHLs in blood serum by analyzing pooled serum samples using high
performance liquid chromatography coupled with tandem mass spectrometry.
Furthermore, when we employed a mice model of colitis, which is representative of
human IBD, we detected a difference between the levels of AHLs in, both, serum and
stool samples of colitic mice and control mice. Although a limited number of mice were
used, this observation supports our hypothesis that microflora perturbations caused by
acute inflammation can lead to changes in the levels of QSMs. These findings can serve
as a basis for further studies aimed at proving the use of QSM detection as a diagnostic
and monitoring tool for IBD as well as other bacteria-related conditions.
In addition to whole-cell based biosensing systems for QSM detection, we also
developed a protein based biosensing system to detect AI-2 molecules. In wild type V.
harveyi, the borated form of AI-2 (BAI-2) binds to the periplasmic binding protein LuxP,
which undergoes a change in conformation upon binding. By using techniques of
molecular cloning, we fused egfp, coding for the enhanced green fluorescent protein
(EGFP), to the C-terminus of luxP. The LuxP in the LuxP-EGFP fusion protein is able to
bind to 7-diethylamino-3-((((2-maleimidyl)ethyl)amino)carbonyl)coumarin (MDCC), an
environmentally sensitive fluorophore. Based on the emission and absorption spectra of
MDCC and EGFP, we developed a protein biosensing system, LuxP-EGFP-MDCC,
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exploiting the principle of Förster Resonance Energy Transfer (FRET). In this construct,
energy is transferred from MDCC to EGFP. The presence of BAI-2, which is the cognate
molecule of LuxP, causes a decrease in the FRET ratio. Using this system, we achieved a
limit of detection of 0.1 nM, the lowest obtained using LuxP protein based sensing
systems and lower than that afforded by the developed whole-cell based biosensing
system. Additionally, the sensor is selective to the AI-2 class of molecules and is able to
respond to, both, BAI-2 and non-borated forms of AI-2, thus widening the sensor’s
utility for applications where AI-2 as well as BAI-2 molecules might be present.
Furthermore, the protein biosensing system was characterized and optimized for
detecting AI-2 molecules in physiological samples such as saliva and blood serum.
In addition to disease detection, monitoring of QSMs can also prove useful for
early detection of food contamination and, thus, prevention of foodborne illnesses.
Bacteria are known to thrive on a variety of food surfaces. Moreover, certain foodborne
pathogens are known to employ QS regulation and QSMs have been found in various
foods, including milk and meat products. Therefore, detecting QSMs in food samples
can provide a convenient method for early detection of food spoilage. To that end, we
developed methods to detect QSMs in food matrices by employing whole-cell
biosensing systems that can detect AHLs and AI-2 molecules. We selected ground beef
and milk as model foods. We showed that QSMs can be detected in these foods with
minimal sample processing, while maintaining the analytical parameters of the sensing
systems. In addition, we applied the sensing systems to detect QSMs produced in
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artificially spoiled food samples. This further corroborates that whole-cell biosensing
systems can be applied to detect food spoilage.
Finally, we tested a number of compounds originating from Generally
Recognized As Safe (GRAS) substances for their effect on QS. These compounds were
previously found to act as antibacterials, although their mechanisms of action have not
been elucidated. For that, we tested these compounds to evaluate whether they may
act through interference with bacterial quorum sensing. Such compounds were
incubated with whole-cell sensing systems alone and in the presence of QSMs. This
allowed us to assess their ability to induce a response in the sensing systems, as well as
to interfere with the bacterial sensing systems response to QSMs. Selected compounds
were also incubated with bacteria that produce QSMs to evaluate their effect on QSM
synthesis. Our study identified four such compounds, namely ascorbic acid, t-cinnamic
acid, tannic acid, and coumarin that affected bacterial QS.
As research at the molecular level in the fields of biology and microbiology
continues, novel features of bacteria are revealed. QS is one such feature of bacteria
that has been discovered and studied extensively only over the past two decades. Given
the close association between bacteria and humans, it is imperative that we enhance
our understanding of QS. We believe that the ability to detect QSMs represents a step
towards understanding the intricate workings of bacteria in the human body. While we
lay the foundation, additional work is necessary to illustrate that QSM detection can be
utilized as a diagnostic tool. This would involve analysis of large numbers of clinical
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samples, such as saliva, stool, bowel secretions, and blood serum, as well as tissue
specimens to ascertain that the levels of QSMs correlate with the status of the disease.
While in the present work we mainly focused on IBD, in principle, these
biosensing systems could also be used to detect QSMs in other bacteria-related
conditions. Furthermore, the developed cell and protein sensing systems could be
immobilized on optical fibers or incorporated into microfluidic platforms to generate
portable analytical devices. This would enable the sensing systems to be used in on-site
applications, such as, in the physician’s office and at the patient’s bedside in hospitals.
Further enhancements in the protein-based sensing system can be brought
about by employing a variety of approaches. For instance, the length of the linker
between the two proteins in the fusion can be changed. A linker length of six amino
acids was employed in the protein construct described in this work; varying the linker
length may further improve the sensor’s limit of detection for AI-2 molecules.
Additionally, the selectivity of the sensor could be tailored in order to enable the
recognition of individual forms of AI-2. In that regard, it is possible to alter the protein
construct by employing other variants of the GFP protein, which would facilitate
multiplex detection.
QS biosensing systems are ideal for the screening of synthetic as well as natural
compounds. The list of such compounds is extensive; while we tested a few compounds
originating from GRAS substances, many other compounds have shown antibacterial
properties and should be evaluated for their effect on QS. The compounds found to
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affect QS could then be studied in animal models to investigate their effects in vivo. This
could be achieved by feeding the animals with a known amount of the QS interfering
compound for a period of time and then comparing the QSMs levels found in various
specimens of the treated animals with those of control animals. Bacterial involvement in
conditions such as IBD is supported by improvement in patient health due to antibiotic
treatment. It would be interesting to study QS interfering compounds, alone and in
combination with antibiotics, to determine if they are effective in treating bacterial
conditions. This hypothesis could also be tested using animal models and evaluating a
number of circulating molecules and tissue parameters.
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